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Abstract 
Health insurance design influences whether a person will receive health services, 
including colorectal cancer (CRC) screening, although how insurance design 
influences utilization is not fully explained.  By disaggregating types of insurance 
into discrete organizational and financial features, specific influential factors may 
be identifiable.   
This study evaluated insurance features as predictors of CRC screening using 
data from the 2009, 2010, and 2011 Medical Expenditure Panel Survey.  Studied 
insurance features included three organizational features: whether a person’s 
insurance defined a provider network (DPN), used gatekeeping, and restricted 
coverage to a DPN; and two financial features: whether a person had a Flexible 
Spending Account (FSA) and categories of cost-sharing experience during the 
survey year.  The primary outcome studied was whether a person was up-to-date 
with United States (US) Preventive Services Task Force (USPSTF)-
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recommended CRC screening.  In sensitivity analyses, any previous-year CRC 
screening was evaluated as an alternative outcome to assess if insurance 
features more strongly affected short-term screening than longer-term USPSTF 
screening.  Multivariate logistic regression models were devised to separately 
evaluate each insurance feature.  In smaller samples of the Western US, 
secondary analyses evaluated if insurance features differentially affected CRC 
screening among Hispanic versus non-Hispanic whites. 
In the logistic models of the full US samples, organizational insurance features 
did not significantly predict the USPSTF outcome.  A significant, >3% point, 
increase in any previous-year CRC screening was predicted by having two 
features, gatekeeping and coverage restricted to a DPN.  The third organizational 
feature, having coverage restricted to a DPN, had a non-significant positive 
effect.  
In the Western US analyses, each organizational feature predicted a more 
favorable change in screening likelihood for Western Hispanic whites than non-
Hispanic whites suggesting a possible effect of reducing disparate CRC 
screening among Hispanics.   
For the financial features in the full and Western US analyses, having a FSA had 
a large positive effect in unadjusted models, although the effect did not remain 
significant in fully-adjusted models.  Cost-sharing categories predicted 
substantial variation in screening likelihood, which was largely mitigated in fully-
adjusted models.  Further research is needed using causal study designs and 
datasets with richer detail about insurance design. 
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Chapter 1 
Introduction 
 
Colorectal cancer (CRC) is one of the largest US cancer burdens.  In 2013, there 
were an estimated 142,820 new CRC cases and 50,830 CRC deaths making it 
the second leading cause of cancer death for men and women combined 
(Surveillance, Epidemiology, and End Results Program 2013).  An average-risk 
individual has a 4.8% risk of being diagnosed with CRC at some point in their 
lifetime.  CRC incidence and mortality have generally declined continuously since 
the mid-1980s (Edwards 2009), although use of CRC screening still lags behind 
other highly effective cancer screening tests (Klabunde 2012). 
CRC screening is highly effective and cost-effective at reducing CRC incidence 
and mortality (Whitlock 2008; Maciosek 2010; Maciosek 2006).  From 1975-
2000, CRC screening explained 53% of the observed decline in CRC mortality, 
while changes in risk factors explained 35% of the decline and improvements in 
treatment explained 12% (Edwards 2009).  The US Preventive Services Task 
Force (USPSTF) recommends  that average risk adults aged 50-75 receive CRC 
screening by any of three strategies: 1) colonoscopy every ten years, 2) flexible 
sigmoidoscopy (FSIG) every five years with high-sensitivity fecal occult blood test 
(FOBT) every three years, or 3) annual FOBT (US Preventive Services Task 
Force 2008), which is generally consistent with other prominent guidelines (Rex 
2009; McFarland 2008)).  While CRC screening use increased recently from 54% 
up-to-date with recommended screening in 2002 to 65% up-to-date in 2012 
(Klabunde 2013), CRC screening use remains low relative to screened 
percentages for other highly effective cancer screening tests, notably 72.4% for 
mammography for breast cancer screening and 83.0% for pap smears for 
cervical cancer screening (Klabunde 2012). 
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The likelihood of being up-to-date with CRC screening varies depending on many 
factors including age, sex/gender, race, Hispanic ethnicity, education, income, 
having health insurance and having a usual source of health care (Shapiro 
2012).  Improving the health of all groups and eliminating disparities/achieving 
health equity are overarching goals of the US government’s HealthyPeople 
campaign (Healthy People 2013).  For the first time in 2012, equivalent 
percentages of whites (65.9%) and blacks (63.1%) were up-to-date with CRC 
screening in the Behavioral Risk Factor Surveillance Survey (BRFSS) (Klabunde 
2013) the Centers for Disease Control and Prevention (CDC).  Also for the first 
time, CRC screening use did not significantly differ between Asians/Pacific 
Islanders (63.2%) and whites or blacks.  Screening differences persist though 
between Hispanics (53.1%), American Indians/Alaskan Natives (AIANs) (54.5%) 
and non-Hispanics (66.4%).   
Many factors contribute to racial/ethnic CRC screening differences.  In multiple 
studies, lower use of CRC screening among Hispanics has been largely or 
entirely mitigated statistically after adjusting for lower socioeconomic status 
(SES) and worse health care access (Gonzales 2012; Cokkinides 2011).  Other 
factors include whether a physician recommended CRC screening (Yepes-Rios 
2006; Jo 2008; Kelly 2007; Cronan 2008), immigration status and time lived in 
the US (Shih 2008), and geographic area-level poverty (Lian 2008).  For 
receiving colonoscopy specifically, an intuitive, but non-obvious, factor found to 
strongly influence whether underserved individuals followed through with a 
scheduled colonoscopy was having a “next of kin” (spouse, family, or friend) 
available as a chaperone after the procedure because of the sedation (Anderson 
2011).   
Many approaches can be considered in the effort to increase CRC screening use 
nationally and reduce inequities.  Screening promotion can use culturally 
appropriate messages to target particular groups, and other policy and practice 
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reforms can address the underlying fundamental social causes of inequities.  
Demographic and socioeconomic factors that are the root causes of inequities 
are not easy to modify, so health care system factors, such as organizational and 
financial factors that can influence preventive services use, may be a more 
suitable focus for strategies aiming to increase screening among vulnerable 
populations and may be more amenable to policy action.  It has been noted that 
health insurance may be particularly well suited for influencing preventive 
services use because of insurer’s organizational and financial connections to 
both providers and patients (Tye 2004). 
The National Committee for Quality Assurance’s (NCQA) produces the 
Healthcare Effectiveness Data and Information Set (HEDIS) that measures 
health plan performance on CRC screening as the percentage of adults aged 50-
75 who are up-to-date with appropriate screening.  Since the early 2000s, HEDIS 
CRC screening performance has steadily improved within each Health 
Maintenance Organizations (HMOs) and Preferred Provider Organizations 
(PPOs) (the two predominant types of health insurance) in the commercial and 
Medicare markets (National Committee for Quality Assurance 2013).  In 2012, 
the HEDIS CRC screening performance measure indicated that HMOs have 
consistently achieved higher CRC screening rates than PPOs in the commercial 
and Medicare markets since the measures began reporting on all health plan 
types in 2005.  HEDIS performance shows that the gap in CRC screening use 
between HMOs and PPOs has narrowed with a jump in CRC screening use 
among PPOs from 2010 to 2011, 47.6 to 54.6% for commercial PPOs and 41.0 
to 55.2% for Medicare PPOs.  
Variation in CRC screening use across types of health insurance has limited 
implications if there are not meaningful distinctions between health insurance 
types.  Insurers exert influence on utilization in multiple ways and insurance 
characteristics may vary within a type of insurance as much as between types 
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(McGlynn 1998).  Deconstructing health insurance types into discrete features is 
a means to more finely examine the effects of insurance characteristics on being 
up-to-date with recommended CRC screening. 
By deconstructing health insurance types into discrete features, the features fit in 
Andersen and colleagues’ frequently used Behavioral Model of Health Services 
Use as enabling factors (Andersen 1968; Andersen 1995; Andersen and 
Davidson 2007; Andersen 2008; Aday, Andersen, and Fleming 1980).  In the 
Behavioral Model, individual and contextual characteristics act as predisposing, 
enabling and need factors that influence health behaviors and ultimately 
outcomes.  Factors that stimulate or inhibit use vary depending on the particular 
service (Andersen 1995).  For instance, an inpatient stay for a life-threatening 
illness would be primarily explained by need-based factors, while whether the 
whether a person obtains a discretionary preventive service, such as CRC 
screening, depends more on predisposing factors such as awareness of the 
service and health beliefs about obtaining needed services, and on enabling 
factors, such as being financially able to obtain the service and being having time 
away from work or other life demands to obtain the service.  While it may be 
impossible to detect differences in the enabling effect of different health 
insurance types, constituent insurance features may act as enabling factors that 
influence a person’s ability to obtain CRC screening.  For instance, copay 
amount would be expected to influence ability-to-pay for CRC screening, and 
organizational features might enable an insurer to influence providers to 
recommend CRC screening. 
A dataset that would permit evaluating insurance feature effects on CRC 
screening likelihood is the Medical Expenditure Panel Survey (MEPS) produced 
by the Agency for Healthcare Research and Quality (AHRQ) (Agency for 
Healthcare Research and Quality 2010).  In addition to a survey component 
inquiring about a variety of personal characteristics and health behaviors, MEPS 
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collects information on medical events, payments and sources of payments.  
MEPS’s unique combination of information includes CRC screening status, some 
insurance features, and a large set of potentially relevant covariates 
encompassing predisposing, enabling and need factors.   
MEPS has been used with conceptual guidance from the Behavioral Model to 
evaluate whether insurance characteristics predicted recent screening 
mammography (Tye 2004).  Primarily using data from the 1996 MEPS, Tye et al. 
assigned organizational and financial health insurance characteristics as 
individual enabling factors and assessed their influence on mammography use.  
Tye et al. created hypotheses for the effects of health insurance characteristics’ 
by drawing on two main theoretical premises or “causal pathways”: 1) if a health 
insurance characteristic increases the insurer’s capacity to manage information 
flows, the health insurer will be better able to communicate to providers and 
patients about appropriate screening mammography (Galbraith 1973) and 2) if a 
health insurance characteristic reduces the effective “price” of screening 
mammography to enrollees, demand will increase (Manning 1987).  The study 
found that mammography use did not differ depending on a woman’s health 
insurance plan being labeled managed care or indemnity, although more specific 
health plan characteristics did predict use including that having insurance that 
defined a provider network and that used gatekeeping were found to predict 
greater likelihood of recent mammography (Tye 2004).  Additional health plan 
characteristics, restricting out-of-network coverage, use of cost containment 
strategies, enrollee cost sharing, and breadth of benefit coverage were not found 
to influence mammography use. 
This study adapted Tye et al.’s approach to accomplish the objective of 
assessing insurance features as predictors of CRC screening.  To accomplish 
the objective, cross-sectional analyses were conducted of pooled data from the 
years 2009, 2010, and 2011 of MEPS data.  The conceptual framework based on 
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the Behavioral Model of Health Services Use and Tye et al.’s causal pathways 
informed specification of analyses using available measures in MEPS.   
As previously noted, CRC screening use is known to be inequitable for Hispanics 
(Klabunde 2013) and for Hispanics in New Mexico as compared to whites 
(Gonzales 2012).  Within Hispanics, variation in CRC screening use has been 
identified between different states and regions of the country (Pollack 2006) and 
based on nation of origin (Gorin and Heck 2005).  Those patterns reveal lower 
CRC screening among Western US Hispanics and among the prevalent Hispanic 
subgroups in the West of Mexican and Central American origin.  In Gonzales et 
al.’s study of the BRFSS data for New Mexico, having health insurance was 
associated with a higher prevalence of up-to-date CRC screening rates for non-
Hispanics than for Hispanics by ~20% points for both men and women.  
Uninsured non-Hispanic white men and women had screening rates ~8% points 
less than uninsured Hispanic men and women, respectively, while insured non-
Hispanic white men and women had CRC screening rates that were 12% and 
14% greater than insured Hispanic men and women, respectively.  Exploring 
insurance feature effects may provide evidence to support a greater benefit to 
CRC screening rates from having insurance among non-Hispanic whites than 
Hispanics.  Because geographic identification of MEPS respondents is limited to 
census regions, this subanalysis examined Hispanic and non-Hispanic whites in 
the Western US census region.  To explore differential insurance feature effects 
between non-Hispanic whites and Hispanic whites in the Western US, the 
subanalysis repeated the full population analysis with the addition of a mediating 
effect for insurance features by Hispanic ethnicity.   
The influences of insurance features studied here has a potential to inform health 
insurance administration and health policy to increase CRC screening use, 
reduce inequities, reduce CRC incidence and mortality, and support the study of 
insurance feature effects on utilization of other health services. 
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Specific Aims and Hypotheses 
 
Aim 1. Evaluate the association between insurance features and likelihood 
of being up-to-date with USPSTF-recommended CRC screening.   
Hypothesis: Higher CRC screening likelihood is predicted by insurance features 
that indicate an insurer had greater capacity to communicate about appropriate 
CRC screening messages to providers and enrollees or by insurance features 
that indicate enrollees experienced lower cost-sharing. 
Aim 2. Evaluate the association between insurance features and likelihood 
of being up-to-date with USPSTF-recommended CRC screening among 
Western US Hispanic and non-Hispanic whites.   
Hypothesis: Aim 1’s hypothesized benefits of increased CRC screening use due 
to insurance features will be smaller for Western Hispanic whites in comparison 
to non-Hispanic whites.  
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Chapter 2  
Literature Review 
 
This chapter provides an overview and synthesis of knowledge on topics relevant 
to this study.  Four content areas were reviewed: 1) CRC Overview: the 
population health burden is summarized including incidence, prevalence, 
mortality, trends, treatments, and costs; 2) CRCS Trends and Predictors: recent 
estimates and trends in CRC screening use are summarized.  A formal literature 
search was performed to broadly assess factors that predict CRC screening that 
will inform covariate specification for multivariate analyses.  Specific issues for 
Aim 2 are addressed relating to assessing the CRC screening inequity between 
non-Hispanic and Hispanic whites in the Western US; 3) Theoretical Framework: 
Use of the Behavioral Model of Health Services Use in this study adapted from 
Tye et al. is explained; 4) Health Insurance Effects: current enrollment in types of 
insurance across the major sources of payment is detailed.  How different 
insurance types generally affect health services use and CRC screening in 
particular is examined.  A formal literature search was conducted to identify 
evidence regarding the effects of health insurance features on health services 
utilization. 
 
Colorectal Cancer Overview 
 
An estimated 1,154,481 people had CRC in the US in 2013 (Surveillance, 
Epidemiology, and End Results Program 2013).  Incidence was 45.0 cases of 
CRC per 100,000 persons, which constitutes 8.6% of all new cancer diagnoses.  
The CRC mortality rate was 16.4 per 100,000 persons, which constitutes 8.8% of 
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all cancer deaths.  For men and women separately, CRC is the third leading 
cause of cancer and third deadliest cancer after lung and prostate cancer and 
lung and breast cancer, respectively.  CRC incidence and mortality have been 
declining since the mid-1980s (Edwards 2009) and have each fallen by nearly 
3% per year over the last ten years (Surveillance, Epidemiology, and End 
Results Program 2013).   
The CRC burden disproportionately affects some groups.  CRC risk increases 
with older age: the median age at diagnosis is 69, and those aged 65-74 and 75-
84 each make up 24% of new cases (Surveillance, Epidemiology, and End 
Results Program 2013).  The median age at death is 74 with those aged 75-84 
making up the largest share, 28.2% followed by those aged 65-74, 21.9% of 
deaths, and those aged 85 and older, 20.8%.  Men in comparison to women 
consistently have higher CRC incidence (50.6 vs. 38.2 per 100,000) and mortality 
(19.6 vs. 13.9 per 100,000).  African American men and women have the highest 
CRC incidence and death rates of all racial and ethnic groups by 1.5-2 times the 
population average.  In comparison to the full population rates, whites have 
slightly lower incidence and mortality rates that are just less; non-Hispanics of all 
races have slightly higher incidence and mortality rates; and Asians/Pacific 
Islanders, Hispanics, and AIANs generally have lower CRC incidence and 
mortality by 10-20%, except AIAN women have a 15% higher mortality rate than 
the full population. 
CRC risk factors include several medical history factors: a family history of CRC 
or other hereditary colorectal conditions; a history of ulcerative colitis or Crohn’s 
disease; a personal history of colorectal, ovarian, or breast cancer; or a personal 
history of polyps (National Cancer Institute 2013a).  Lifestyle risk factors include 
lack of regular physical activity, a diet low in fruit and vegetables or a low-fiber 
and high-fat diet, obesity, excessive alcohol consumption, and cigarette smoking.  
Several medications have been evaluated for CRC prevention effects:  although 
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evidence is mixed, long-term aspirin use has been found to reduce CRC risk; 
evidence is insufficient to conclude if non-aspirin non-steroidal anti-inflammatory 
drugs decrease CRC incidence; evidence is mixed or unsupportive regarding 
vitamin supplements including vitamin E, antioxidant vitamins, folic acid 
supplements, and statin use.  Associational benefits of calcium supplements 
have been found although the evidence is inconclusive.   
From 2003-2009, five-year survival for new cases was 64.9%.  There are six 
standard treatments for CRC: surgery by local excision within the colon or 
resection of the colon with anastomosis or colostomy; chemotherapy; radiation 
therapy; radiofrequency ablation; cryosurgery; and targeted therapy with 
monocolonal antibodies or angiogenesis inhibitors (National Cancer Institute 
2013b).  The five-year survival rate is much higher for persons whose cancers 
are detected at an earlier stage, greater than 90% for local stage cancers vs. 
~10% for distant cancers.  The strong rationale for routine CRC screening is due 
to earlier detection (Edwards 2009).  In 2010, annual medical expenditures for 
CRC were estimated to be $14.1 billion and were projected to rise to $17.4 billion 
in 2020 (in 2010$) in analyses accounting for only changes in the US population, 
with a range of estimates from $14.4 billion to $20.4 billion in different scenarios 
varying incidence, survival, and cost assumptions (Mariotto 2011). 
 
Predictors of Colorectal Cancer Screening 
 
A formal literature search was conducted to identify studies evaluating CRC 
screening predictors other than health insurance features.  A PubMed search 
was conducted on 06/03/2013 covering the previous ten years.  The search 
terms contained three components: 1) National Cancer Institute’s “Cancer Topic 
Search” for “Digestive System Cancer: Screening and Prevention” modified to 
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exclude non-colorectal cancers (Appendix) (National Cancer Institute ), 2) the 
U.S. National Library of Medicine’s health disparities search terms (U.S. National 
Library of Medicine ) and 3) any of three words to identify predictors: (predictor* 
OR factor* OR determinant*).  The search strategy yielded 131 search results, 
and 43 articles were reviewed.  The most current, original findings from US 
settings on unique CRC screening predictors, quantitative and qualitative, were 
reviewed to inform the specification of control variables in this study’s analyses.  
Evidence from additional applicable sources are included where appropriate 
notably an extensive 2010 systematic review of CRC screening use and quality 
that was conducted on behalf of AHRQ (Holden 2010a). 
Changes in CRC screening Use Over Time 
Repeated measures over time using national health surveys including the  
National Health Interview Survey (NHIS) and BRFSS show that CRC screening 
use has continuously increased over time from the late 1980s to the present 
(Klabunde 2013; Cokkinides 2011; Miranda 2012; Shavers 2010; Klabunde 2011; 
Bandi 2012; Soneji 2012; Rim 2011; Holden 2010b).  In the CRC screening 
eligible population of 50-75 year old average-risk persons, nation-wide 65.1% 
were up-to-date with USPSTF-recommended CRC screening strategy in a recent 
estimate from the 2012 BRFSS (Klabunde 2013).  From 2000-2008, the 
percentage of the population aged 50-75 that was up-to-date with any 
recommended CRC screening strategy increased by 15.9% point (38.6 to 54.5%) 
(Klabunde 2011).   
Medicare Policies influencing Trends of Different CRC screening Techniques 
CRCS trends by screening technique from the early 2000s to the present are a 
continuation of trends relating to Medicare policy changes for CRC screening 
around the turn of the millennium (Gross 2006).  Beginning in January 1998, 
Medicare was required by Congress to pay for FOBT, FSIG, double-contrast 
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barium enema (DCBE) screening, and colonoscopy for high-risk persons 
according to American Cancer Society recommendations.  Coverage was later 
expanded to require Medicare to reimburse screening colonoscopy every 10 
years for all persons as of July 1, 2001, no longer for just those at high-risk.  In a 
trend analysis of number of procedures received per 100,000 Medicare 
beneficiaries from 1991-2003, it was demonstrated that a switch occurred from 
more FSIG use in the early period from 1991-7 to more colonoscopy use after 
the first policy change in 1998 (Gross 2006).  FSIG peaked at 691.9 procedures 
per calendar-year quarter per 100,000 beneficiaries in 1999-2000 before 
declining to 267.5 in 2002-2003.  Colonoscopy use increased from 284.6 
procedures per calendar-year quarter per 100,000 beneficiaries in 1996-1997 to 
1918.9 procedures in 2002-2003, an increase by a factor of greater than six.  
Colonoscopy use superseded FSIG as the predominant screening technique, 
even before the universal colonoscopy coverage expansion in July 2001.   
Provider Opinion 
Besides reimbursement policy, provider opinion has contributed to the trends in 
CRC screening use by different techniques.  In the 2006-2007 National Survey of 
Primary Care Physicians’ Recommendations and Practices for Breast, Cervical, 
Colorectal, and Lung Cancer Screening (Klabunde 2009), 95.3% of primary care 
physicians (PCPs) perceived colonoscopy to be effective in reducing mortality, 
while only 22.6% of PCPs perceived computed tomography (CT) colonography to 
be effective, and less than 20% of PCPs perceived to be effective each of FOBT, 
FSIG, DCBE, and fecal DNA testing.  Comparing the techniques that PCPs said 
that they would recommend in that survey to the previous 1999-2000 survey, the 
percentage of PCPs recommending FOBT declined from 95% to 80%, while the 
percentage of PCPs recommending each FSIG and colonoscopy more than 
switched with a decline for FSIG from 78 to 26% and an increase for 
colonoscopy from 38 to 95%. 
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CRCS Trends within Racial/Ethnic Groups 
Major racial/ethnic groups, African Americans, Hispanics, Asians and non-
Hispanic whites have generally experienced increasing CRC screening use 
consistent with trends in the general population over the same period (Shavers 
2010; Klabunde 2011; Bandi 2012; Soneji 2012).  The magnitude of trends varies 
though: Hispanics have not increased screening use as much as other major 
racial/ethnic groups (i.e. disparities have widened) due to a smaller increase in 
colonoscopy use, although at the same time Hispanics have also had smaller 
declines in FOBT and FSIG (Klabunde 2011; Bandi 2012).   
CRC screening adoption has varied among Hispanic subethnicities as well: using 
pooled MEPS data from 2000-2007 (Miranda 2012), CRC screening use trends 
were studied for Hispanic subethnicities, blacks and whites aged 50 and older.  
Puerto Ricans, Cubans, blacks, and whites experienced a similar ≥10% points 
gain in combined use of FOBT and/or endoscopy from 2000-2007, although CRC 
screening use was essentially flat for Mexicans and declined among “Other 
Latinos”.  These trends are relevant to this study’s second Aim because Mexican 
and Central Americans are heavily represented in the Western US while Puerto 
Ricans and Cubans are concentrated in the Eastern US (Ennis 2012).   
CRCS Trends by Other Factors 
Inequities have also widened relating to other factors, particularly social status 
and SES factors: from 2000-2008, smaller gains in CRC screening use were 
experienced by those with less income and education, by the disabled, and by 
immigrants (Klabunde 2011; Rim 2011).  Inequities widened for those with 
deficient health care access including those lacking health insurance (Rim 2011), 
those having no physician visits in the previous year, and those without a usual 
source of care (Klabunde 2011).  Among the insured, CRC screening disparities 
relating to age subgroups and insurance types have shifted over time (Klabunde 
 
 
14 
 
2011).  Among the insured 50-64 age group, the disparity between the publicly 
(historically inequitable) and privately insured widened slightly by 5% points.  In 
the insured 65-75 age group, the CRC screening gap narrowed by more than 5% 
points for those having basic Medicare without supplemental insurance 
(historically inequitable) in comparison to those with Medicare HMO coverage or 
Medicare with private supplemental insurance.   
Changes in CRC Screening Over Time Summary 
In the context of Medicare’s CRC screening reimbursement expansions in 1998 
and 2001 (Gross 2006), and a shift in provider opinions to favor colonoscopy 
more and favor FSIG and FOBT less (Klabunde 2009), colonoscopy became the 
strongly preferred CRC screening strategy type by the early 2000s.  Declining 
FSIG and FOBT use has been more than replaced by increasing colonoscopy 
use such that overall CRC screening use consistent with recommendations 
increased from 38.6% in 2000 to 54.5% in 2008 (Klabunde 2011) and most 
recently has been estimated to be 65.1% in 2012 (Klabunde 2013).  These gains 
have been experienced broadly, although CRC screening use has notably not 
increased as much among Hispanics resulting in a widening disparity in 
comparison to non-Hispanic whites (Klabunde 2011) and some Hispanic 
subgroups (Miranda 2012).  Inequities have also widened among those of lower 
socioeconomic and social status and those with poorer health care access 
(Klabunde 2011; Rim 2011). 
Predisposing Factors 
Demographics 
Age  
As age increases above from the recommended start age, 50, CRC screening 
use increases (Shapiro 2012; Cokkinides 2011; Miranda 2012) until plateauing at 
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70-75 years and gradually declining thereafter (Soneji 2012; Mobley 2010; 
O'Malley 2005).  In the 50-59, 60-69, and 70-75 age groups in the 2010 NHIS, 
50.0, 65.8 and 68.2%, respectively, were estimated to be up-to-date with CRC 
screening by any of the USPSTF-recommended strategies (Shapiro 2012).  In 
the 50-59, 60-69, and 70-75 age groups in the 2010 BRFSS, 55.1, 72.9 and 
76.9%, respectively, were estimated to be up-to-date with CRC screening by any 
of the USPSTF-recommended strategies (Joseph 2012).  The discrepancy 
between the estimates from the NHIS and BRFSS is due to survey administration 
differences and different response rates: NHIS has a higher response rate, and 
since non-responders are less likely to be screened, NHIS has less non-
response bias than BRFSS, so the NHIS is less likely to overestimate screening 
rates (Holden 2010b). 
Explanations for the Association with Increasing Age 
Many explanations have been proposed for the positive association between 
increasing age and CRC screening use including greater awareness of CRC and 
CRC screening, elevated concern about CRC, more diagnostic testing for other 
gastrointestinal issues, more positive FOBT tests with increasing age that prompt 
endoscopy (Ioannou 2003), poorer health that prompts health care system 
encounters increasing the likelihood of a CRC screening provider 
recommendation, and the removal of health insurance coverage barriers for the 
uninsured/underinsured once they receive Medicare at age 65 (although CRC 
screening use increases substantially in the 50-64 year olds age group prior to 
Medicare eligibility) (Hudson 2012). 
Sex/Gender 
Men and women are similarly likely to receive CRC screening with many studies 
finding no difference in CRC screening use  (Cokkinides 2011; Soneji 2012; 
Carcaise-Edinboro and Bradley 2008), although some, mostly larger studies, 
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have found that women have a small, independently significant, lower likelihood 
of CRC screening use (Miranda 2012; Shavers 2010; Rim 2011; Ioannou 2003; 
Homayoon 2013).  Recent estimates though suggest that if there has historically 
been a small gender gap, it may have recently reversed: in the 2010 BRFSS, 
women had significantly higher CRC screening use than men (65.0 vs. 63.9) 
(Joseph 2012), and in the 2012 BRFSS, women had further gains in CRC 
screening use since 2010, while use did not change among men, 66.2% vs. 
63.9% (Klabunde 2013).  No literature was found pertaining to CRC screening 
use among any non-heteronormative genders. 
Explanations for Gender Disparities 
Explanations for gender differences in CRC screening use include differences in 
physician recommendation patterns and differential attitudes and beliefs about 
CRC screening.  In the Supporting Colorectal Cancer Outcomes Through 
Participatory Enhancements (SCOPE) study, a predominantly white, insured, and 
higher SES sample visiting primary care practices in New Jersey between 2006 
and 2008 (Hudson 2012), men were recommended to receive CRC screening 
significantly more often than women, although men and women did not differ in 
their likelihood of adhering to a recommendation.  Another study though did not 
find gender significantly predicted receiving a recommendation for FOBT, FSIG, 
colonoscopy, any endoscopy, or any CRC screening among black and white, 
North and South Carolina Medicare beneficiaries (Klabunde 2006).  In a study 
assessing attitudes and beliefs associated with CRC screening use, it was found 
that women were more likely than men to report agreement with attitudes and 
beliefs that were associated with lower likelihood of being up-to-date with 
endoscopy use (Farraye 2004) including being more frightened or embarrassed 
about having a FSIG exam, considering having a FSIG to be very inconvenient 
with one’s daily schedule, being more willing to have a FSIG if the endoscopist 
was the same gender as the respondent, and being less likely to agree that 
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having an FSIG every five years after the age of 50 is important for general 
health. 
Race 
Estimates from the 2012 BRFSS indicate that differences in CRC screening use 
are not significant between whites, 65.9% up-to-date with recommended 
screening; blacks, 65.5%; and Asians/Pacific Islanders, 63.2%; although 
screening is still inequitable among AIANs, 54.5% (Klabunde 2013).  Those 
estimates are a change from estimates two years earlier in the 2010 BRFSS and 
2010 NHIS, which indicated that CRC screening use among Asians was lower 
than whites and blacks (Shapiro 2012; Joseph 2012). 
Hispanic Ethnicity 
In recent 2012 BRFSS estimates, Hispanics’ CRC screening use lagged non-
Hispanics, 53.1% vs. 66.4% (Klabunde 2013).  Among Hispanics, CRC 
screening use varies depending on multiple factors, which suggest higher risk of 
CRC screening underuse among Western US Hispanics that are the focus of Aim 
2.  In a multivariate analysis of the 2000 NHIS examining two CRC screening 
techniques separately (Gorin and Heck 2005), CRC screening use varied across 
Hispanic subgroups: Puerto Ricans and Central/South Americans had half the 
odds of Mexican Americans (OR: 0.50 (0.28-0.89) and 0.42 (0.21-0.85), 
respectively) of having received any endoscopy in the past five years, although 
for the second technique considered, no Hispanic subgroups had significantly 
different FOBT use within the previous year than Mexican Americans.  It may not 
have been possible to detect differences between Mexican Americans and each 
Cubans and Dominican Americans because of small sample sizes for those 
subgroups.  In another study examining Hispanic subgroups, which used 
combined data from 2001-2005 MEPS and 2000-2004 NHIS (Jerant 2008), 
Hispanics of Mexican or Dominican origin had larger disparities in comparison to 
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non-Hispanic whites than Hispanics of Cuban or Puerto Rican origin vs. non-
Hispanic whites.  CRC screening use among Hispanics varies across geographic 
areas as well.  A state-level analysis of the 2002 BRFSS (Pollack 2006) found 
that Hispanics in Northeastern states (Massachusetts, New Jersey and New 
York) had greater CRC screening use within recommended time intervals than 
Hispanics in Western States (Arizona, California, Colorado, and New Mexico).   
Explanations for Inequitable CRC screening use Among Hispanics 
Evidence indicates many factors contribute to Hispanic CRC screening 
disparities.  In multiple studies, lower SES among Hispanics than non-
Hispanics/whites has been attributed as a cause of CRC screening underuse 
among Hispanics.  SES measures that have been studied include income, 
employment, education, and health care access factors.  Addressing these 
factors, which have been labeled fundamental social causes of disease, has 
been theorized to be sine qua non for eliminating health inequities (Link and 
Phelan 1995).   
In a study assessing CRC screening use among Latino subgroups (Miranda 
2012), all subgroups had unadjusted disparities in CRC screening use compared 
to non-Hispanic whites when only adjusting for age and sex.  In a model that 
adjusted for education, income, and insurance, only Mexicans and “Other 
Latinos” still had inequitable CRC screening use while Cubans and Puerto 
Ricans did not have significantly different CRC screening use from non-Hispanic 
whites.  In analyses of the 2006 New Mexico BRFSS stratified by sex (Gonzales 
2012), New Mexico Hispanic women had inequitable CRC screening use versus 
white women (OR: 0.55 (0.44-0.70)) that was not statistically eliminated after 
controlling for several blocks of covariates including survey language, 
demographics, SES, clinical factors, lifestyle factors, preventive services 
utilization factors, or a full model including all the aforementioned covariate 
blocks.  Controlling for socioeconomic factors (health care coverage, current 
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employment status, annual household income and high school-level education) 
most noticeably, partially statistically mitigated the disparity for Hispanic women 
(OR: 0.73 (0.56-0.97).  Gonzales et al. noted that New Mexican Hispanic women 
in their sample were less likely to have health care coverage and were more 
likely to report being low income (<$25,000), being unemployed or having less 
than a high school education. Therefore residual differences remain between 
New Mexican Hispanic and non-Hispanic white women that explain the statistical 
difference.  For New Mexico Hispanic men in contrast, most of the blocks did 
statistically eliminate inequitable CRC screening use in comparison to non-
Hispanic white men except for demographic, clinical and lifestyle factors.  In 
addition to SES, cultural factors including nation of origin, acculturation factors 
and health beliefs/psychosocial factors have also been shown to contribute to 
Hispanic CRC screening inequities, which are discussed in a subsequent 
sections.  While Hispanics have lower CRC incidence and mortality than non-
Hispanics (Surveillance, Epidemiology, and End Results Program 2013) as was 
noted earlier, Hispanics may have excess CRC risk due to lifestyle factors that 
increases the need for CRC screening in the Hispanic population including higher 
rates of obesity and lower use of other cancer screening tests than non-
Hispanics whites, although Hispanics have favorably lower rates of smoking and 
frequent alcohol consumption (Cokkinides 2012). 
Barriers to CRC screening Among Hispanic Men  
Although screening rates indicate that CRC screening use has historically been 
inequitable among Hispanic women in comparison to men (Gorin and Heck 2005; 
Crawley 2008), unique barriers to CRC screening use for Hispanic men have 
been noted.  In focus group responses of low income/education Hispanics mostly 
of Mexican-birth who were living in U.S. cities along the Texas-Mexico border 
(Fernandez 2008), the concept of machismo was identified as a barrier to CRC 
screening among men, that CRC screening is a violation to manhood.  One man 
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was even quoted as jokingly saying that men avoid CRC screening because they 
think, “I may die, but I’ll die a virgin”.  In this study, participants also expressed 
the opinion that women visit the doctor more often than men and are inherently 
more inclined to accept CRC screening.  In an exploratory qualitative study of 
attitudes and beliefs about CRC screening among New Mexico Hispanic 
subpopulations (Getrich 2012), the importance of machismo notably differed for 
two particular subgroups: 1) Hispanos (Hispanics who trace their ancestry from 
late-16th century Spanish colonists) concentrated in northern New Mexico and 2) 
first-generation Mexicans concentrated in southern New Mexico.  For first-
generation Mexicans, perceptions about receiving colonoscopy included that it 
was an affront to heterosexual manhood and/or would negatively affect a man’s 
reputation in the community.  These privacy and stigma concerns were not held 
by Hispanos possibly because of a tighter knit community going back many 
generations and the absence of recent immigration enforcement threats, which is 
an issue for southern New Mexico first-generation Mexican communities. 
Geography 
CRCS use varies over geographic regions and depending on population density.  
Arkansas had the lowest proportion of its population up-to-date with 
recommended CRC screening in 2012, 55.7%, while Massachusetts had the 
highest proportion, 76.3% (Klabunde 2013).  Among US census regions the 
Northeast had higher predicted recommended CRC screening use than the 
Midwest and South, but not the West in multivariate analyses of a combined 
sample of the 2000, 2003, 2005, and 2008 NHIS (Klabunde 2011).  Studies have 
consistently found a disparity in CRC screening use for persons living in rural 
areas in comparison to their urban counterparts (Shih 2008; Carcaise-Edinboro 
and Bradley 2008; Homayoon 2013; Schumacher 2008).   
Acculturation 
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Some evidence supports an association between CRC screening use and 
acculturation (acculturation measures, immigration status, and spoken language) 
and cultural factors (factors potentially related to traditional lifestyle for Native 
Americans).  For measures of Hispanic acculturation evaluated in two studies, 
CRC screening use was not significantly predicted by either the Acculturation 
Rating Scale for Mexican Americans-II (ARSMA-II) (Yepes-Rios 2006) or the 
Marin and Marin Short Acculturation Scale (Shah 2006).  Across immigration 
status categories, CRC screening use was found to vary.  Foreign-born persons 
who had been in the US for 15 or more years or for ten or fewer years were less 
likely to have ever received CRC screening than US-born non-Hispanic whites, 
OR: 0.58 (0.51-0.67) and OR: 0.46 (0.29-0.71), in analyses of the 2000 NHIS 
(Shih 2008).  No difference was found for foreign-born persons residing in the US 
for 10-14 years, OR: 0.85 (CI: 0.49-1.46), although the 10-14 years group had a 
small sample.  Spoken language has been assessed as a CRC screening 
predictor in multiple ways.  In two small studies, measures of English speaking 
proficiency did not predict CRC screening use (Anderson 2011; Homayoon 
2013).  In two larger studies, language spoken at home did predict CRC 
screening use, among Native Americans (Schumacher 2008) and in a nationally 
representative sample comparing English and Spanish speakers in the 2004 
MEPS (Carcaise-Edinboro and Bradley 2008).  Survey language was found to 
significantly predict CRC screening use in one larger study of Latinos and non-
Latinos in 23 states offering the 2006 BRFSS in Spanish (Diaz 2008).  Factors 
potentially related to traditional lifestyle (use of traditional medicines, advice from 
traditional healer, identity with tribal tradition, identity with non-Native culture and 
participation in traditional events) did not predict CRC screening use, in the large 
Education Towards Research and Health (EARTH) Study that surveyed 11,358 
Native Americans from Alaska and the Navajo Nation (Schumacher 2008). 
Health Beliefs 
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Three studies are highlighted that examined health belief/psychosocial factors as 
a determinant of CRC screening use.  In a survey of 158 European Americans, 
African Americans and Mexican Americans recruited in public settings in three 
zip codes in San Diego selected based on racial representation and median 
income below $50,000 (Cronan 2008), greater perceived efficacy of screening 
predicted greater likelihood of being up-to-date with recommended CRC 
screening; perceived vulnerability also positively predicted screening, but did not 
reach statistical significance; while self-efficacy for screening and perceived 
barriers were not significant (Cronan 2008).  After having sequentially controlled 
other covariates in three earlier models, the addition of psychological factors in 
the full, final model statistically eliminated the CRC screening disparity between 
European and Mexican Americans.   
CRCS psychosocial factors were studied at a community health center in the 
University of Kansas Medical center in a sample that was majority aged 40-49 
(52.9%), African American (69.3%), low-income (70.6% <$1200/month), 
unmarried (85%), and had low health care access (44.4% uninsured) (Greiner 
2005).  In the subset of the sample aged 50 and older, cancer fatalism 
significantly predicted returning the FOBT card that had been provided during 
survey administration, and not having any FOBT barriers was positively 
predictive and nearly reached statistical significance (particular psychosocial 
factors derived for the study from focus group responses), OR: 2.72 (CI:0.95-
7.81).  FOBT card return did not depend on CRC screening test preference; trust 
in health care providers; or having endoscopy barriers.   
Differences between population and provider beliefs about CRC screening in 
New Mexico were assessed using a primary survey of PCPs in 2006 and the 
2004 New Mexico BRFSS CRC screening module (Hoffman 2011).  Population 
and provider beliefs were dissonant: physicians attributed patient barriers as 
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primarily at fault for CRC screening underuse, while the population attributed not 
receiving a physician recommendation as the leading barrier. 
Preventive Services Utilization 
History of receiving preventive services is a proxy for being health-aware and, 
therefore, for being more likely to receive other preventive services.  Other 
cancer screenings have strongly predicted CRC screening use including recent 
receipt of mammography (Gonzalez 2012), recent receipt of pap smears 
(Schumacher 2008) and for Hispanics having received other non-CRC cancer 
screening tests (Gorin and Heck 2005).  A study found that having received an 
influenza or pneumonia vaccine predicted being up-to-date with CRC screening 
(Klabunde 2007).  Whether a person takes preventive medications including a 
multivitamin or aspirin did not predict CRC screening in two studies (Anderson 
2011; Ioannou 2003). 
Patient-Provider Communication 
In multiple forms, better patient-provider communication predicts CRC screening 
use.  Reporting “sometimes”, “usually” , or “always”  vs. “never” in response to 
questions in the Consumer Assessment of Healthcare Providers and Systems 
(CAHPS) survey about how often health care encounters in several ways were 
satisfying predicted a higher likelihood of ever having received CRC screening 
(Carcaise-Edinboro and Bradley 2008).  Provider recommendation has 
repeatedly strongly predicted CRC screening use (Yepes-Rios 2006; Jo 2008; 
Kelly 2007; Cronan 2008).  Perceived medical discrimination strongly negatively 
predicted being up-to-date with recommended CRC screening with generally 
stronger effects for men than women among African Americans, AIANs, Asians 
and Latinos (Crawley 2008). 
Health Status 
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Evidence is mixed regarding whether worse health predicts CRC screening: 
worse health predicted CRC screening for measures of perceived health status 
(Cokkinides 2011; Shih 2008; Gorin and Heck 2005; Ioannou 2003) and for 
having chronic conditions (Klabunde 2006; Schumacher 2008).  Other studies 
though did not find that worse perceived health status or having chronic or 
comorbid conditions predicted CRC screening (Lian 2008; Anderson 2011; 
O'Malley 2005; Hudson 2012; Homayoon 2013; Schumacher 2008; Gonzalez 
2012).  Worse health status may predict CRC screening use because persons in 
poorer health have more health care encounters during which a provider could 
prompt them to obtain CRC screening. 
Need-Based Factors 
Any CRC risk factor is a potential CRC screening predictor because by affecting 
a person’s CRC risk, risk factors are need-based factors for CRC screening in 
the Behavioral Model of Health Services Use since higher risk implies a stronger 
recommendation to receive CRC screening. 
Medical History 
Family history of CRC or any cancer predicted CRC screening use in two large 
studies (Schumacher 2008; Murff 2008).  One study has evaluated differences in 
CRC screening likelihood between African Americans and whites who had a 
family CRC history (Murff 2008).  Whites had a higher odds of having received 
colonoscopy in the past five or ten years, and comparing high and low family 
history risk level, whites had an even greater advantage compared to African 
Americans in the high risk subpopulation (having a first degree relative who was 
younger than 50 years when diagnosed with CRC or having multiple first degree 
relatives) than in the lesser risk subpopulation (having only one first degree 
relative diagnosed at age 50 or later).  CRC-related symptoms, personal CRC 
history or irritable bowel disease, strongly predicted recent endoscopy use 
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(Mobley 2010), although such use is presumably for diagnostic rather than 
screening purposes, which should exclude those individuals from an evaluation 
of CRC screening predictors.  Breast cancer survivors had a small increased 
probability of recent endoscopy, as well (Mobley 2010).   
Lifestyle Factors 
Evidence on the association between lifestyle factors and CRC screening use is 
generally mixed.  There have been equivocal findings regarding whether tobacco 
use negatively predicts CRC screening (Hudson 2012; Homayoon 2013), does 
not predict CRC screening (Lian 2008; Anderson 2011; Gorin and Heck 2005; 
Schumacher 2008), or is a protective factor (Soneji 2012).  Multiple studies found 
that former smokers are more likely to have received CRC screening than never 
smokers (Ioannou 2003; Schumacher 2008; Wong and Coups 2011; 
Brennenstuhl 2010); that finding may be explained by successful quitters being 
more health-aware otherwise and motivated to obtain recommended CRC 
screening to reduce their CRC risk.  In one study of individuals visiting primary 
care practices in New Jersey, non-smokers had greater odds of receiving a CRC 
screening recommendation, OR: 1.876 (1.24-2.84), and even greater odds of 
adhering to a recommendation, OR: 2.59 (1.52-4.43) (Hudson 2012).  Evidence 
is also mixed for alcohol use: one study found heavy drinking (2+ drinks/day for 
men; 1+ drinks/day for women) predicted endoscopy use (Lian 2008) and one 
study did not find an effect for alcohol consumption (2+ drinks/day) on CRC 
screening use for men who had been recently screened for prostate cancer 
(Wong and Coups 2011).  A low-fat diet to prevent heart disease predicted CRC 
screening in one study (Ioannou 2003).  Evidence is mixed that greater physical 
activity predicts increased CRC screening (Ioannou 2003; Wong and Coups 
2011) or did not affect it (Lian 2008).  Evidence is mixed that obesity predicts 
increased CRC screening use (Lian 2008; Soneji 2012; Hudson 2012), 
decreased use (for compliance with a free scheduled colonoscopy in a low-
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income underserved population) (Anderson 2011), or does not predict use 
(Homayoon 2013; Schumacher 2008). 
Enabling Factors 
Socioeconomic Status 
In the Behavioral Model of Health Services Use, individual and community SES 
influence a person’s ability to pay for and access health services.  Individual SES 
has been theorized to act as a fundamental social cause of disease by 
determining access to resources that influence health (Link and Phelan 1995).  
Multiple individual measures of SES predict CRC screening.  Increasing 
household income consistently predicts greater use of CRC screening (Shapiro 
2012; Cokkinides 2011; Shih 2008; Lian 2008; Miranda 2012; Shavers 2010; 
Soneji 2012; O'Malley 2005; Joseph 2012; Ioannou 2003; Carcaise-Edinboro and 
Bradley 2008; Homayoon 2013; Schumacher 2008).  Higher educational 
attainment is also consistently positively predictive (Shapiro 2012; Cronan 2008; 
Shih 2008; Lian 2008; Pollack 2006; Miranda 2012; Soneji 2012; O'Malley 2005; 
Joseph 2012; Carcaise-Edinboro and Bradley 2008; Homayoon 2013).  A 
combined income and education criteria (less than a 12th grade education and/or 
annual income of less than $15,000) was used to dichotomize low vs. high SES 
in one study, which also predicted CRC screening use (Diaz 2008).  Employment 
status has mixed evidence from multiple studies (Yepes-Rios 2006; Ioannou 
2003; Homayoon 2013) including that unemployment or retirement (multivariate 
adjusted including age 65+ vs. 50-64) positively predicts CRC screening in 
comparison to being employed (Lian 2008; Ioannou 2003).  The employed may 
be less likely to receive CRC screening because they are unable to leave work to 
obtain CRC screening.  Respondent’s ability to pay was measured in one study 
as whether they stated that cost had prevented a doctor’s visit in the previous 
year, which did not significantly predict CRC screening use (Wong and Coups 
2011).   
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Contextual-level SES effects may also be relevant CRC screening predictors, 
although evidence is limited.  Medicare beneficiaries living in communities with 
generally poorer elderly were less likely in six states and more likely in two states 
to have recently received endoscopy (Mobley 2010).  In another assessment of a 
community-level SES effect on CRC screening, greater area-level poverty 
predicted lower CRC screening use after controlling for six sets of individual-level 
covariates, and CRC screening use was found to vary across smaller ZIP5 area 
codes, but not ZIP3 areas (Lian 2008).   
Health Care Access 
Greater health care access strongly predicts CRC screening use.  Having a usual 
source of care consistently strongly predicts CRC screening use (Shapiro 2012; 
Shih 2008; Shih 2008; Pollack 2006; Shavers 2010; Klabunde 2006), as well as 
having a usual PCP (Jo 2008; Lian 2008; Wong and Coups 2011), having a 
longer history with one’s current PCP (Farraye 2004), and having health 
insurance vs. not (Shapiro 2012; Shih 2008; Lian 2008; Pollack 2006; Miranda 
2012; Shavers 2010; Soneji 2012; Joseph 2012; Ioannou 2003; Carcaise-
Edinboro and Bradley 2008; Fernandez 2008; Gonzalez 2012; Wong and Coups 
2011).  Insurance further predicts CRC screening depending on source of 
coverage: both those under 65 with private insurance and those aged ≥65 with 
Medicare plus a private supplemental tended to have higher CRC screening use 
than their only publically insured age-specific counterparts, although source of 
coverage was not independently significant after  adjusting for individual-level 
covariates (Shapiro 2012).   
At the contextual level, living in a state with a greater privately insured portion of 
the 50-64 year old population was positively associated with CRC screening use, 
although did not independently predict use in multivariate analyses (Cokkinides 
2011).  In the same study, states with a mandate requiring comprehensive 
private insurance coverage for CRC screening procedures that had been in effect 
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for one or more years predicted endoscopy in the previous year in comparison to 
states without a mandate or a mandate for less than one year.  Provider density 
was found to influence CRC screening use (Soneji 2012): increasing 
gastroenterologist density positively predicted greater CRC screening use, while 
increasing PCP density negatively predicted CRC screening use, although the 
authors commented that positive effects for PCP density might have been 
masked by other factors including collinearity with gastroenterologist density.  In 
a sample of 272,077 Medicare beneficiaries in 11 states covered by the 
Surveillance, Epidemiology, and End Results (SEER) Medicare cancer registry 
who survived from 2000-2005, effects of each gastroenterologist, oncologist, and 
nurse density on endoscopy use were mixed across states (Mobley 2010).  
Effects were also mixed for density of endoscopy facilities.  More difficult 
transportation conditions generally had a negative influence on the probability of 
receiving endoscopy in some states including having moved to a different zip 
code, experiencing greater commuter intensity, and, to a lesser extent, a 
respondent’s distance to an endoscopy provider (Mobley 2010). 
Health Care Utilization 
Health care utilization is an indication of opportunities to receive a CRC 
screening recommendation and of a patient’s willingness to encounter the health 
care system.  A greater number of recent doctor visits strongly predicted CRC 
screening use in two studies (O'Malley 2005; Homayoon 2013).  Having a check-
up or preventive visit in the last year vs. further in the past also positively 
predicted CRC screening use (Lian 2008; Ioannou 2003; Klabunde 2006; Wong 
and Coups 2011). 
Social Ties 
Indicators of greater social ties usually predict CRC screening use include being 
married or partnered in comparison to not being married (Cokkinides 2011; Shih 
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2008; Gorin and Heck 2005; Shavers 2010; Soneji 2012; Hudson 2012; 
Homayoon 2013; Klabunde 2006; Wong and Coups 2011); and having an 
available next of kin, which predicted 4-5 times greater odds of underserved 
individuals following through with a scheduled free colonoscopy appointment 
(Anderson 2011).  The authors noted that since colonoscopy has become the 
overwhelming screening technique of choice, the large majority of patients have 
a logistical need for another person to drive them home from the encounter 
because of the sedation. 
Summary of Colorectal Cancer Screening Predictors 
A large variety of factors predicts CRC screening use encompassing 
predisposing, enabling and need factors from the Behavioral Model of Health 
Services Use.  Overall, CRC screening has increased substantially in the last 15 
years from less than half of the US population up-to-date with recommended 
CRC screening then to nearly two-thirds up-to-date now.  Those gains are due to 
increasing colonoscopy use, and despite declining FSIG and FOBT use, that can 
be attributed to Medicare colonoscopy reimbursement expansions in 1998 and 
2001 that lowered financial barriers for colonoscopy and to a shift in provider 
opinions favoring colonoscopy.    
Amid substantial overall gains in CRC screening use, gains have occurred 
broadly with some inequities closing pertaining to predisposing factors, 
particularly racial inequities, such that screening rates among whites, blacks, and 
Asians are now similar, although inequities persist for AIANs and Hispanics.  
CRC screening use varies according to other demographic factors generally 
increasing with age, varying substantially across states, and generally being 
lower in rural areas, although men and women are similarly likely to be screened.  
For minority groups with large immigrant populations, other predisposing factors 
salient to CRC screening use include acculturation, such as lower CRC 
screening use found among persons born outside the US and among persons 
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less comfortable speaking or using English.  Some studies have found that 
positive health beliefs and attitudes predict CRC screening use, and that health 
beliefs are relevant to disparities including racial and ethnic minorities and for 
barriers to screening for women.  Additional predisposing factors that influence 
CRC screening use include having a history of receiving other preventive 
services, such as other cancer screenings and immunizations, and having better 
patient-provider communication including whether minorities perceive medical 
discrimination.  Evidence is mixed that worse health status predicts CRC 
screening use. 
Need-based factors for CRC screening are indicators of increased CRC risk, i.e. 
a person is at higher CRC risk that CRC screening potentially would detect.  
Some need-based factors pertain to medical history including hereditary or health 
status-related risks.  Family history of CRC or having CRC-related symptoms 
have each strongly predicted likelihood of CRC screening.  Other need-based 
factors relate to lifestyle risk factors for CRC.  Tobacco use generally predicts 
CRC screening underuse, although multiple studies have found that former 
smokers are more likely to have received screening than never smokers are.  
Evidence is mixed for associations between CRC screening and obesity, physical 
activity, alcohol consumption and having a healthy diet. 
Important enabling factors for CRC screening include SES, health care access, 
health care utilization, and social ties.  Higher SES generally predicts higher CRC 
screening use, often approximated by single-measure proxies such as household 
income or education, although less community-level poverty generally also 
predicts CRC screening.  An exception to higher SES predicting CRC screening 
use is the greater likelihood of having received CRC screening among the 
unemployed and retired in comparison to the employed, plausibly because of 
having more free time to seek CRC screening.  Many facets of greater health 
care access predict CRC screening use especially having health insurance, 
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having a usual source of care, having a usual PCP, and having a longer history 
with one’s current PCP.  Effects were mixed for the impact of greater provider 
density in a community including of gastroenterologists, oncologists, and nurses, 
as well as for the density of endoscopy facilities.  Living somewhere with more 
difficult transportation conditions was negatively predictive.  A persons’ recent 
health care utilization history suggests the amount of opportunity they have had 
to receive a CRC screening recommendation and willingness/lack of barriers to 
encounter the health care system.  Having a greater number of recent doctor 
visits or having had a more recent checkup strongly predicts CRC screening.  
Last, more close social ties generally increases CRC screening use with benefits 
to screening use for being married or partnered vs. otherwise and having an 
available next of kin to chaperone the patient from a colonoscopy appointment. 
 
Theoretical Framework 
 
The theoretical framework for this study adapts the framework of Tye et al.’s 
evaluation of health plan characteristics as predictors of breast cancer screening 
mammography (Tye 2004; Tye 2002).  Tye et al. began with the commonly used 
Behavioral Model of Health Services Use developed by Andersen, Aday and 
colleagues (Andersen 1968; Andersen 1995; Andersen and Davidson 2007; 
Andersen 2008; Aday, Andersen, and Fleming 1980).  In the Behavioral Model, 
an individual’s use of health services is influenced by individual and contextual 
characteristics that act as either predisposing, enabling or need factors.  
Predisposing factors are innate qualities that influence propensity to obtain a 
service; enabling factors influence capability to obtain a service; and need factors 
indicate perceived need (by the individual) or technical need (based on expert 
judgment of the clinician or from evidence-based guidelines) for a service 
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(Andersen 1995).  Health services utilization contributes to health outcomes, and 
the experience from receiving health services and their outcomes provides 
feedback that recursively influences a person’s individual and contextual 
characteristics and ultimately future health services use. 
Tye et al. conducted a literature review to determine organizational and financial 
characteristics of health plans that fit in Anderson’s behavioral model as 
individual, enabling factors.  Although insurance features could be considered 
contextual, health plan characteristics were placed at the individual level because 
the dataset for their analyses, MEPS, identifies individuals as having certain 
health plan characteristics.  Several health plan characteristics were classified as 
having either an organizational or a financial effect.  Tye et al. chose not to use 
general health plan categories and/or dichotomous comparisons, such as 
managed care vs. indemnity or managed care typologies (e.g. fee-for-service 
(FFS), PPOs, HMOs, and point of service (POS)).  The broad nature of plan 
typologies complicates assessing their effects: the meaning of effects is 
obscured by plans within a category varying in their essential features and plans 
in different categories sharing features.  In addition, although meaningful 
differences in service use may be distinguishable by plan type, the specific 
feature responsible may be unclear.  Instead of using general categories, Tye et 
al. decided to assess a set of health plan characteristics as others had done 
previously (Conrad 1998; Gold and Hurley 1997; Weiner and de Lissovoy 1993).  
Tye et al.’s set of health plan characteristics consisted of eight features: whether 
a plan has a defined network of providers; whether coverage for care is restricted 
to a network; whether enrollees are required to have a primary care gatekeeper; 
the copayment for a physician visit; the deductible amount; the coinsurance rate; 
breadth of benefit coverage (medical, dental, vision, and prescription drugs); and 
whether a respondent’s health plan used cost containment strategies (e.g. 
utilization management; derived from the 1996 MEPS Health Insurance Plan 
Abstraction (HIPA) file). 
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Tye et al. proposed hypotheses for effects of the health plan characteristics on 
utilization of screening mammography, which was informed by causal pathways 
derived from two organizational and economic theories.  Information-Processing 
Theory (Galbraith 1973) was drawn on to propose that organizational 
characteristics affect a health plan’s capacity to coordinate and process 
information flows.  The theory proposes that increasing information processing 
capacity enables a health plan to increase awareness of cancer screening 
guidelines among providers and patients, which will increase demand for 
screening.  Financial characteristics were proposed to influence screening by 
affecting the out-of-pocket price of mammography, which relates inversely to 
demand for screening according to the law of demand from economics and 
empirical evidence (Broyles and Rosko 1988), and has been demonstrated 
empirically, most notably, by the RAND Health Insurance Experiment (Manning 
1987).  Using the 1996 MEPS and the adapted Behavioral Model framework, Tye 
et al. devised multivariate logistic regression models with a control variable set of 
predisposing and enabling factors.  Repeated Regressions were conducted to 
evaluate each health plan characteristic separately because multicollinearity 
between characteristics and missing data for plan characteristics prohibited 
testing all characteristics in one model.  
This study followed Tye et al.’s theoretical framework and study design to 
evaluate insurance features as predictors of CRC screening.  Insurance features 
were parameterized as discrete organizational and financial features that act as 
individual enabling factors, in contrast to categorizations of health plan labels, 
typologies, or dichotomous comparisons.  The insurance features and covariates 
included in multivariate logistic regression analyses were decided based on 
evidence from the literature reviews of insurance and non-insurance CRC 
screening predictors and by available data in MEPS.  Hypotheses for specific 
insurance features are proposed in the methods following Tye et al.’s causal 
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pathways.  The Aim 2 analysis for Western Hispanic and non-Hispanic whites 
was derived from the Aim 1 analyses. 
 
Health Insurance Effects Review 
 
Overview of Health Insurance in the US 
Americans obtain health insurance from private and/or public sources, although a 
large portion of the population remains uninsured; an estimated 47.3 million, 
18%, of the nonelderly population (<65 years) were uninsured in 2012 (Kaiser 
Commission on Medicaid and the Uninsured 2013).  Nearly all the elderly (65+ 
years) population receives Medicare as a guaranteed entitlement, although 
nearly 640,000 elderly (<2%) remained uninsured in 2012 (Kaiser Commission 
on Medicaid and the Uninsured 2013).  Including all elderly and nonelderly 
recipients, Medicare insured over 50 million Americans in 2012, 8 million (17%) 
of whom were nonelderly persons with permanent disabilities (The Henry J. 
Kaiser Family Foundation 2012).  In the nonelderly population (aged <65), 266.9 
million in 2012 (of the total 312 million 2012 population), the majority, 55.7% had 
employer-sponsored insurance personally or from a spouse or parent; the 
second largest portion of the nonelderly, 20.8%, had Medicaid or other public 
insurance including the Children’s Health Insurance Plan (CHIP), Medicare, and 
military-related coverage; and a small minority, 5.8% had private, non-group 
insurance.  Considering the extent that being insured actually makes health care 
affordable, 31.7 million insured nonelderly persons qualified as underinsured in 
2012 (defined as a “household that spent 10% or more of income on medical 
care (excluding premiums) or 5% or more if income under 200% poverty”) and 
were at risk for not being able to afford needed health care.  In total, at least 79 
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million Americans were at risk for not being able to afford needed care in 2012 
due to being uninsured or underinsured (Schoen 2014).   
Population insurance coverage is undergoing a seismic shift due to the full rollout 
of the Patient Protection and Affordable Care Act’s (ACA) major provisions in 
2014 with uncertain long-term outcomes.  During the period from October 1 2013 
to May 1 2014, an estimated 20 million Americans gained coverage or have 
enrolled in a new insurance offering (Blumenthal and Collins 2014) including an 
estimated 8.0 million who obtained insurance through the ACA’s state-based 
individual marketplaces, 6.0 million who enrolled in Medicaid or CHIP, 5.0 million 
who obtained insurance directly from an insurer, and 1.0 million young adults 
aged 19-26 who gained coverage from their parent’s policy.  In the most rigorous 
calculation to date, researchers have estimated that 57% of enrollees on the 
individual marketplaces were previously uninsured, although other survey 
estimates ranged from 24-87% (Kliff 2014), so the precise portion of enrollees 
who were previously uninsured is unknown.  New coverage due to ACA 
provisions though undoubtedly represents a substantial reduction of the 
uninsured of at least several millions and possibly more than ten million, which is 
likely to increase in coming years (Blumenthal and Collins 2014).  As noted, the 
ways by which the ACA increases the number of insured persons is by easing 
enrollment in extant insurance options, rather than introducing fundamentally 
new models or entirely replacing existing options.  Within and across those 
options, insurance features vary, which constrains the interactions and 
responsibilities of and between individual enrollees, providers and payers and 
ultimately influences enrollees health services utilization including for preventive 
services such as CRC screening.  In the three largest sources of health 
insurance coverage, employer-sponsored insurance, Medicare and Medicaid, 
patterns and trends of enrollment in different types of insurance provide an 
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indication of the evolving nature of the insurance constraints influencing 
enrollees’ utilization including for CRC screening. 
Employer-sponsored insurance 
In 2013, nearly half of the US population, 149 million nonelderly people, obtained 
coverage from employer-sponsored insurance offerings (The Kaiser Family 
Foundation and Health Research & Educational Trust 2013).  Enrollment by 
types of plans has substantially evolved since the intense public focus and state-
level regulatory backlash against managed care in the 1990s (Kronebusch 2009).  
In 2000, the proportion of covered workers with conventional FFS coverage was 
8% after a steep decline in the previous decade from 73% in 1988, to 46% in 
1993, and 27% in 1996 (The Kaiser Family Foundation and Health Research & 
Educational Trust 2013).  By 2009, the proportion of persons with employer-
sponsored FFS plans dropped below 1%.  The proportion of workers in HMO 
plans was 14% in 2013 a decline by half from 29% in 2000 (down from a high of 
31% in 1996), and Point-of-Service (POS) plans (a hybrid HMO-FFS plan with a 
network of providers with lower cost-sharing like an HMO provider and the option 
to see non-network providers with higher cost-sharing (Office of Personnel 
Management )) have also considerably diminished from a peak of 24% in 1999 to 
9% in 2013.  Enrollment has increased for two plan types: PPOs are the majority 
plan type of covered workers in 2013 (57%) up from 42% in 2000, although the 
peak PPO share was 61% in 2005; and high-deductible health plans with a 
savings option (HDHP/SO) have a 20% share that has risen from a 4% share 
when they were first included in the report for the year 2006 (in the Kaiser Family 
Foundation report, the HDHP/SO category refers to the federal legal designation 
of such plans, although all HDHP/SOs have an underlying PPO, HMO, POS, or 
conventional FFS plan).  The trends suggest that employers wanting to offer the 
most comprehensive and unrestrictive coverage or employees desiring such 
coverage opt for PPOs that have an option of network providers at somewhat 
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lower cost, but are less restrictive about access to non-network providers than 
other plan types with a greater emphasis on steering enrollees to network 
providers.  The remaining, more cost-conscious consumers/employers are nearly 
split between the less risk-averse who opt for HDHP/SO plans and those who 
accept more restrictive HMO or POS plan types with more generous in-network 
coverage. 
Medicare Managed Care 
In 2013, 14.4 million Medicare beneficiaries, 28% of the total 51.4 million, were 
enrolled in Medicare Advantage (MA) plans offered by a private company that 
contracts with Medicare to provide all Medicare Part A and B benefits (Gold 
2013).  Current enrollment is an increase from the enrollment low of 5.3 million 
MA plan enrollees and 13% of all Medicare beneficiaries in 2003 and 2004.  MA 
plan enrollment does include private FFS plans, but they had declined to 3% of 
enrollees in 2013 from a high of 21% in 2009, so nearly all MA plan enrollees are 
in managed care plans.  Enrollment grew by 1 million from 2012 to 2013, a 9.7% 
increase and by 30% since 2010.  The majority, 65%, of MA plan enrollees in 
2013 had an HMO plan, a share of enrollees that has been steady recently as 
HMO enrollment increased similarly to total MA plan enrollment.  The next largest 
share of MA plan enrollees, 29%, had local or regional PPOs in 2013, an 
increase from a 6% share in 2007.   
Managed Care Medicaid 
In 2011, 42.4 million Medicaid recipients, 74.2% of the total 57.1 million covered 
by Medicaid, were enrolled in a managed care program, an increase from 57.6% 
in 2002 (Swisher 2011).  Of the 61.5 million Medicaid managed care policies 
(19.1 million had more than one plan type), 28.2 million individuals had a 
comprehensive coverage plan from either a commercial or Medicaid-only 
Managed Care Organization (MCO); 8.9 million had a primary care case 
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management plan; and 22.0 million were covered by a prepaid inpatient or 
ambulatory care health plan for specific services (e.g. dental or long-term care) 
that is a narrower breadth of services than what is considered comprehensive 
coverage.  
Current Composition and Trends in Health Plan Enrollment Summary 
Collectively these figures suggest approximately two-thirds of Americans, around 
200 million people, possess health plans that belong to the general umbrella of 
managed care (commercial, Medicare or Medicaid plans labeled HMO, POS, 
PPO, or HDHP/SO).  Plans vary in the extent of how managed they are.  The 
large share of the employer-sponsored insurance population with PPO plans, 
~85 million people, receive and are reimbursed for health services in much the 
same way as traditional FFS plans except for having preferred provider networks.  
As discussed before, labels belie a health plan’s underlying makeup, but the 
enormous number of Americans identified as belonging to some kind of MCO 
indicates that the constituent insurance features that make up health plans 
influence all Americans’ health services use, directly as plan holders or indirectly 
through spillover effects on the greater health care system. 
Summary Measures of Health Plan Performance 
A few sources offer summary assessments of performance by types of health 
plans.  HEDIS reports annual health plan performance covering 136 million 
Americans enrolled in HMOs and PPOs in the commercial nonelderly and MA 
markets (National Committee for Quality Assurance 2013).  HEDIS is used to 
inform health plans’ internal efforts to improve quality, to inform NCQA’s 
accreditation of health plans, and to rank quality across health plans.  Although 
summary metrics have been devised to summarize performance across HEDIS 
measures (Reid 2010), deriving such metrics is difficult because either all 
individual HEDIS measures have to be assumed equally important or justification 
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needs to be provided for weighting measures unequally and/or considering only 
subgroups of measures.  In addition, the composition of HEDIS measures 
evolves because NCQA’s review process adds to, drops and modifies measures 
annually, which makes assessing HEDIS trends difficult, as well; although NCQA 
reports that most measures improve over time (National Committee for Quality 
Assurance 2013). 
Literature sources that review summary domains of performance (i.e. not 
individual process and outcomes measures as HEDIS assesses) for health plans 
by type are dated.  Miller and Luft published three literature reviews of managed 
care performance covering 1980-2001 (Miller and Luft 1997; Miller and Luft 1994; 
Miller and Luft 2002).  The last review of HMO plan performance from 1997-2001 
(Miller and Luft 2002) found that quality of care was similar between HMOs and 
non-HMOs; some evidence suggested that HMOs had lower use of expensive 
services including hospitals; and that HMO enrollees generally experienced 
poorer access to care and had lower satisfaction levels.  In their 1997 review of 
managed care plan performance (Miller and Luft 1997), Miller and Luft found that 
managed care plans generally had reduced use of more expensive services, 
increased outpatient services, and had inconsistent effects on hospital care, 
access and quality.  Miller and Luft warned that the literature had largely varying 
technical rigor and generalizability and often was older with limited relevance to 
the current makeup of managed care.  No similarly comprehensive assessment 
of managed care plan performance (or a more comprehensive review 
distinguishing health plan types and features) was found since Miller and Luft’s 
2002 review. 
Managed Care and Preventive Services Use 
Miller and Luft (Miller and Luft 2002) detailed general effects of HMO 
membership on preventive services use.  HMOs in comparison to non-HMOs had 
predominantly favorable preventive service use with no unfavorable findings.  For 
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preventive services that HMOs probably had less cost-sharing for than non-
HMOs (cancer screenings and flu shots), 12 of 31 study findings were 
predominantly favorable to HMOs with no predominantly unfavorable findings.  
For preventive services where HMOs likely provided equivalent financial 
coverage as non-HMOs (blood pressure checks, clinical breast exams, digital 
rectal exams and smoking advice), two of nine results were predominantly 
favorable for HMOs with no predominantly unfavorable results. 
Managed Care and Overuse of Health Care Services 
Studies comparing FFS and managed care populations were included in a recent 
systematic review of overuse of health care services in different health care 
systems/coverage models with inconclusive findings (Keyhani 2010).  Managed 
care and FFS covered populations were compared in four studies and found 
similar rates of inappropriate use of cardiology procedures, and mixed findings 
regarding inappropriate antibiotics use and inappropriate diagnostic testing for 
respiratory conditions.  Only one of the studies included in the review was 
published since 2000, and the authors concluded that the evidence on overuse in 
different systems of care is limited and does not suggest any particular system 
that best reduces overuse.   
Summary of Overall Health Plan Performance 
Evidence is limited for summarizing health plan performance.  HEDIS measures 
are reported annually for health plans that provide coverage to 44% of 
Americans, although NCQA does not report summary metrics of overall 
performance (National Committee for Quality Assurance 2013).  In the most 
recent review of managed care plan performance (Miller and Luft 2002), quality 
of care was similar for HMOs and non-HMOs, although the authors cautioned 
that the methodological quality of the literature varied, and it is now very dated.  
Similar caveats were stated in a more recent systematic review of the overuse of 
 
 
41 
 
health care services in different systems that found similar overuse of services 
between managed care and FFS covered population (Keyhani 2010). 
 
 
Health Plan Colorectal Cancer Screening Performance 
In the 2012 HEDIS, the CRC screening measure estimated that 63.3 and 55.8% 
of eligible persons in commercial HMOs and PPOs, respectively, and 62.1 and 
58.4% of eligible persons in Medicare HMOs and PPOs, respectively, were up-
to-date with recommended CRC screening defined as colonoscopy in the 
previous ten years, FSIG in the previous five years, or FOBT within the last year 
(National Committee for Quality Assurance 2013).  Over time, there has been a 
general trend of better performance on the CRC screening measure for all plan 
types since the early 2000s.  Two studies have assessed the effects of Medicare 
plan types on CRC screening use.  
Medicare Plan Types 
Using data from 10,173 Medicare beneficiaries in the 2000 Medicare Current 
Beneficiary Survey (MCBS) (Schneider 2008b), differences in CRC screening 
use across Medicare plan types were compared (FFS with supplemental 
insurance; FFS with no supplemental; and Medicare managed care (MMC) for 
each having received 1) endoscopy in the past five years, 2) FOBT in the past 
two years, or 3) overall being up-to-date with screening by either technique.  
Schneider et al. had hypothesized that MMC plans favored a cost-effective 
screening strategy emphasizing FOBT and limiting more expensive endoscopy 
use while FFS Medicare with supplemental insurance would increase endoscopy 
use by reducing coinsurance.  In propensity score adjusted analyses,   MMC 
predicted greater FOBT use and overall screening than FFS without 
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supplemental coverage, although endoscopy use alone was similar, consistent 
with first hypothesis.  FFS with supplemental insurance in comparison to MMC 
predicted increased odds of endoscopy and overall CRC screening, although 
FOBT use was similar between the two plan types, consistent with the second 
hypothesis.  Schneider et al. reasoned that the findings accorded with policy 
changes around that time following CMS initiating coverage of FOBT, FSIG, and 
DCBE for average-risk beneficiaries in 1998, but before expanding coverage to 
include colonoscopy in 2001 (Gross 2006).  In another study using the 2000 
MCBS, but examining beneficiaries who had a usual physician (O'Malley 2005), 
HMO beneficiaries had higher odds of overall CRC screening (defined as 
endoscopy in the  past five years or FOBT in the previous year) than FFS 
beneficiaries. 
Managed Care Medicare Penetration Spillover Effects 
In the 11 state analysis of FFS Medicare beneficiaries included in the SEER 
cancer registries  from 2000-2005 (Mobley 2010), MMC penetration spillover was 
measured as the proportion of Medicare beneficiaries enrolled in MMC 
organizations in a Primary Care Service Area (PCSA) (a set of validated 
geographic units more numerous than counties developed by Dartmouth 
researchers designating natural PCP markets derived from Medicare patients 
flows to PCPs (Goodman 2003)).  Significant coefficients for this variable were 
reported at the α = 0.10 level because of its policy importance.  For each 
percentage point increasing in MMC penetration, the probability of endoscopy 
use decreased in eight states by 0.05-0.6%, while Iowa was the only state to 
experience positive effects, 0.25% increase in probability of endoscopy use for 
each percentage point increase in MMC penetration.  The authors commented 
that these effects are consistent with Schneider et al.’s findings that MMC favors 
FOBT over endoscopy in comparison to FFS Medicare, and the finding may be 
explained by spillover of managed care practices and/or if increased managed 
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care penetration limited the supply of endoscopic services by discouraging entry 
of providers.  
Summary of Health Plan Colorectal Cancer Screening Performance 
HEDIS performance for CRC screening is the percentage of the covered eligible 
population up-to-date with recommended CRC screening and had a range of 
55.8 to 63.3% for commercial and Medicare HMOs and PPOs in 2012 (National 
Committee for Quality Assurance 2013).  In HEDIS 2012, HMOs outperformed 
PPOs in both the commercial and Medicare markets, and commercial HMOs 
achieved higher screening rates than Medicare HMOs, while Medicare PPOs 
achieved higher rates than commercial PPOs.  Studies have assessed CRC 
screening use by screening strategy, and findings suggest that MMC plans 
favored FOBT over endoscopy before Medicare expanded colonoscopy 
reimbursement to all average risk persons.  Using 2000 Medicare data, 
hypothesized effects of Medicare plan types on the use of endoscopy vs. FOBT 
were substantiated (Schneider 2008b): MMC predicted greater low-cost FOBT 
use while Medicare FFS with a supplemental predicted greater endoscopy use.  
In another study of Medicare FFS beneficiaries from 2000-2005 (Mobley 2010), 
increasing MMC penetration, a greater proportion of MMC enrollment in a market 
area, was found to generally predict lower endoscopy use in Medicare FFS, 
plausibly due to hypothesized managed care spillover effects.  No more recent 
studies were found addressing variations in use of different CRC screening 
strategies for nonelderly/non-Medicare commercial health plan types. 
Health Insurance Attributes Literature Review 
A formal literature search in PubMed covering the previous ten years was 
conducted on 06/08/2013 to obtain evidence regarding insurance features that 
might predict CRC screening use.  General insurance terms and terms for types 
of health insurance were paired with specific phrases that would suggest health 
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insurance attributes or would suggest a study used the Behavioral Model of 
Health Services Use (Andersen 1995): ("Insurance, Health"[Mesh] OR "fee-for-
service" OR "health maintenance organization" OR "preferred provider 
organization" OR "point of service" OR "independent practice association" OR 
"health insurance" OR "health plan" OR "managed care") AND (typolog* OR 
"system factors" OR "system characteristics" OR Andersen[tiab] OR "behavioral 
model" OR "predisposing characteristics" OR "enabling characteristics").  The 
search was designed to generate a breadth of evidence, although the challenge 
of searching this topic without any standardized terminology prohibited 
conducting a more sensitive search due to the reduced specificity that would 
have been necessary.  The findings are supplemented with relevant literature 
found elsewhere.  The literature search generated 107 results from 2003 to 2013; 
14 studies were obtained and reviewed; and six were determined to have studied 
insurance features effects on health services use.  Four additional articles were 
identified from reference lists and the literature search of CRC screening 
predictors.  The findings pertain to provider factors, cost-sharing, and composite 
measures of managed care. 
Summary of insurance feature Literature search 
The insurance feature literature search findings identified many potential 
influences of insurance features relating to provider arrangements, cost-sharing, 
and composite measures of managed care (Table 2.1). 
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Table 2.1 Features Identified by Insurance Features Literature Review 
Perspective General Factors Specific Factors 
Enrollee Cost-sharing 
Favored services/tiered 
cost-sharing 
  
Deductible Amount 
First-dollar coverage for 
preventive services 
 Consumer Access* 
Standing referrals for 
chronically ill 
  
Exemptions from prior 
authorization 
  Ombudsperson program 
 Consumer Protection* Right to sue health plan 
  
Time limit for approval 
decisions/internal 
appeals 
  
External review 
procedures required 
Provider 
Contractual 
Relationships* 
Prompt payment to 
providers 
  
Whether there are “Hold 
harmless” provisions 
 Professional Autonomy* 
Providers can learn 
review criteria 
  
Reviewer is professional 
peer 
  
Internal appeals are 
reviewed by professional 
peer 
  
Limit financial incentives 
for utilization review 
employees 
  
Prohibit discharge of 
physicians for 
nonmedical reasons 
  Prohibit “gag clauses” 
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Whistle-blower 
protections 
  
Require that medical 
director be licensed in 
state 
 
Nature of risk or 
rewards to providers Withholds for ER use 
  
Bonuses for (relevant) 
preventive service use 
Medical Group Organization 
% of (relevant) MD type 
in PCP or specialty 
network 
  
Use of nurse/mid-level 
provider coordinators 
 
Basic compensation to 
medical group 
% of providers paid by 
FFS 
  
% of providers paid by 
salary 
*All from Kronebusch et al. 2009 
 
Four studies reported findings pertaining to provider arrangements.  First, 
physician gatekeeping was associated with delays in melanoma biopsy, but no 
change in health outcomes (Swetter 2007).  Second, individuals cared for in their 
last year of life by physicians compensated on a FFS basis rather than capitation 
had more prescription drug fills, prescription drug claims and out-of-pocket 
expenditures (Fahlman 2006).  Third, a Medicare beneficiary having specialists 
available when s/he thought they were needed significantly positively predicted 
recent CRC screening (O'Malley 2005).  Last, percentage of practice revenue 
from managed care did not influence utilization of six common preventive 
services by the practice’s Medicare patients including lower endoscopy (Pham 
2005). 
Three studies reported findings on cost-sharing effects.  First, for every 1% point 
increase in the proportion of family income spent on all health care out-of-pocket 
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payments, child asthma exacerbations increased 14% (Ungar 2011).  Second, 
first dollar (zero deductible) coverage of preventive services contributed to 
increased use of four common preventive services assessed, which included 
FOBT, in comparison to a control health plan without first dollar coverage, and 
preventive services use gains were greater for a low deductible group within the 
first dollar coverage cohort than a high deductible group (Meeker 2011).  The 
authors proposed that individuals who select high-deductible plans are 
predisposed to use fewer health services for fundamental unobserved reasons.  
Third, having a higher copayment for brand name prescriptions (>$5 in 1998) 
reduced prescription drug switching from initial using lansoprazole, the proton 
pump inhibitor (PPI) that did not have direct-to-consumer advertising, to 
subsequently using of omeprazole, the PPI with direct-to-consumer advertising 
(Hansen 2005), while having a deductible for outpatient services predicted higher 
switching.   
Three studies reported findings on composite measures of managed care.  First, 
practicing in a state with high managed care state-level regulations vs. no 
regulations generally predicted higher physician-level satisfaction on measures of 
clinical practice for physicians with a high portion of practice with managed care 
enrollees, but markets with greater managed care activity (measured by the 
market HMO penetration rate) in states with high state-level managed care 
regulations did not experience satisfaction effects at the market-level 
(Kronebusch 2009).  Second, in a study assessing the health services utilization 
of children with special health care needs (CSHCN), principle component and 
factor analyses were used to derive three MCO indices of composite MCO 
qualities, and their effects were assessed: 1) the Pediatrician-Focused Index 
predicted lower outpatient and inpatient use; 2) the Specialist-Focused Index 
predicted increased ER visits; and 3) the FFS MCO Index predicted greater 
outpatient use and charges.  Third, examining the same sample of CSHCN as in 
the previous study, an increased likelihood of CSHCN receiving an outpatient 
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specialty care visit was predicted by a higher percentage of pediatricians in a 
MCO’s PCP network, a lower percentage of network PCPs paid on a FFS basis 
versus capitation, and giving bonuses to PCPs for high quality care were 
associated with increased odds of receiving an outpatient specialty care visit, 
while visits were not predicted by prior authorization exemptions for CSHCN or 
percentage of MCO PCPs who were salaried (Shenkman 2005). 
Summary of Health Insurance Effects 
Overall, the review of health insurance effects on health services utilization did 
not provide substantial evidence that pertains to insurance feature effects on 
CRC screening.  The present enrollment composition of health plans indicates 
that managed care network restrictions and cost controls are ubiquitous today, 
although the continued popularity of PPOs with less restrictive network rules and 
the rising share of persons covered by HDHP/SO plans indicates that access to 
providers and affordability are clearly key concerns for consumers  (The Kaiser 
Family Foundation and Health Research & Educational Trust 2013).  Long-term 
trends for annual HEDIS measures show that health plan performance on some 
process and outcome measures of quality has been improving across plan types 
(National Committee for Quality Assurance 2013).  For CRC screening 
performance specifically, the HEDIS CRC screening measure indicates that 
HMOs achieve higher CRC screening rates than PPOs, and study findings 
suggest that consistent with expected organizational incentives, MMC plans have 
historically favored lower cost FOBT compared to endoscopy procedures 
(Schneider 2008b).   
A systematic literature search discovered only three findings that pertained to 
CRC screening utilization specifically; first-dollar coverage of preventive services 
increased FOBT use in a commercial health plan compared to a control plan 
without first-dollar coverage (Meeker 2011); believing that specialists were 
available when desired predicted increased CRC screening use (O'Malley 2005); 
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and percentage of practice revenue from managed care did not affect use of six 
preventive services including lower endoscopy (Pham 2005).  Many of the 
variables in these studies may be unlikely to affect CRC screening use because 
the questions they were originally used to assess are not relevant to whether an 
individual receives CRC screening (e.g. coinsurance effects on medication 
utilization and MCO characteristics’ effects on CSHCN receiving needed 
services).  Even if variables are specified in a way that is applicable to CRC 
screening, including them in analyses depends on their availability in MEPS, 
which may be limited.  In addition, even though the insurance feature literature 
search was constrained to the previous ten years, the findings mostly pertain to 
data from the late 1990s and early 2000s and therefore do not indicate more 
recent evolving or emerging influences of insurance features. 
 
Full Literature Review Summary 
 
CRC causes substantial morbidity and mortality.  CRC incidence and mortality 
increases with age, is greater for men than women, and is particularly high for 
African Americans compared to other racial and ethnic groups.  Other racial and 
ethnic minorities (Asians, Hispanics, and AIANs) generally have CRC incidence 
and mortality rates lower than the population average, as well as rates among 
whites and non-Hispanics (Surveillance, Epidemiology, and End Results 
Program 2013).  CRC risk increases due to medical history factors including 
family history of CRC and personal history of some gastrointestinal conditions 
and due to lifestyle risk factors including obesity and cigarette smoking.  Overall 
five-year survival is 64.9%, although prognosis varies from >90% survival for 
earliest stage cancers to <10% survival for late stage cancers, which provides 
the rationale for routine CRC screening by detecting cancers earlier and 
removing pre-cancerous polyps. 
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Rates of CRC screening use have increased substantially since the 1980s, 
driven by increased colonoscopy use after Medicare’s reimbursement 
expansions (Gross 2006) and by a shift in provider opinion (Klabunde 2009).  A 
large number of diverse factors predict CRC screening use, which were reviewed 
and organized according to the Behavioral Model of Health Services Use 
framework as predisposing, enabling, and need-based factors (Andersen 1995).  
Predisposing factors include the categories of demographics, acculturation, 
health beliefs, preventive services utilization history, patient-provider 
communication, and health status; need-based factors include the categories of 
medical history related to CRC risk and risk-modifying lifestyle factors; and 
enabling factors include SES, health care access, health services utilization 
history, and social ties.  The large number of factors influencing CRC screening 
implies many potential origins and mechanisms contributing to disparities and 
many potential avenues for promoting CRC screening to under screened groups. 
To evaluate the influence of insurance features on CRC screening use, this study 
adopted Tye et al.’s framework based on the Behavioral Model of Health 
Services Use specifying insurance features as individual enabling factors.  By 
assessing insurance features instead of types of health insurance, the study 
attempted to isolate effects of specific insurance features.  Testable hypotheses 
of insurance feature effects are guided by organizational theory that insurance 
features affect CRC screening use among enrollees by influencing a health 
insurer’s information-processing capacity that affects how effectively an insurer 
communicates appropriate CRC screening to providers and enrollees (Galbraith 
1973), and by economic theory, which posits that insurance features can 
influence the inverse relationship between out-of-pocket costs and demand for 
CRC screening (Manning 1987). 
An informal review of general effects of health plan types and a systematic 
review of insurance feature effects were conducted to inform the selection of 
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insurance features for analysis.  The informal review of general effects of health 
plans by type provided a small amount of mostly dated evidence.  Health plan 
performance for a couple big categorizations (HMOs vs. PPOs and Commercial 
vs. Medicare markets) is reported annually by NCQA in the HEDIS measures, 
which have generally improved over time including CRC screening, although 
NCQA does not aggregate HEDIS performance into assessments of general 
performance domains for different type of health plans or by insurance features 
(National Committee for Quality Assurance 2013).  Reviews of studies of health 
plan performance by type concords with expected effects: MCOs tend to have 
lower use of expensive services and have lower performance on patient access 
and satisfaction than FFS plans (Miller and Luft 2002).  General effects of health 
plans on CRC screening performance include improving HEDIS performance 
over time and the consistently higher rates of CRC screening for HMOs 
compared to PPOs (National Committee for Quality Assurance 2013).  
Additionally, literature evidence suggests that MMC plans in comparison to 
Medicare FFS plans prefer low-cost FOBT CRC screening to endoscopic CRC 
screening (Schneider 2008b).  The systematic literature search of insurance 
feature effects yielded a small number of studies.  Many insurance features were 
suggested in the studies pertaining to provider arrangements, cost-sharing and 
composite measures of managed care, although it is unlikely that the influences 
of insurance features assessed in the reviewed studies would be helpful for 
determining insurance feature effects on CRC screening. 
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Chapter 3 
Methods 
 
This section details the study design, data sources, eligibility criteria, study 
variables, data management and statistical analyses for each specific aim. 
Study Design 
The study is a cross-sectional analysis of secondary survey data assessing the 
association between insurance features and likelihood of being up-to-date with 
recommended CRC screening.  The dependent variable, insurance features, and 
control variables were derived from literature review findings and available 
measures in the data.  The study sample was all respondents in the survey data 
who were eligible for CRC screening.  Effects of insurance features on CRC 
screening likelihood were estimated in multivariate logistic regression models 
with several alternate specifications of covariates decided after preliminary 
diagnostic analyses.  Each insurance feature was evaluated separately because 
of collinearity between features.  Analyses were guided by the Behavioral Model 
of Health Services Use, and hypotheses for the effects of insurance features 
were informed by economic and organizational theory. 
Data Sources 
The data source for this analysis was the MEPS Household Component (MEPS-
HC), the primary component of the family of MEPS health and health services 
utilization surveys, produced by AHRQ, which has a unique breadth of 
information on insurance coverage details, CRC screening use, and 
demographic and socioeconomic predictors of CRC screening (Agency for 
Healthcare Research and Quality 2010).  The MEPS-HC is a nationally 
representative sample of the civilian non-institutionalized population and collects 
 
 
53 
 
information pertaining to household and individual-level demographics and SES; 
health status, medical conditions and health behaviors; health care encounters, 
payments and sources of payment; and health insurance characteristics.  MEPS-
HC data was pooled from the years 2011, 2010 and 2009. 
The MEPS-HC uses an overlapping panel design whereby a new respondent 
panel is formed each year and surveyed five times over two years by computer-
assisted personal interviewing (CAPI) (Agency for Healthcare Research and 
Quality 2013c).  Each new panel is sampled from the previous year’s NHIS, 
which is produced by the National Center for Health Statistics (NCHS).  The 
primary MEPS-HC data file is the full-year consolidated file.  The 2011, 2010, 
and 2009 MEPS-HC sampled 33,622 persons (13,449 families) from panels 15 
and 16; 31,228 persons (12,445 families) from panels 14 and 15; and 34,920 
persons (13,875 families) individuals from panels 13 and 14, respectively.  The 
combined response rates for each of the 2009, 2010 and 2011 full year files were 
57.2%, 53.5% and 54.9%, respectively.  Individuals who appeared twice in the 
pooled 2009-2011 dataset (panels 14 and 15) were included in the analyses 
twice, which was recommended by MEPS for this study’s multiyear cross-
sectional analyses by using appropriate survey analyses (rather than only 
including them in only one of their two appearances) (Zibman 2014).  In addition 
to the full-year consolidated file, the Medical Conditions File, one of the other 
MEPS-HC data files, was used to derive a comorbidity index (Agency for 
Healthcare Research and Quality 2013a).  The study exclusively used de-
identified data, so institutional review board approval was not needed. 
Eligibility Criteria 
MEPS respondents were included in the study if they were aged 50-75, did not 
have a prior CRC diagnosis, were insured for any amount of time during the year, 
and had been “in scope” for the entire survey year (had responded during all 
scheduled interview rounds in the survey year) (2009, 2010 or 2011). 
 
 
54 
 
 
Study Variables 
 
Dependent Variable 
The outcome measure for CRC screening status was a binary variable for 
whether a person had received CRC screening by any technique within the 
USPSTF recommended time intervals (US Preventive Services Task Force 
2008).  According to the Grade A recommendation for average risk persons aged 
50-75, acceptable screening techniques and intervals are 1) a colonoscopy every 
ten years, 2) FSIG every five years with FOBT every three years, or 3) FOBT 
annually.  The MEPS questionnaire asks when a respondent last received each 
test (within the past one, two, three, five, or ten years, more than ten years, or 
never), which was used in this study to determine if a respondent was up-to-date 
with the recommendations.  Persons with missing values for all CRC screening 
techniques were conservatively assumed not up-to-date with CRC screening. 
The 2008 USPSTF recommendations were used, although other notable 
guidelines with minor differences were also released around that time including, 
in 2008, the “joint effort of the American Cancer Society, US Multisociety Task 
Force on Colorectal Cancer, and American College of Radiology”, (McFarland 
2008), and, in 2009, the American College of Gastroenterology (Rex 2009).  All 
of the guidelines agree that routine screening for average risk persons should 
begin at age 50 (the American College of Gastroenterology uniquely 
recommends that African Americans should start screening at 45 (Rex 2009)), 
and have screening strategy recommendations and time intervals that are very 
similar to the USPSTF.  The USPSTF uniquely asserts that FSIG within the past 
five years should be accompanied by FOBT every three years based on findings 
from a meta-analysis and modeling simulation of different screening strategies 
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(Whitlock 2008).  The USPSTF concluded that the evidence was insufficient to 
recommend CT colonography and fecal DNA testing and was sufficient to 
recommend against DCBE, although the other guidelines have recommendations 
for each of those techniques.  While the other guidelines do not declare a stop 
age for CRC screening (Rex 2009; McFarland 2008), the USPSTF guidelines 
recommend stopping routine CRC screening at age 75.  The USPSTF 
recommendations have been used to define being up-to-date with CRC 
screening in recent benchmark estimates of the percentage of the national 
population that was screened using national survey data (Klabunde 2013; 
Shapiro 2012; Joseph 2012).  By specifying the dependent variable in this study 
consistent with the main USPSTF screening recommendation for those aged 50-
75, this study focused on the segment of the population that is most universally 
agreed upon by all guidelines and was consistent with recent benchmark 
estimates of national CRC screening use. 
Control Variables 
Different combinations of CRC screening predictor covariates were controlled for 
in several models.  Table 3.1 lists the relevant control variables that were 
available in MEPS for all three data years.  All control variables were derived 
from respondent self-report either in the full-year consolidated file or the Medical 
Conditions File for self-reported medical conditions, which were used to compute 
the updated Charlson comorbidity score (Quan 2011).  The available control 
variables encompassed all three domains of factors that influence health services 
use according to the Behavioral model, which are predisposing factors: 
demographics, acculturation, preventive services utilization and health status; 
need-based factors: lifestyle factors and personal medical history; and enabling 
factors: education/income, health care access, and social ties.  Fixed effect 
dummy variables for survey year were included in all models. 
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Table 3.1 Control Variables 
Variable Levels 
Predisposing Factors 
Demographics 
Age Continuous 
Sex Male/Female 
Race/Ethnicity 
White, non-Hispanic 
White, Hispanic 
Black, non-Hispanic 
Asian, non-Hispanic 
Other 
Census region 
Northeast 
Midwest 
South 
West 
Metropolitan Statistical Area Yes/No 
Acculturation 
Immigration status 
US born 
Foreign born, lived in US <15 years 
Foreign born, lived in US >15 years 
Whether comfortable speaking English Yes/No 
Survey Language 
English 
Spanish/English and Spanish/Other 
Preventive Services Utilization 
Dental check-up frequency 
Twice a year or more 
Once a year 
Less than once a year 
Never go to the dentist 
Most recent flu vaccine 
Within the last year 
Within past two years 
More than two years 
Never 
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Table 3.1 (cont.) 
Health Status 
Self-reported health status 
Excellent 
Very good 
Good 
Fair/Poor 
Comorbidity (Quan et al.’s updated 
Charlson’s comorbidity index) 
 
0 
1 
2 
3 or more comorbidities 
Need-Based Factors  
Lifestyle Factors 
Current smoker Yes/No 
Body mass index 
Underweight 
Normal weight 
Overweight 
Obese 
Personal Medical History 
Personal cancer diagnosis other than 
CRC 
Yes/No 
Enabling Factors 
Education/Income 
Educational attainment 
Less than a HSD 
HSD/GED 
Bachelor’s degree 
Graduate/Doctorate degree 
Other degree 
Household income (% of the federal 
poverty level) 
<100% 
100-200% 
200-400% 
>400% 
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Table 3.1 (cont.) 
Health Care Access 
Having a usual source of care Yes/No 
Months of insurance coverage in 
survey year 
1-6 months 
7-11 months 
Continuous coverage 
Number of office-based physician/nurse 
practitioner/physician’s assistant visits 
in last year 
Zero 
One 
Two 
Three 
Four or more 
Social Ties 
Marital status 
Married 
Widowed 
Divorced/Separated 
Never Married 
HSD: high school degree; GED: general educational development 
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Insurance Features 
Insurance features were the primary independent variables of interest, which act 
as individual enabling factors.  Organizational health plan features and whether a 
respondent’s household had a FSA were derived from self-reported health plan 
characteristics in the Managed Care (MC) questionnaire section.  Self-reported 
responses are obtained using computer-assisted personal interview, which 
includes questions, instructions, help available with definitions for key terms (e.g. 
HMO, primary care doctor, and routine care), and skip patterns depending on the 
topic and a respondent’s answers.  Cost-sharing percentage was calculated 
using payment amount and sources of payments data.  Insurance features and 
variable levels are listed in Table 3.2. 
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Table 3.2 Insurance Features (Enabling Factors)  
Variable Levels MEPS Criteria for 
having feature 
Organizational 
Whether respondent’s 
insurance defined a 
provider network (DPN) 
Yes/No PRVDRL31/42/11 = 1 
or PRVHMO31/42/11 = 1 
or MCDHMO31/42/11 = 1 
Whether respondent’s 
insurance restricted 
coverage to a DPN 
Yes/No PRDRNP31/42/11 = 2 
or PHMONP31/42/11 = 2 
or PMNCNP31/42/11 = 2 
(No if INSURC11 = 4 or 6) 
Whether insurance used 
gatekeeping 
Yes/No PRVMNC31/42/11 = 1 
or MCDMC31/42/11 = 1 
or PRVHMO31/42/11 = 1 
or MCDHMO31/42/11 = 1 
Financial 
Cost-sharing categories  0% 
 Top fifth percentile of cost-
sharing distribution 
 Internal tertiles of cost-
sharing distribution (other 
than 0% and top fifth 
percentile) 
 Those with no spending in 
the survey year 
Cost-sharing computation: 
TOTSLF09/10/11 / 
TOTEXP09/10/11 
Variable categories: 
 0% cost-sharing 
 >0% to 35th percentile 
 35th to 65th percentile 
 65th to 95th percentile 
 95th percentile to 100%  
 TOTEXP11 = 0 
 
Whether respondent’s 
family had a Flexible 
Spending Account (FSA) 
Yes/No FSAGT31 = 1 
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Organizational Features 
Having a DPN 
Respondents were identified as having insurance with a DPN if the respondent 
reported being in an HMO from a private source (PRVHMO31/42/11 = 1) or 
through Medicaid (MCDHMO31/42/11 = 1), or if they reported having “coverage 
by a private insurance source that has a book or list of doctors” 
(PRVDRL31/42/11 = 1). 
Provider network restrictions 
Respondents were defined as having insurance that restricted care to a coverage 
network if the respondent reported having insurance that does not pay for visits 
to non-plan doctors without a referral (PRDRNP31/42/11 = 2, or 
PHMONP31/42/11 = 2 or PMNCNP31/42/11 = 2).  The MEPS variables used to 
construct this variable only apply to those with any private insurance, i.e., those 
who are privately insured under age 65 and MA beneficiaries.  Medicare 
recipients without any private insurance (i.e. traditional FFS Medicare) were 
assumed to not have provider network restrictions (INSURC11 = 4 or 6; 
INSURC11 was introduced in MEPS 2011, so was manually derived to use with 
MEPS 2009 and 2010).  Whether individuals under age 65 with only public 
insurance had coverage restricted to a DPN could not be ascertained, so those 
respondents were excluded from analyses of this variable.   
Gatekeeper requirement 
Respondents were defined as having insurance that used gatekeeping if the 
respondent reported being in an HMO (PRVHMO31/42/11 = 1 
or MCDHMO31/42/11 = 1) or being in a gatekeeper plan from any private 
insurance (PRVMNC31/42/11 = 1) or Medicaid (MCDMC31/42/11 = 1) meaning 
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the respondent was required to sign up with a gatekeeper for all routine care 
(physician, group of doctors or clinic). 
Financial Features 
Cost-sharing percentage 
A respondent’s level of cost-sharing in the survey year was estimated by 
computing the proportion of total expenditures that were paid out-of-pocket by 
the respondent (TOTSLF09/10/11 / TOTEXP09/10/11), which corresponds to a 
percentage from 0% to 100%.  Cost-sharing percentage could not be estimated 
for those who did not have any spending in the survey year (TOTEXP09/10/11 = 
0).  The cost-sharing distribution had decreasing density of respondents from to 
zero to 100% with a bolus of people at each 0% and 100%.  The boluses and 
persons with no spending potentially contain unique population segments.  At the 
low end of the cost-sharing distribution, those with zero cost sharing were 
probably more likely to be recipients of public insurance, Medicaid or other 
programs with zero cost-sharing, and made up ~6% of each sample.  Having 
zero cost-sharing because of having public insurance suggests this segment of 
the distribution was more likely poorer and disadvantaged in other ways.  The 
disadvantage in the population segment with 0% cost-sharing was expected 
would reduce the likelihood of being up-to-date with recommended CRC 
screening independent of the effect of having zero or extremely low cost-sharing.  
It is not clear what would be the net effect to screening use for this population 
segment when also accounting for the cost-sharing effect.   
At the other end of the cost-sharing range, two possible, non-exhaustive 
explanations for having 100% or close to 100% cost-sharing were that a 
respondent had insurance with a high deductible, which was not exceeded in the 
year, or that a respondent was only insured for part of the year and only or 
primarily had health care expenses during the time that they were uninsured.  
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These two explanations did not suggest a single gestalt for those with 100% or 
near 100% cost-sharing, so it is unclear what would be the ultimate effect on 
screening use for this population segment. 
The ultimate effect of cost-sharing at each end of the cost-sharing distribution is 
unclear and may not accord with the expected inverse relationship between cost-
sharing and utilization (Manning 1987).  In consideration of this ambiguity, cost-
sharing was specified as a categorical variable cutting the cost-sharing 
distribution into five levels.  The first level was those with no (0%) cost-sharing 
(approximately 6% of the distribution as previously noted) and the fifth level was 
the top 5% of the cost sharing distribution (95th percentile to 100% cost-sharing) 
for the practical analytic purpose of ensuring that all samples had at least 100 
respondents in the highest cost-sharing category.  The remaining internal 
distribution was split into three groups, so each includes approximately 30% of 
the sample (>0% to the 35th percentile, 35th to 65th percentile, and 65th to 95th 
percentile).  Sample weights were accounted for when splitting the cost-sharing 
distribution.  Those without any medical spending in the survey year were 
included in the cost-sharing variable as a sixth category.  Not having any 
spending in the survey year suggests a person did not encounter the health care 
system in the survey year, which may indicate that the person was fairly healthy 
and/or not health aware, although the ultimate implication for CRC screening use 
among those without any spending is unclear.  The procedure for constructing 
the categorical variable was repeated separately for each sample.   
Flexible Spending Accounts 
A binary variable for whether a respondent’s household had a FSA in the survey 
year was included for the first time in the 2011 MEPS.  A FSA is an employer-
established savings account that the employee funds with pre-tax dollars and can 
use to pay for qualified out-of-pocket medical expense (Internal Revenue Service 
2013).  FSA funds are “use-it-or-lose-it”: remaining funds in the FSA account are 
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forfeit at the end of the plan year, although plans are allowed to permit a grace 
period of up to 2.5 months into the following plan year during which the funds 
may be used.  The literature review findings and causal pathways used from Tye 
et al. did not provide immediate guidance for how having a FSA account might 
affect CRC screening use.  For these analyses, it was assumed that having an 
FSA (FSAGT31 = 1) suggests that a person is health aware, so those who have 
FSAs were expected to be more likely to be up-to-date with recommended 
preventive services including CRC screening.  Analyses for the FSA variable are 
restricted to the MEPS 2011 sample. 
Data Management 
The 2009, 2010 and 2011 MEPS Household Components and Medical 
Conditions files were freely downloadable on the MEPS website (Agency for 
Healthcare Research and Quality 2013).  Survey methods were used to account 
for MEPS’ complex survey design and correlation between survey years, so that 
standard errors were correctly computed.  Sampling weights were used 
corresponding to the US civilian, non-institutionalized population.  Stata version 
13.1 was used for all analyses (StataCorp, LP College Station, TX).  All 
categorical covariates were included with a “missing” category, because STATA 
removes observations from analyses “listwise” (if a value for any covariate is 
missing, the observation is dropped from the analyses).  In addition to preserving 
sample size, including the “missing” category accounts for variance in the 
outcome explained by missing values. 
 
Statistical Analyses 
 
Aim 1.  Evaluate the association between insurance features and likelihood 
of being up-to-date with USPSTF-recommended CRC screening.   
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Analytic Plan for Aim 1 
The analytic approach for Aim 1 was to perform multivariate logistic regression to 
assess insurance feature effects on likelihood of being up-to-date with 
recommended CRC screening while accounting for covariates.  The following 
sections detail descriptive statistics, fitting the multivariate logistic regression 
models, and sensitivity analyses. 
Descriptive Univariate and Bivariate Statistics 
Summary univariate statistics were computed.  For age, counts were reported by 
five-year increments, although age was included in analyses as a continuous 
variable.  Any sparse variable levels were combined with other levels of the 
variable.  Bivariate associations between CRC screening status and independent 
variables were assessed by performing Chi-square tests using an F statistic, 
which is derived from the Pearson Chi-Square statistic corrected for the survey 
design with the second-order correction of Rao and Scott (Rao and Scott 1984).  
This statistic, the “Design-based F statistic” is Stata 13.1’s default test of 
independence for two-way tables of survey data and is recommended “in all 
situations”.  The p value is interpreted in the same way as the uncorrected 
Pearson Chi-Square test.  Covariates that did not have a significant bivariate 
association at p<0.1 were not included in subsequent analyses. 
Multivariate Logistic Regressions 
MVLR was performed to assess insurance feature effects while controlling for 
covariates.  Logistic regression is the standard method to model binary 
outcomes.  Logistic regression is a generalized linear model that uses maximum 
likelihood estimation with a binomial family and logit link function to predict 
probabilities between zero and one.  The following procedure was used to select 
covariates for models and estimate insurance feature effects. 
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Multiple models were run for each insurance feature and for each sample to 
reveal variation in insurance effects depending on model specification.  First, 
covariates were assessed in blocks of substantively related covariates 
(demographics; acculturation; education and income; lifestyle factors; health 
status; prevention history; and health care access) in multivariate logistic 
regressions without including any insurance features.  In this step, marital status 
was included in the demographics block and personal cancer history was 
included in the health status block.  Any covariates in each block that did not 
remain significant at p<0.05 were not included in subsequent analyses.  For the 
remaining covariates in each block, whether any covariates were collinear or 
collinear with the outcome was assessed using the stata command ––_–rmdcoll–
, which can accommodate categorical variables.   
Second, Insurance features were then assessed with each covariate block 
separately.  In this step, demographics and acculturation factors were collapsed 
as one block, and lifestyle and health status/personal cancer history were 
collapsed as one block.  The effect of the binary insurance features on likelihood 
of being up-to-date with recommended CRC screening was estimated in terms of 
multivariate adjusted percentage point change (e.g. “having a DPN predicted an 
X% point change in likelihood of being up-to-date with recommended CRC 
screening”) with 95% confidence interval using the Stata –margins– command 
and –dydx()– option and in terms of multivariate-adjusted percentages for the 
categories of the cost-sharing percentage variable using the main option in the –
margins– command.  The reported multivariate adjusted percentages are the 
percentages of respondents predicted to be up-to-date with recommended CRC 
screening at each level of an independent variable level when the independent 
variable is alternately artificially fixed at each of its levels while all other 
covariates remain varied at their observed levels.  Multivariate-adjusted 
percentages are known by other names including “predictive margins” (Graubard 
and Korn 1999) and “recycled predictions” (Basu and Rathouz 2005).  
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Multivariate-adjusted percentages are easy to interpret and avoid the problem of 
adjusted odds ratios diverging from relative risk ratios when the outcome variable 
is common, especially >50%, as is the case for CRC screening status. 
Third, Insurance feature effects were then assessed in two multi-block models 
including multiple covariate blocks.  A full model was assessed including all 
blocks, and a reduced full model was run including all covariate blocks except for 
the preventive services utilization and health care access blocks, which may bias 
insurance feature effects toward a null effect if factors in those blocks (or 
unobserved factors associated with those factors) are intermediate factors on the 
causal pathway from insurance features to obtaining CRC screening. 
Logistic Equation formula and notation 
The general logistic equation for the analyses is 
Yi = log (pi/(1-pi)) = β0 + β1 (insurance feature) + Σβ(covariates) + μ 
Where  
Yi = logit of the probability, pi, that a person was up-to-date with recommend 
CRC screening 
β0 = intercept 
 μ = error term 
 
Hypotheses 
 
Hypotheses for the insurance features that were actually analyzed were specified 
based on the criteria in the overarching Aim 1 hypothesis in Chapter 1.  Study 
hypotheses were derived from the causal pathways noted by Tye et al., which 
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proposed that organizational factors would influence CRC screening use 
according to the information-processing theory, and financial characteristics 
influence out-of-pocket costs thereby altering demand for CRC screening 
procedures.  This study’s three organizational insurance features were the same 
as those used by Tye et al. and have equivalent hypotheses.  This study’s two 
financial insurance features were newly examined.  As previously discussed, an 
effect for the FSA variables was not suggested by the extant literature and the 
causal pathways, so a basis for a hypothesis for that variable has been 
proposed.  The hypotheses are tested by assessing whether multivariate logistic 
regression coefficient estimates for the insurance features are different from 
zero. 
Organizational Hypotheses  
DPN 
Having insurance that defined a provider network was hypothesized would 
increase likelihood of being up-to-date with recommended CRC screening in 
comparison to individuals with insurance without a DPN. 
Coverage Restricted to a DPN 
Having insurance that restricted care to a DPN was hypothesized would increase 
likelihood of being up-to-date with recommended CRC screening in comparison 
to not having insurance that restricted care to a DPN 
Physician Gatekeeper Requirement 
Having insurance that used gatekeeping was predicted would increase likelihood 
of being up-to-date with CRC screening in comparison to not having gatekeeping 
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Rationale for Organizational insurance feature Hypotheses 
Following Tye et al.’s rationale, structures that enable insurers to improve 
information flows from administration to clinicians and enrollees will be more 
likely to achieve organizational goals (Galbraith 1973) such as increasing CRC 
screening.  Having a DPN, having care restricted to a DPN, and using 
gatekeeping were expected to increase the insurer’s ability to communicate and 
motivate appropriate CRC screening to providers and enrollees. 
Financial Hypotheses 
Cost-Sharing 
Overall, greater cost-sharing, i.e. a higher percentage of total payments paid out-
of-pocket in the survey year, was hypothesized would predict decreased 
likelihood of being up-to-date with recommended CRC screening.  An exception 
to that relationship occurred: having 0% cost-sharing predicted a negative effect 
on likelihood of being up-to-date with recommended CRC screening, although it 
is unclear what effect 0% cost-sharing would have relative to other cost-sharing 
percentages.  Having no spending in a year was hypothesized would have a 
negative effect on likelihood of being up-to-date with recommended CRC 
screening, although it is unclear what effect having no spending would have 
relative to the cost-sharing percentages.  
Flexible Spending Account 
Having a FSA was hypothesized would increase likelihood of being up-to-date 
with CRC screening in comparison not having a FSA. 
Rationale for Financial insurance feature Hypotheses 
Having greater cost-sharing during the survey year was expected would be 
correlated with higher out-of-pocket costs or otherwise greater financial barriers 
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to obtaining needed services (and/or possibly is associated with other non-
financial barriers).  The disadvantage suggested by greater cost-sharing during 
the survey year was therefore expected would predict decreased likelihood of 
being up-to-date with recommended CRC screening.  Those with 0% cost-
sharing were probably more likely to be recipients of public insurance, Medicaid 
or other programs with 0% cost-sharing in the survey year.  Disadvantage that is 
associated with being a recipient of those programs was expected to have a 
negative effect on CRC screening likelihood.  Individuals who had no medical 
spending during the survey year probably had not encountered the health care 
system during the survey year, which may indicate that the person was fairly 
healthy; averse to encountering the health care system because of financial 
barriers, personal preferences, or other reasons; and/or was not health aware.  
Intentional or unintentional avoidance of the healthcare system would reduce the 
probability of receiving a recommendation to obtain CRC screening.  In total, not 
having any spending was expected to predict reduced CRC screening likelihood. 
Evidence of financial planning for medical expenses may be associated with 
generally being more health aware.  Having a FSA may indicate that an 
individual or family was planning for medical expenses. 
Aim 2.  Evaluate the association between insurance features and likelihood 
of being up-to-date with USPSTF-recommended CRC screening among 
Western US Hispanic and non-Hispanic whites.   
Hypothesis: Aim 1’s hypothesized benefits of increased CRC screening use due 
to insurance features will be greater for Western non-Hispanic whites than 
Hispanic whites.  
Rationale for Hypothesis for Aim 2: 
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Greater socioeconomic disadvantage among Western Hispanic whites in 
comparison to non-Hispanic whites is expected to limit the ability of Hispanic 
whites to benefit from having insurance features that foster CRC screening use. 
Analytic Plan for Aim 2 
The sample for the Aim 2 sub-analysis of Western Hispanic and non-Hispanic 
whites was generated using the sample from Aim 1 analyses and further limiting 
eligibility to Hispanics and non-Hispanic whites in the Western US census region.  
Model selection for Aim 2 followed the same procedure as for Aim 1 with two 
modifications.  In the multivariate logistic regressions, Hispanic vs. non-Hispanic 
white ethnicity was included in the models without insurance features and the 
models with insurance features and separate covariate blocks.  In the models 
with covariate blocks and insurance features, an interaction term for insurance 
features and Hispanic ethnicity was included to assess if ethnicity mediated 
insurance feature effects.   
In all Aim 2 analyses that estimated main effects, the Bonferroni correction was 
applied for calculating 95% confidence intervals to account for multiple 
comparisons within the interaction term (insurance feature*Hispanic ethnicity).  
The Bonferroni correction protects against inflating the experimentwise error rate 
(the probability of a Type I error) by dividing the experimentwise error rate by the 
number of comparisons performed to calculate the comparisonwise error rate. 
Contrast tests were performed to test specific effects in the findings.  For the 
binary insurance features, five contrast test were performed: the difference 
between predicted screening likelihood for Hispanics vs. non-Hispanics, 1) 
without the insurance feature, and 2) with the insurance feature; the difference 
between predicted screening likelihood with the feature vs. without the feature, 3) 
for non-Hispanic whites, and 4) for Hispanics whites; and 5) the net effect for 
Hispanics vs. non-Hispanics of contrast test 4) minus contrast test 3).  For the 
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cost-sharing variable, five contrast tests were performed for Hispanics vs. non-
Hispanics whites within each of the cost-sharing variable levels. 
 
Sensitivity Analyses 
 
Potential Incorrect Temporal Ordering of Insurance Features and Being Up-
To-Date with Recommended CRC screening 
A sensitivity analysis was performed to account for potential bias due to incorrect 
temporal ordering, that a person could have gained their current insurance 
features after their last screening.  Respondents’ insurance features pertained to 
the MEPS survey year although a respondent could have been up-to-date with 
recommended CRC screening due to having received screening prior to the 
survey year (as much as 10 years before for colonoscopy).  Because people 
change insurance when they gain employment, change employment, enroll in 
Medicare or for other reasons, it is likely that some respondents had different 
insurance when they were last screened than reported in MEPS, and the 
likelihood of having different insurance is expected to increase for individuals 
who had their last CRC screening further in the past.  In order to assess this 
temporal ordering concern, sensitivity analyses of Aims 1 and 2 were conducted 
with a second dependent variable: any colonoscopy, FSIG or FOBT within the 
last year.  If insurance features more strongly influenced more recent CRC 
screening use, insurance features would be expected to have a greater impact 
on CRC screening use in the previous year than on being up-to-date with 
USPSTF-recommended CRC screening.  For the sensitivity analyses, the 
samples were restricted to those who had been screened in the past year and 
those who were not up-to-date with recommended CRC screening.  Those who 
were up-to-date with screening but not in the past year were excluded from the 
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sample because it would not have been appropriate to combine them with those 
who were not up-to-date with screening.  The procedure used to fit models for 
Aims 1 and 2 was repeated to perform the sensitivity analysis. 
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Chapter 4 
Results 
 
This chapter presents analytic findings that address the main and sensitivity 
analyses for Aims 1 and 2.  The reported analyses include univariate sample 
characteristics; unadjusted bivariate associations of the CRC screening 
outcomes and the levels of the covariates and of the insurance features; and 
multivariate adjusted estimates of the main effects for each insurance feature.  
Results are presented for the binary insurance features first for each Aim and 
then for the cost-sharing variable for each Aim.   
 
Sample Characteristics 
 
Aim 1 Sample Characteristics 
Table 4.1a presents the characteristics of the full Aim 1 sample, which included 
all MEPS respondents who were eligible for CRC screening.  The sample 
included persons aged 50-75, with insurance for any part of the survey year and 
without a prior colon or rectal cancer diagnosis, which includes 21,085 
respondents from 2009-2011 MEPS representing an annualized population-
weighted 74,526,972 Americans.  The MEPS years 2009, 2010, and 2011 made 
contributions of 31.8%, 33.2%, and 35.0% of the weighted sample, respectively.  
The sample mostly represented insured Baby Boomers, so the sample was more 
white, non-Hispanic, and female than the full American population, which also 
includes those under age 50, greater than age 75, and the uninsured.  The 
sample’s mean and median ages were 60.5 and 60, and each subsequent five-
year band had fewer respondents with 5,440 (26.3%) respondents aged 50-54 
years and 3,008 (14.3%) respondents aged 70-75 years.  The sample was 
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52.3% female and 76.8% non-Hispanic white with small minorities each of 
Hispanic whites, 7.3%; non-Hispanic blacks, 9.9%; non-Hispanic Asians, 3.9%; 
and other race/ethnicities, 2.1%.  The contributions of the categories of  
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Table 4.1 Univariate Summary Statistics 
 4.1a, Aim 1 Full Sample 4.1b, Aim 2 Full Sample 
 
Weighted-
sample 
annualized 
population 
size 
Unweighted 
sample size 
Weighted 
% of 
sample 
Weighted-
sample 
annualized 
population 
size 
Unweighted 
sample size 
Weighted 
% of 
sample 
       
Total 74,526,972 21,085 100.0 13,853,125 3,751 100.0 
       
Covariates 
       
Age groups       
50-54 19,616,829 5,440 26.3 3,732,117 976 26.9 
55-59 17,113,336 4,955 23.0 3,093,918 848 22.3 
60-64 14,799,696 4,006 19.9 2,755,905 728 19.9 
65-69 12,344,575 3,676 16.6 2,310,724 675 16.7 
70-75 10,652,535 3,008 14.3 1,960,462 524 14.2 
       
Sex       
Male 35,522,688 9,659 47.7 6,689,884 1,775 48.3 
Female 39,004,283 11,426 52.3 7,163,240 1,976 51.7 
       
Race/Ethnicity       
non-Hispanic white 57,230,823 12,086 76.8    
Hispanic white 5,435,947 2,933 7.3    
non-Hispanic black 7,402,528 4,062 9.9    
non-Hispanic Asian 2,893,011 1,429 3.9    
Other 1,564,664 575 2.1    
 
 
77 
 
Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
White/Ethnicity       
non-Hispanic white    11,647,438 2,584 84.1 
Hispanic white    2,205,687 1,167 15.9 
       
Marital status       
Married 49,932,668 13,180 67.0 9,287,045 2,463 67.0 
Widowed 5,579,601 1,880 7.5 883,773 276 6.4 
Divorced/Separated 13,698,075 4,289 18.4 2,699,080 741 19.5 
Never married 5,316,628 1,736 7.1 983,226 271 7.1 
       
Census region       
Northeast 14,602,864 3,639 19.6    
Midwest 16,826,354 4,432 22.6    
South 26,798,988 7,935 36.0    
West 16,298,767 5,079 21.9    
       
Metropolitan Statistical Area Status       
Urban 61,445,605 17,598 82.4 12,163,438 3,412 87.8 
Rural 13,081,367 3,487 17.6 1,689,686 339 12.2 
       
Immigration status       
US born 65,621,990 16,955 88.1 11,861,037 2,843 85.6 
Foreign born, lived in US <15 years 1,175,053 574 1.6 169,394 66 1.2 
Foreign born, lived in US > 15 years 7,546,034 3,388 10.1 1,770,013 812 12.8 
missing 183,895 168 0.2 52,681 30 0.4 
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Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
Whether comfortable speaking English       
Comfortable 71,561,893 19,307 96.0 13,129,265 3,277 94.8 
Not comfortable 2,297,908 1,358 3.1 573,108 374 4.1 
missing 667,170 420 0.9 150,751 100 1.1 
       
Interview language       
English 71,683,863 19,379 96.2 13,021,417 3,220 94.0 
Spanish, Spanish and English, or other 2,843,108 1,706 3.8 831,708 531 6.0 
       
Dental checkup frequency       
Twice a year or more 35,880,939 8,550 48.1 7,300,778 1,703 52.7 
Once a year 14,571,697 4,434 19.6 2,830,157 837 20.4 
Less than once a year 12,437,074 4,003 16.7 2,245,895 702 16.2 
Never go to dentist 10,949,689 3,754 14.7 1,345,834 453 9.7 
missing 687,572 344 0.9 130,461 56 0.9 
       
Most recent flu shot       
Within past year 39,279,276 10,632 52.7 7,071,013 1,892 51.0 
Within past two years 6,072,806 1,752 8.1 1,342,285 348 9.7 
More than two years 6,691,000 1,859 9.0 1,436,096 354 10.4 
Never received flu shot 20,816,672 6,177 27.9 3,684,262 1,046 26.6 
missing 1,667,217 665 2.2 319,469 111 2.3 
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Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
Perceived health status       
Excellent 14,710,229 3,660 19.7 3,097,957 736 22.4 
Very good 24,730,156 6,461 33.2 4,740,141 1,230 34.2 
Good 22,582,379 6,692 30.3 3,729,675 1,064 26.9 
Fair/Poor 12,431,749 4,219 16.7 2,268,360 713 16.4 
missing 72,459 53 0.1 16,992 8 0.1 
       
Have any personal non-CRC cancer 
history       
No 61,732,591 17,944 82.8 11,294,213 3,139 81.5 
Yes 12,768,428 3,114 17.1 2,558,130 611 18.5 
missing 25,953 27 0.0 782 1 0.0 
       
Quan et al.’s updated Charlson 
comorbidity index       
0 47,693,178 13,186 64.0 9,118,062 2,419 65.8 
1 13,852,869 4,287 18.6 2,316,786 709 16.7 
2 7,772,125 2,111 10.4 1,546,859 391 11.2 
3+ 5,208,799 1,501 7.0 871,417 232 6.3 
       
Smoking status       
Non-smoker 58,449,915 15,887 78.4 11,448,867 3,019 82.6 
Current Smoker 10,969,071 3,189 14.7 1,419,922 394 10.2 
missing 5,107,986 2,009 6.9 984,336 338 7.1 
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Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
BMI categories       
Underweight 676,202 201 0.9 103,927 29 0.8 
Normal weight 19,842,682 5,489 26.6 3,966,023 1,025 28.6 
Overweight 27,122,296 7,577 36.4 5,159,187 1,419 37.2 
Obese 25,133,732 7,243 33.7 4,300,219 1,184 31.0 
missing 1,752,059 575 2.4 323,768 94 2.3 
       
Household income as a percentage of the federal poverty 
level      
Poor/Negative (<100%) 5,931,779 2,580 8.0 950,485 353 6.9 
Near poor/Low income (100-200%) 10,094,014 3,598 13.5 1,738,222 606 12.5 
Middle Income (200-400%) 20,011,870 6,226 26.9 3,623,543 1,107 26.2 
High Income (>400%) 38,489,309 8,681 51.6 7,540,875 1,685 54.4 
       
Educational attainment       
Less than a HSD 7,820,961 3,597 10.5 1,392,248 714 10.1 
HSD/GED 35,097,336 9,935 47.1 6,016,338 1,581 43.4 
Bachelor's 14,292,606 3,410 19.2 2,900,712 638 20.9 
Graduate/Doctorate Degree 9,722,163 2,168 13.0 1,973,788 432 14.2 
Other Degree 7,176,365 1,730 9.6 1,457,629 338 10.5 
missing 417,540 245 0.6 112,410 48 0.8 
       
Number of months insured in survey year       
1-6 2,277,851 902 3.1 478,550 161 3.5 
7-11 2,988,984 1,019 4.0 623,928 206 4.5 
12 69,260,137 19,164 92.9 12,750,646 3,384 92.0 
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Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
Number of outpatient provider visits in 
year including physicians PAs and NPs       
0 11,980,980 4,129 16.1 2,541,009 827 18.3 
1 10,245,516 3,026 13.7 1,947,692 526 14.1 
2 9,597,893 2,744 12.9 1,774,052 486 12.8 
3 7,695,299 2,135 10.3 1,395,529 361 10.1 
4 6,170,006 1,659 8.3 1,032,987 271 7.5 
5+ 28,837,278 7,392 38.7 5,161,856 1,280 37.3 
       
Had a usual source of care       
No 7,283,012 2,345 9.8 1,341,419 415 9.7 
Yes 66,335,649 18,239 89.0 12,397,949 3,270 89.5 
missing 908,310 501 1.2 113,756 66 0.8 
       
Year       
2009  7,153 31.8  1,283 31.7 
2010  6,662 33.2  1,196 34.3 
2011  7,270 35.0  1,272 34.1 
       
Insurance Features       
       
Insurance had a DPN       
No 35,547,734 10,095 47.7 6,017,505 1,596 43.4 
Yes 36,606,857 10,085 49.1 7,536,354 2,048 54.4 
missing 2,372,381 905 3.2 299,265 107 2.2 
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Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
Coverage was restricted to a DPN       
No 56,370,038 15,068 75.6 9,709,907 2,469 70.1 
Yes 12,317,995 3,588 16.5 3,194,268 903 23.1 
missing 5,838,938 2,429 7.8 948,950 379 6.9 
 
Insurance used gatekeeping       
No 45,724,432 12,314 61.4 7,798,892 1,989 56.3 
Yes 26,577,943 7,941 35.7 5,768,384 1,667 41.6 
missing 2,224,596 830 3.0 285,849 95 2.1 
       
Household had a FSA       
No 22,746,654 6,440 87.2 4,121,188 1,130 87.3 
Yes 2,713,425 579 10.4 493,562 101 10.5 
missing 631,509 251 2.4 107,077 41 2.3 
       
Cost-sharing categories for Aim 1 Sample       
0% 3,675,780 1,392 4.9    
0.1 to 13.0% 21,048,250 6,211 28.2    
13.1 to 29.8% 21,017,985 5,415 28.2    
29.8 to 85.8% 21,110,164 5,373 28.3    
85.8 to 100% 3,498,345 980 4.7    
No spending in year 4,176,448 1,714 5.6    
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Table 4.1 (cont.) Aim 1 Full Sample Aim 2 Full Sample 
Cost-sharing categories for Aim 2 Sample       
0%    659,872 216 4.8 
0.1 to 13.9%    3,961,279 1,127 28.6 
14.0 to 32.3%    3,945,991 972 28.5 
32.3 to 88.4%    3,940,298 974 28.4 
88.4 to 100%    655,187 172 4.7 
No spending in year    690,499 290 5.0 
 
Prevalence of Being Up-to-Date with USPSTF-Recommended CRC Screening Strategies 
Received colonoscopy in past ten years      
No 30,691,116 9,621 41.2 6,063,081 1,806 43.8 
Yes 43,835,855 11,464 58.8 7,790,043 1,945 56.2 
       
Received flexible sigmoidoscopy in past five years with FOBT in past three years    
No 72,487,484 20,461 97.3 13,142,436 3,542 94.9 
Yes 2,039,488 624 2.7 710,689 209 5.1 
       
Received FOBT in past year       
No 65,427,664 18,430 87.8 11,546,560 3,123 83.3 
Yes 9,099,307 2,655 12.2 2,306,565 628 16.7 
       
Up-to-Date with USPSTF recommended CRC screening by any strategy     
No 27,913,067 8,739 37.5 5,082,242 1,519 36.7 
Yes 46,613,905 12,346 62.5 8,770,883 2,232 63.3 
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race/ethnicity corresponded to weighted, annualized populations of 57.2 million 
white non-Hispanics, 5.4 million Hispanic whites, 7.4 million non-Hispanic blacks, 
2.9 million non-Hispanic Asians, and 1.6 million persons of other race/ethnicity.  
Over one-third of respondents, 36.0%, resided in the Southern census region, 
while approximately one-fifth resided in the Northeast (19.6%), Midwest (22.6%), 
and Western (21.9%) regions.  Large majorities of the respondents resided within 
a MSA, 82.4%; were born in the US, 88.1%; were comfortable speaking English, 
96.0%; and had completed the MEPS-HC in English only, 96.2%.  As a portion of 
the full sample, most foreign-born persons had resided in the US 15 or more 
years, 10.1% of the full sample, while foreign-born persons who had resided in 
the US less than 15 years comprised only 1.6% of the sample. 
Majorities or near majorities reported being up-to-date with recommended 
preventive care and being in good health without serious illness.  Nearly half 
reported receiving dental checkups twice a year or more often (48.1%), while 
progressively smaller minorities reported less frequent checkups.  Most reported 
receiving a flu shot within the past year, 52.7% although the largest minority 
reported never having received a flu shot, 27.9%.  For lifestyle-related need-
based factors, respondents reported low smoking rates, 14.7%, and the mean 
and median BMI (to the tenth of a BMI point) were 28.6 and 27.5, respectively, 
with high rates of obesity, 33.7%, and overweight BMI, 36.4%, while only 0.9% 
were underweight.  Most people reported very good, 33.2%, or good, 30.3%, 
health status, while small proportions perceived their health status to be at the 
extremes: excellent, 19.7%, and fair/poor, 16.7%.  The mean score on Quan et 
al.’s updated Charlson Comorbidity index was 0.67, and the distribution was 
positively skewed with nearly two-thirds of the sample, 64.0%, having a score of 
zero (i.e. no conditions that accrued points on the index) and the largest minority, 
18.6%, had an index score of one.  17.1% of the sample reported a prior cancer 
diagnosis other than CRC. 
 
 
85 
 
For enabling factors, the largest proportions had a household income that was 
considered high (>400% of the FPL), 51.6%; had only completed high school, 
47.1%; were insured for all of the survey year, 92.9%; had visited outpatient 
providers five or more times in the survey year, 38.7%; had a usual source of 
care, 89.0%; and were married, 67.0%.  The mean and median household 
incomes as a percentage of the federal poverty level were 499.4% and 413.7%, 
and the distribution of household income was negatively skewed.  The mean and 
median numbers of outpatient provider visits were 5.6 and three, and the 
distribution was positively skewed with the largest minority having no visits, 
16.1%.   
Prevalence of the insurance features indicates the nature of some of the variation 
in national health insurance coverage.  Nearly half of the sample, 49.1%, had 
insurance with a DPN, while only 16.5% had coverage that was restricted to their 
provider network.  Just over one-third of the sample, 35.7%, had insurance that 
used gatekeeping.  The mean and median cost-sharing percentages, were 
27.6% and 20.7%, respectively while 5.6% had no spending (the cost-sharing 
percentage estimate for the entire 2009-2011 MEPS sample was consistent with 
recent national estimates of the percentage of national health expenditures paid 
by households (Martin 2014)).  In 2011, only 10.4% of the respondents’ 
households had a FSA. 
CRCS use was consistent with other recent estimates of screening rates.  In the 
sample, 62.5% were up-to-date with USPSTF-recommended CRC screening, 
which mostly reflected the 58.8% of the sample who had received colonoscopy 
within the previous ten years.  In the sample, 12.2% had received FOBT in the 
previous year and 2.7% had received FSIG within the previous five years with 
FOBT within the previous three years.  Over the included survey years, 60.4%, 
63.4% and 63.6% of respondents were up-to-date with recommended CRC 
screening in 2009, 2010, and 2011, respectively. 
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Aim 2 Sample Characteristics 
The Aim 2 sample of Western US Hispanic and non-Hispanic whites (Table 4.1b) 
was generally similar to the Aim 1 full US sample although had some notable 
differences.  Patterns of key sociodemographic factors were generally similar 
between the samples including age, sex and marital status, although less of the 
Aim 2 sample resided in a rural area than the Aim 1 sample, 12.2 vs. 17.6%.  
The Aim 2 sample was less acculturated than the Aim 1 sample.  In comparison 
to the Aim 1 sample, the Aim 2 sample had a greater proportion of foreign-born 
respondents, 14.4 vs. 11.9%; a greater proportion of respondents who were not 
comfortable speaking English, 4.1 vs. 3.1%; and a greater proportion of 
respondents who completed MEPS in Spanish, Spanish and English or another 
language, 6.0 vs. 3.8%.   
Health-related covariates were generally similar between the samples.  Receipt 
of preventive services was similar between Aim 1 and Aim 2’s samples, and the 
health measures suggested similar overall health.  Lifestyle factors were slightly 
favorable for the Aim 2 sample, which had a lower proportion of smokers 10.2 vs. 
14.7%, a higher proportion of normal weight, 28.6 vs. 26.6%, and a lower 
proportion of obese, 31.0 vs. 33.7%.   
Enabling factors were generally similar between the samples.  The Aim 2 sample 
had a slightly more favorable profile for education and income measures, proxies 
for SES, with slightly greater proportions in higher income and education 
categories and smaller proportions in lower income and education categories 
than the Aim 1 sample.  Health care access patterns did not consistently differ in 
a substantive way between the two aims’ samples.  
For the insurance features, the Aim 2 sample was more likely to have an 
organizational insurance feature indicating the insurer had greater administrative 
control.  The Aim 2 sample, in comparison to the Aim 1 sample, had a larger 
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proportion of respondents with insurance that defined a provider network, 54.4 
vs. 47.7%; a larger proportion with coverage restricted to a DPN, 23.1 vs. 16.5%; 
and a larger proportion of respondents with insurance that used gatekeeping, 
41.6 vs. 35.7%.  For the financial insurance features, the Aim 2 sample had an 
equal proportion of respondents who had a FSA as the Aim 1 sample, and the 
Aim 2 sample had a slightly greater cost-sharing mean, 29.4 vs. 27.6%, and 
median, 22.0 vs. 20.7%, than the Aim 1 sample. 
A slightly greater proportion of the Aim 2 sample was up-to-date with 
recommended CRC screening by any technique, 63.3 vs. 62.5%, although the 
Aim 2 sample more often was up-to-date with screening by having received 
screening other than colonoscopy.  Aim 2 had slightly lower colonoscopy use in 
the previous ten years, 56.2 vs. 58.8%; greater guideline-consistent FSIG use, 
5.1 vs. 2.7%; and greater FOBT use in the previous year, 16.7 vs. 12.2%. 
 
Bivariate Analyses 
 
Aim 1 Analyses 
In the Aim 1 samples, likelihood of being up-to-date with recommended CRC 
screening significantly varied across levels of most variables, which included the 
full Aim 1 sample (Table 4.2a, unadjusted n=21,085), the reduced sample 
excluding those under age 65 with only public insurance (Table 4.2b, unadjusted 
n=18,686) and the reduced sample with only MEPS 2011 (Table 4.2c, 
unadjusted n=7,270).  The associations generally agreed with patterns in the 
literature.  In this section, “significant” findings refer to all three samples unless 
noted otherwise.  Reported percentages of screening likelihood apply only to the 
full sample unless noted otherwise.   
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CRCS likelihood varied significantly for some innate sociodemographic 
characteristics.  As age increased screening likelihood generally increased, 
although did not significantly differ between the 60-64, 65-69, and 70-75 groups 
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Table 4.2 Aim 1 Bivariate Associations with Likelihood of Being Up-to-Date with Recommended CRC Screening  
for Main Analysis Samples 
4.2 a, Full MEPS 2009-2011 sample 
Table 4.2b, Reduced MEPS 2009-2011 
sample excluding those age 50-64 with 
only public insurance 
Table 4.2c, Reduced sample of only 
MEPS 2011 
 % 95% CI  % 95% CI  % 95% CI 
         
Total (n=21,085) 62.5 [61.3,63.8] Total (n=18,686) 63.7 [62.4,65.0] Total (n=7,270) 63.6 [61.8,65.4] 
         
Covariates 
         
Age groups   Age groups   Age groups   
50-54 (n=5,440) 47.1 [45.0,49.2] 50-54 (n=4,551) 47.8 [45.5,50.1] 50-54 (n=1,825) 47.8 [44.4,51.1] 
55-59 (n=4,955) 61.3 [59.1,63.5] 55-59 (n=4,153) 62.9 [60.6,65.2] 55-59 (n=1,675) 62.4 [59.0,65.6] 
60-64 (n=4,006) 69.5 [67.6,71.3] 60-64 (n=3,298) 71.1 [68.9,73.1] 60-64 (n=1,396) 70.5 [67.9,72.9] 
65-69 (n=3,676) 72.4 [70.1,74.6] 65-69 (n=3,676) 72.4 [70.1,74.6] 65-69 (n=1,298) 74.1 [70.8,77.2] 
70-75 (n=3,008) 71.9 [69.3,74.4] 70-75 (n=3,008) 71.9 [69.3,74.4] 70-75 (n=1,076) 72.3 [68.3,76.0] 
         
Design-based F(3.91, 809.91) = 111.4834 Pr 
= 0.000 
Design-based F(3.94, 816.11) = 96.9452 Pr 
= 0.000 
Design-based F(3.68, 761.51) = 52.1362 Pr 
= 0.000 
         
Sex   Sex   Sex   
Male (n=9,659) 63.0 [61.3,64.6] Male (n=8,722) 64.3 [62.7,66.0] Male (n=3,339) 64.9 [62.6,67.1] 
Female (n=11,426) 62.2 [60.6,63.7] Female (n=9,964) 63.1 [61.5,64.7] Female (n=3,931) 62.5 [60.3,64.7] 
         
Design-based F(1.00, 207.00) = 0.6461 Pr = 
0.422 
Design-based F(1.00, 207.00) = 1.3966 Pr = 
0.239 
Design-based F(1.00, 207.00) = 3.2829 Pr = 
0.071 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Race/Ethnicity   Race/Ethnicity   Race/Ethnicity   
non-Hispanic white 
(n=12,086) 64.6 [63.2,66.1] 
non-Hispanic white 
(n=11,213) 65.5 [63.9,67.0] 
non-Hispanic white 
(n=4,164) 65.5 [63.3,67.6] 
Hispanic white (n=2,933) 53.1 [50.2,56.1] Hispanic white (n=2,380) 54.6 [51.4,57.7] Hispanic white (n=991) 56.0 [51.9,60.0] 
non-Hispanic black 
(n=4,062) 61.3 [58.9,63.5] 
non-Hispanic black 
(n=3,315) 63.9 [61.3,66.4] 
non-Hispanic black 
(n=1,415) 63.8 [60.6,66.9] 
non-Hispanic Asian 
(n=1,429) 46.2 [42.6,49.8] 
non-Hispanic Asian 
(n=1,312) 47.0 [43.2,50.8] 
non-Hispanic Asian 
(n=499) 44.4 [38.7,50.2] 
Other (n=575) 54.7 [49.1,60.1] Other (n=466) 56.1 [50.0,62.0] Other (n=201) 61.3 [53.0,69.1] 
         
Design-based F(3.86, 799.27) = 34.6689 Pr 
= 0.000 
Design-based F(3.90, 807.79) = 30.2854 Pr 
= 0.000 
Design-based F(3.89, 806.05) = 16.4120 Pr 
= 0.000 
         
Marital status   Marital status   Marital status   
Married (n=13,180) 64.4 [62.8,66.0] Married (n=12,406) 65.0 [63.4,66.6] Married (n=4,490) 65.6 [63.4,67.8] 
Widowed (n=1,880) 67.3 [64.1,70.4] Widowed (n=1,669) 68.4 [65.1,71.5] Widowed (n=635) 67.2 [62.0,71.9] 
Divorced/Separated 
(n=4,289) 57.9 [55.8,60.0] 
Divorced/Separated 
(n=3,349) 59.4 [57.1,61.7] 
Divorced/Separated 
(n=1,501) 59.3 [55.9,62.6] 
Never married (n=1,736) 52.2 [48.8,55.5] Never married (n=1,262) 54.7 [50.9,58.5] Never married (n=644) 53.7 [48.8,58.6] 
         
Design-based F(2.92, 603.45) = 24.1075 Pr 
= 0.000 
Design-based F(2.93, 607.20) = 15.5427 Pr 
= 0.000 
Design-based F(2.92, 603.47) = 10.1448 Pr 
= 0.000 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Census Regions   Census Regions   Census Regions   
Northeast (n=3,639) 64.4 [61.8,66.9] Northeast (n=3,104) 65.7 [62.9,68.4] Northeast (n=1,277) 64.4 [60.6,68.0] 
Midwest (n=4,432) 61.4 [58.7,64.0] Midwest (n=4,018) 62.2 [59.5,64.8] Midwest (n=1,589) 62.9 [59.9,65.7] 
South (n=7,935) 62.7 [60.4,64.9] South (n=7,021) 63.7 [61.4,65.9] South (n=2,687) 64.9 [61.3,68.3] 
West (n=5,079) 61.8 [59.3,64.3] West (n=4,543) 63.5 [60.9,66.1] West (n=1,717) 61.6 [57.4,65.7] 
         
Design-based F(2.96, 613.61) = 0.9510 Pr = 
0.415 
Design-based F(2.98, 617.17) = 1.0715 Pr = 
0.360 
Design-based F(2.84, 588.61) = 0.6872 Pr = 
0.553 
         
Metropolitan Statistical Area 
Status  
Metropolitan Statistical Area 
Status  
Metropolitan Statistical Area 
Status  
Urban (n=17,598) 63.2 [61.8,64.7] Urban (n=15,650) 64.4 [62.9,65.8] Urban (n=6,097) 64.3 [62.2,66.3] 
Rural (n=3,487) 59.3 [56.5,62.1] Rural (n=3,036) 60.3 [57.4,63.3] Rural (n=1,173) 60.8 [56.9,64.6] 
         
Design-based F(1.00, 207.00) = 5.9579 Pr = 
0.015 
Design-based F(1.00, 207.00) = 5.7149 Pr = 
0.018 
Design-based F(1.00, 207.00) = 2.3982 Pr = 
0.123 
         
Immigration status   Immigration status   Immigration status   
US born (n=16,955) 64.0 [62.6,65.3] US born (n=15,193) 65.0 [63.6,66.4] US born (n=5,851) 65.4 [63.4,67.4] 
Foreign born, lived in US 
<15 years (n=574) 33.7 [26.6,41.6] 
Foreign born, lived in US 
<15 years (n=468) 34.2 [26.4,42.9] 
Foreign born, lived in US 
<15 years (n=203) 36.0 [28.0,44.8] 
Foreign born, lived in US 
> 15 years (n=3,388) 55.3 [52.6,58.0] 
Foreign born, lived in US 
> 15 years (n=2,882) 56.6 [53.6,59.6] 
Foreign born, lived in US 
> 15 years (n=1,139) 53.7 [49.4,58.0] 
missing (n=168) 41.3 [28.6,55.3] missing (n=143) 41.0 [26.9,56.7] missing (n=77) 54.0 [34.9,72.0] 
         
Design-based F(2.63, 545.41) = 38.1498 Pr 
= 0.000 
Design-based F(2.67, 551.97) = 31.8609 Pr 
= 0.000 
Design-based F(2.59, 535.45) = 23.5010 Pr 
= 0.000 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Whether comfortable 
speaking English  
Whether comfortable 
speaking English  
Whether comfortable 
speaking English  
Comfortable (n=19,307) 63.3 [62.0,64.5] Comfortable (n=17,337) 64.3 [63.0,65.6] Comfortable (n=6,646) 64.3 [62.4,66.1] 
Not comfortable 
(n=1,358) 44.2 [39.9,48.6] Not comfortable (n=992) 43.8 [38.6,49.2] Not comfortable (n=475) 47.2 [40.7,53.7] 
missing (n=420) 48.6 [41.4,55.8] missing (n=357) 50.3 [42.2,58.3] missing (n=149) 59.1 [47.0,70.3] 
         
Design-based F(1.65, 341.03) = 48.8486 Pr 
= 0.000 
Design-based F(1.61, 333.85) = 38.6057 Pr 
= 0.000 
Design-based F(1.85, 383.18) = 15.1457 Pr 
= 0.000 
         
Interview Language   Interview Language   Interview Language   
English (n=19,379) 63.1 [61.9,64.4] English (n=17,396) 64.2 [62.9,65.5] English (n=6,666) 64.1 [62.3,66.0] 
Spanish, Spanish and 
English, or other 
(n=1,706) 47.6 [43.3,52.1] 
Spanish, Spanish and 
English, or other 
(n=1,290) 47.8 [42.9,52.7] 
Spanish, Spanish and 
English, or other (n=604) 52.7 [46.1,59.1] 
         
Design-based F(1.00, 207.00) = 49.7657 Pr 
= 0.000 
Design-based F(1.00, 207.00) = 45.2884 Pr 
= 0.000 
Design-based F(1.00, 207.00) = 12.1468 Pr 
= 0.001 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Dental checkup 
frequency   
Dental checkup 
frequency   
Dental checkup 
frequency   
Twice a year or more 
(n=8,550) 72.4 [70.8,74.0] 
Twice a year or more 
(n=8,207) 72.8 [71.1,74.4] 
Twice a year or more 
(n=2,981) 74.3 [72.1,76.4] 
Once a year (n=4,434) 59.8 [57.4,62.1] Once a year (n=3,947) 60.2 [57.6,62.7] Once a year (n=1,516) 60.5 [56.6,64.3] 
Less than once a year 
(n=4,003) 53.0 [50.7,55.4] 
Less than once a year 
(n=3,298) 53.5 [50.9,56.1] 
Less than once a year 
(n=1,404) 53.5 [50.4,56.5] 
Never go to dentist 
(n=3,754) 48.1 [45.8,50.4] 
Never go to dentist 
(n=2,918) 49.8 [47.1,52.5] 
Never go to dentist 
(n=1,234) 47.8 [43.3,52.2] 
missing (n=344) 7.2 [4.2,12.1] missing (n=316) 6.7 [3.8,11.7] missing (n=135) 5.0 [1.5,14.9] 
         
Design-based F(3.38, 699.65) = 151.3427 Pr 
= 0.000 
Design-based F(3.42, 707.65) = 124.7639 Pr 
= 0.000 
Design-based F(3.86, 799.26) = 68.0761 Pr 
= 0.000 
         
Most recent flu shot   Most recent flu shot   Most recent flu shot   
Within past year 
(n=10,632) 72.7 [71.3,74.0] 
Within past year 
(n=9,515) 73.7 [72.4,75.0] 
Within past year 
(n=3,693) 74.6 [72.7,76.5] 
Within past two years 
(n=1,752) 60.8 [57.6,64.0] 
Within past two years 
(n=1,521) 62.3 [59.0,65.5] 
Within past two years 
(n=633) 62.0 [56.8,66.9] 
More than two years 
(n=1,859) 55.4 [52.2,58.5] 
More than two years 
(n=1,624) 56.1 [52.8,59.5] 
More than two years 
(n=626) 55.9 [50.7,61.1] 
Never received flu shot 
(n=6,177) 49.2 [47.2,51.1] 
Never received flu shot 
(n=5,441) 50.5 [48.4,52.5] 
Never received flu shot 
(n=2,066) 48.5 [45.1,51.8] 
missing (n=665) 25.4 [20.4,31.1] missing (n=585) 25.5 [20.1,31.7] missing (n=252) 24.0 [16.6,33.5] 
         
Design-based F(3.88, 803.84) = 179.1230 Pr 
= 0.000 
Design-based F(3.86, 799.26) = 162.9618 Pr 
= 0.000 
Design-based F(3.91, 809.16) = 78.7728 Pr 
= 0.000 
         
         
 
 
 
94 
 
Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Perceived health status Perceived health status Perceived health status 
Excellent (n=3,660) 62.1 [60.1,64.2] Excellent (n=3,539) 62.5 [60.4,64.6] Excellent (n=1,305) 62.4 [59.3,65.4] 
Very good (n=6,461) 64.4 [62.5,66.3] Very good (n=6,177) 65.1 [63.1,67.0] Very good (n=2,224) 65.5 [62.4,68.4] 
Good (n=6,692) 62.2 [60.4,63.8] Good (n=5,932) 63.5 [61.8,65.3] Good (n=2,296) 62.7 [60.0,65.4] 
Fair/Poor (n=4,219) 60.3 [58.2,62.4] Fair/Poor (n=2,990) 62.8 [60.3,65.2] Fair/Poor (n=1,428) 63.5 [60.4,66.5] 
missing (n=53) 4.8 [1.0,19.8] missing (n=48) 5.1 [1.1,20.8] missing (n=17) 13.8 [2.0,55.1] 
         
Design-based F(3.45, 714.99) = 8.6670 Pr = 
0.000 
Design-based F(3.46, 715.46) = 6.6498 Pr = 
0.000* 
Design-based F(3.70, 766.37) = 2.4395 Pr = 
0.050* 
         
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
No (n=17,944) 60.1 [58.8,61.4] No (n=15,851) 61.2 [59.9,62.5] No (n=6,172) 60.9 [58.9,62.8] 
Yes (n=3,114) 74.4 [71.8,76.8] Yes (n=2,809) 75.5 [72.8,78.0] Yes (n=1,086) 76.9 [73.2,80.1] 
missing (n=27) 36.1 [9.6,75.0] missing (n=26) 36.1 [9.6,75.0] missing (n=12) 27.2 [3.2,81.0] 
         
Design-based F(1.78, 367.80) = 69.7013 Pr 
= 0.000 
Design-based F(1.75, 362.37) = 64.5696 Pr 
= 0.000 
Design-based F(1.82, 376.10) = 37.9292 Pr 
= 0.000 
         
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
0 (n=13,186) 58.9 [57.6,60.3] 0 (n=12,180) 60.0 [58.6,61.3] 0 (n=4,503) 59.7 [57.8,61.6] 
1 (n=4,287) 65.6 [63.2,68.0] 1 (n=3,582) 67.4 [64.7,69.9] 1 (n=1,549) 67.7 [64.0,71.1] 
2 (n=2,111) 72.8 [70.1,75.4] 2 (n=1,786) 75.4 [72.4,78.1] 2 (n=702) 72.6 [67.8,76.9] 
3+ (n=1,501) 72.0 [68.8,75.0] 3+ (n=1,138) 73.9 [70.5,77.0] 3+ (n=516) 75.1 [70.7,78.9] 
         
Design-based F(2.93, 607.16) = 46.0909 Pr 
= 0.000 
Design-based F(2.92, 604.14) = 47.8177 Pr 
= 0.000 
Design-based F(2.94, 608.39) = 21.8104 Pr 
= 0.000 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Smoking status   Smoking status   Smoking status   
Non-smoker (n=15,887) 65.6 [64.2,66.9] Non-smoker (n=14,396) 66.5 [65.1,67.9] Non-smoker (n=5,505) 66.2 [64.2,68.2] 
Current Smoker 
(n=3,189) 51.1 [48.6,53.5] 
Current Smoker 
(n=2,510) 52.6 [50.0,55.2] 
Current Smoker 
(n=1,083) 53.6 [49.7,57.4] 
missing (n=2,009) 52.4 [48.8,56.0] missing (n=1,780) 52.8 [49.0,56.6] missing (n=682) 53.6 [47.9,59.1] 
         
Design-based F(1.97, 407.39) = 86.1723 Pr 
= 0.000 
Design-based F(1.97, 407.35) = 73.6614 Pr 
= 0.000 
Design-based F(1.97, 407.65) = 26.3518 Pr 
= 0.000 
         
BMI categories   BMI categories   BMI categories   
Underweight (n=201) 57.0 [47.2,66.2] Underweight (n=154) 59.1 [48.1,69.2] Underweight (n=76) 49.8 [32.9,66.6] 
Normal weight (n=5,489) 59.8 [57.9,61.7] Normal weight (n=4,991) 60.9 [58.9,62.8] Normal weight (n=1,909) 60.9 [58.0,63.8] 
Overweight (n=7,577) 63.5 [61.8,65.2] Overweight (n=6,849) 64.6 [62.9,66.3] Overweight (n=2,538) 64.4 [61.6,67.2] 
Obese (n=7,243) 65.1 [63.4,66.8] Obese (n=6,176) 66.6 [64.8,68.3] Obese (n=2,534) 67.0 [64.6,69.4] 
missing (n=575) 43.3 [37.7,49.0] missing (n=516) 43.8 [37.9,49.8] missing (n=213) 42.3 [34.1,50.9] 
         
Design-based F(3.93, 814.16) = 17.6989 Pr 
= 0.000 
Design-based F(3.91, 809.78) = 17.6372 Pr 
= 0.000 
Design-based F(3.75, 775.36) = 8.9901 Pr = 
0.000 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Poor/Negative (<100%) 
(n=2,580) 55.1 [52.2,58.0] 
Poor/Negative (<100%) 
(n=1,464) 60.6 [56.9,64.1] 
Poor/Negative (<100%) 
(n=940) 59.3 [55.1,63.5] 
Near poor/Low income 
(100-200%) (n=3,598) 54.0 [51.6,56.4] 
Near poor/Low income 
(100-200%) (n=2,838) 55.8 [53.3,58.4] 
Near poor/Low income 
(100-200%) (n=1,338) 55.7 [52.3,59.1] 
Middle Income (200-
400%) (n=6,226) 58.6 [56.6,60.5] 
Middle Income (200-
400%) (n=5,806) 59.0 [57.0,61.0] 
Middle Income (200-
400%) (n=2,092) 59.5 [56.6,62.4] 
High Income (>400%) 
(n=8,681) 68.0 [66.4,69.6] 
High Income (>400%) 
(n=8,578) 68.0 [66.4,69.7] 
High Income (>400%) 
(n=2,900) 68.6 [66.2,70.9] 
         
Design-based F(2.68, 555.57) = 56.4553 Pr 
= 0.000 
Design-based F(2.67, 551.82) = 39.8194 Pr 
= 0.000 
Design-based F(2.91, 602.19) = 21.2537 Pr 
= 0.000 
         
Educational attainment   Educational attainment   Educational attainment   
Less than a HSD 
(n=3,597) 50.2 [47.2,53.1] 
Less than a HSD 
(n=2,654) 51.7 [48.5,54.8] 
Less than a HSD 
(n=1,188) 52.6 [48.7,56.6] 
HSD/GED (n=9,935) 60.3 [58.7,61.8] HSD/GED (n=8,844) 61.3 [59.6,62.9] HSD/GED (n=3,446) 62.6 [60.3,64.8] 
Bachelor's (n=3,410) 67.5 [65.2,69.7] Bachelor's (n=3,258) 68.0 [65.6,70.3] Bachelor's (n=1,163) 65.7 [62.0,69.3] 
Graduate/Doctorate 
Degree (n=2,168) 72.3 [69.4,75.1] 
Graduate/Doctorate 
Degree (n=2,121) 72.5 [69.6,75.3] 
Graduate/Doctorate 
Degree (n=776) 72.7 [68.4,76.6] 
Other Degree (n=1,730) 65.2 [62.1,68.2] Other Degree (n=1,603) 65.6 [62.4,68.8] Other Degree (n=589) 64.2 [59.2,68.9] 
missing (n=245) 42.6 [30.9,55.1] missing (n=206) 45.1 [31.8,59.1] missing (n=108) 49.5 [35.3,63.8] 
         
Design-based F(4.76, 985.11) = 32.5034 Pr 
= 0.000 
Design-based F(4.72, 977.23) = 24.9177 Pr 
= 0.000 
Design-based F(4.32, 894.51) = 10.5883 Pr 
= 0.000 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Number of months insured in survey year Number of months insured in survey year Number of months insured in survey year 
 1-6  (n=902) 43.5 [38.7,48.4]  1-6  (n=666) 45.0 [39.8,50.4]  1-6  (n=325) 41.1 [33.2,49.5] 
 7-11  (n=1,019) 47.1 [42.8,51.4]  7-11  (n=787) 48.6 [43.7,53.5]  7-11  (n=380) 54.8 [48.1,61.3] 
 12  (n=19,164) 63.8 [62.5,65.1]  12  (n=17,233) 64.8 [63.5,66.1]  12  (n=6,565) 64.8 [63.0,66.6] 
         
Design-based F(2.00, 413.72) = 61.0515 Pr 
= 0.000 
Design-based F(1.99, 412.91) = 47.4388 Pr 
= 0.000 
Design-based F(1.99, 411.30) = 21.1575 Pr 
= 0.000 
         
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
0 (n=4,129) 35.4 [33.2,37.6] 0 (n=3,745) 36.4 [34.2,38.8] 0 (n=1,500) 37.3 [33.8,41.0] 
1 (n=3,026) 53.3 [51.0,55.6] 1 (n=2,801) 54.3 [51.9,56.6] 1 (n=1,037) 56.1 [52.1,59.9] 
2 (n=2,744) 61.5 [59.1,63.8] 2 (n=2,477) 62.5 [60.0,65.0] 2 (n=934) 59.9 [55.3,64.2] 
3 (n=2,135) 64.1 [61.3,66.8] 3 (n=1,918) 65.9 [62.9,68.7] 3 (n=724) 65.3 [61.0,69.3] 
4 (n=1,659) 68.3 [65.3,71.3] 4 (n=1,503) 69.7 [66.6,72.6] 4 (n=575) 68.6 [63.2,73.5] 
5+ (n=7,392) 75.8 [74.2,77.4] 5+ (n=6,242) 77.7 [76.0,79.3] 5+ (n=2,500) 76.9 [74.6,79.0] 
         
Design-based F(4.77, 987.34) = 222.3643 Pr 
= 0.000 
Design-based F(4.79, 991.82) = 212.1011 Pr 
= 0.000 
Design-based F(4.68, 969.59) = 79.9336 Pr 
= 0.000 
         
Had a usual source of 
care   
Had a usual source of 
care   
Had a usual source of 
care   
No (n=2,345) 34.6 [31.7,37.6] No (n=2,048) 35.6 [32.7,38.7] No (n=795) 32.7 [27.9,37.9] 
Yes (n=18,239) 66.0 [64.7,67.2] Yes (n=16,184) 67.2 [65.9,68.5] Yes (n=6,264) 67.2 [65.4,69.0] 
missing (n=501) 34.2 [27.5,41.6] missing (n=454) 33.6 [26.7,41.2] missing (n=211) 36.2 [24.1,50.3] 
         
Design-based F(1.94, 400.74) = 257.2895 Pr 
= 0.000 
Design-based F(1.94, 402.21) = 243.7756 Pr 
= 0.000 
Design-based F(1.98, 410.31) = 88.6458 Pr 
= 0.000 
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced MEPS 2011 sample  
Year   Year   Year   
2009 (n=7,153) 60.4 [58.8,62.0] 2009 (n=6,366) 61.5 [59.9,63.1] 2009 (n=0) 0.0  
2010 (n=6,662) 63.4 [61.8,65.0] 2010 (n=5,910) 64.6 [62.9,66.2] 2010 (n=0) 0.0  
2011 (n=7,270) 63.6 [61.8,65.4] 2011 (n=6,410) 64.8 [63.0,66.7] 2011 (n=7,270) 63.6 [61.8,65.4] 
         
Design-based F(1.77, 365.88) = 6.8504 Pr = 
0.002 
Design-based F(1.78, 369.39) = 6.7254 Pr = 
0.002    
         
Insurance Features 
         
Insurance had a DPN  Coverage was restricted to a DPN Household had a FSA   
No (n=10,095) 63.5 [61.8,65.2] No (n=15,068) 64.0 [62.6,65.4] No (n=6,440) 63.2 [61.2,65.1] 
Yes (n=10,085) 62.1 [60.6,63.6] Yes (n=3,588) 62.2 [59.6,64.7] Yes (n=579) 69.9 [64.8,74.6] 
missing (n=905) 54.3 [49.7,58.8] missing (n=30) 67.0 [43.5,84.3] missing (n=251) 53.7 [42.7,64.4] 
         
Design-based F(1.89, 391.33) = 6.6330 Pr = 
0.002* 
Design-based F(1.94, 401.00) = 1.0863 Pr = 
0.337 
Design-based F(1.95, 403.74) = 4.8483 Pr = 
0.009 
         
Insurance used 
gatekeeping         
No (n=12,314) 63.8 [62.2,65.4]       
Yes (n=7,941) 61.0 [59.2,62.7]       
missing (n=830) 54.7 [50.0,59.4]       
         
Design-based F(1.85, 381.98) = 8.3021 Pr = 
0.000       
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Table 4.2 (cont.) 
Full MEPS 2009-2011 sample       
Cost-sharing categories for Aim 1 full 
Sample       
0.0% (n=1,392) 51.7 [48.3,55.1]       
0.1 to 13.0% (n=6,211) 67.4 [65.6,69.1]       
13.1 to 29.8% (n=5,415) 69.4 [67.5,71.2]       
29.8 to 85.8% (n=5,373) 63.9 [61.9,65.9]       
85.8 to 100% (n=980) 44.1 [39.9,48.4]       
No spending in year 
(n=1,714) 21.5 [18.9,24.4]       
         
Design-based F(4.77, 988.09) = 151.8004 Pr 
= 0.000       
         
* there was not an overall significant difference (p<0.1) for the variable after excluding the missing category 
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and non-significantly declined in the 70-75 group compared to the 65-69 group.  
For race/ethnicity categories, screening likelihood was higher among non-
Hispanic whites and non-Hispanic blacks than Hispanic whites and non-Hispanic 
Asians.  For marital status, married and widowed persons had greater screening 
likelihood than divorced/separated or never married persons did.  For the 
respondent’s MSA designation, urban vs. rural had 4% points greater screening 
likelihood, 63.2 vs. 59.3%, which was significant in the full sample and the 
reduced 2009-2011 sample although the difference did not reach significance in 
the reduced MEPS 2011 sample, 64.3 vs. 60.8% (p=0.123).  The 
sociodemographics with non-significant variation in screening likelihood were sex 
and census region, although the difference in the reduced 2011 MEPS sample 
almost reached significance for men having greater screening likelihood than 
women, 64.9 vs. 62.5% (p =0.071).   
For other predisposing and enabling factors related to social status or SES, 
greater social status or SES generally predicted significantly higher screening 
likelihood including greater acculturation and higher income and educational 
attainment.  Each greater income category did not though consistently increase 
screening likelihood.  The lowest income category (household income <100% 
FPL) had non-significantly greater screening likelihood than the second lowest 
category (100-200% FPL) in the full sample and both reduced samples.  The 
lowest sample income category also had similar screening likelihood as the 
middle-income category (200-400% FPL) in both reduced samples.  Over the 
survey years, screening likelihood was equivalent in 2010, 63.4%, and 2011, 
63.6%, which was an increase from 2009, 60.4%.  
Considering the lifestyle and health-related predisposing and need factors, level 
of health and screening likelihood had inconsistent associations.  For some 
variables, better health predicted greater screening likelihood including 
consistent and large increases for more frequent or recent use of other 
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preventive services (dental checkups and flu shots) and a large difference for 
being a non-smoker vs. smoker, 65.6 vs. 51.1%.  For other variables, worse 
health predicted greater screening likelihood including having any non-CRC 
cancer diagnosis, 74.4 vs. 60.1%; being obese or overweight compared to 
normal weight; or having a Charlson Comorbidity Index score of two or greater in 
comparison to a score of one or having a score of one compared to zero.  
Perceived health status was a weaker predictor of screening likelihood and did 
not remain significant in either of the two reduced sample models for Aim 1.  
Greater health care access consistently predicted substantial significant 
increases in screening likelihood including being insured for all vs. part of the 
survey year, having a greater number of outpatient provider visits in the survey 
year, and having a usual source of care vs. not, 66.0 vs. 34.6%.   
Insurance features were sometimes associated with significant variation in 
screening likelihood.  Screening likelihood was significantly higher for 
respondents who had insurance that did not use gatekeeping, 63.8 vs. 61.0%; for 
respondents whose household had an FSA, 69.9 vs. 63.2% (Table 4.2b); and for 
respondents whose cost-sharing was in any of the internal tertiles of the cost-
sharing distribution (greater than 0% and below the 95th percentile of cost-
sharing) in comparison to respondents with 0% cost-sharing, cost-sharing in the 
top 5th percentile (85.8-100% of spending in the survey year paid out-of-pocket 
for the Aim 1 main analysis), or had no spending in the survey year.  Screening 
likelihood did not significantly vary depending on having insurance with a DPN or 
having insurance that restricted coverage to a DPN (Table 4.2c). 
Bivariate associations for the Aim 1 sensitivity analysis (Table 4.3) for the binary 
outcome of having received any CRC screening in the previous year vs. being 
not up-to-date with recommended screening were generally consistent with the 
main analysis findings.  
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Table 4.3 Aim 1 Bivariate Associations with Likelihood of Having Received CRC Screening in the Past Year 
for Sensitivity Analysis Samples 
Full MEPS 2009-2011 sample of those 
screened in previous year and those 
not up-to-date with recommended CRC 
screening 
Reduced MEPS 2009-2011 sample 
excluding those age 50-64 with only 
public insurance Reduced sample of only MEPS 2011 
 % 95% CI  % 95% CI  % 95% CI 
         
Total (n=13,929) 40.3 [39.0,41.7] Total (n=12,103) 41.2 [39.7,42.8] Total (n=4,574) 38.1 [36.2,40.1] 
         
Covariates 
         
Age groups   Age groups   Age groups   
50-54 (n=4,150) 27.9 [25.9,30.0] 50-54 (n=3,420) 28.0 [25.8,30.3] 50-54 (n=1,366) 27.1 [24.2,30.2] 
55-59 (n=3,219) 36.6 [34.3,39.1] 55-59 (n=2,630) 37.5 [34.8,40.3] 55-59 (n=1,050) 34.8 [30.9,38.8] 
60-64 (n=2,486) 48.4 [45.8,51.0] 60-64 (n=1,979) 50.2 [47.2,53.2] 60-64 (n=807) 43.8 [39.8,48.0] 
65-69 (n=2,237) 51.0 [47.9,54.0] 65-69 (n=2,237) 51.0 [47.9,54.0] 65-69 (n=728) 49.5 [45.0,54.1] 
70-75 (n=1,837) 52.2 [48.4,56.0] 70-75 (n=1,837) 52.2 [48.4,56.0] 70-75 (n=623) 49.5 [43.9,55.0] 
         
Design-based F(3.84, 794.38) = 68.0447 Pr 
= 0.000 
Design-based F(3.86, 799.60) = 61.6643 Pr 
= 0.000 
Design-based F(3.86, 798.02) = 25.2433 Pr 
= 0.000 
         
Sex   Sex   Sex   
Male (n=6,371) 40.9 [39.2,42.7] Male (n=5,631) 42.0 [40.1,43.9] Male (n=2,105) 39.8 [37.1,42.6] 
Female (n=7,558) 39.8 [38.1,41.5] Female (n=6,472) 40.6 [38.7,42.5] Female (n=2,469) 36.7 [34.1,39.3] 
         
Design-based F(1.00, 207.00) = 1.0386 Pr = 
0.309 
Design-based F(1.00, 207.00) = 1.3598 Pr = 
0.245 
Design-based F(1.00, 207.00) = 2.9176 Pr = 
0.089 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Race/Ethnicity   Race/Ethnicity   Race/Ethnicity   
non-Hispanic white 
(n=7,357) 41.3 [39.7,43.0] 
non-Hispanic white 
(n=6,736) 42.1 [40.3,43.9] 
non-Hispanic white 
(n=2,413) 38.6 [36.0,41.1] 
Hispanic white (n=2,267) 37.1 [34.0,40.3] Hispanic white (n=1,810) 37.6 [34.2,41.0] Hispanic white (n=716) 35.8 [31.3,40.6] 
non-Hispanic black 
(n=2,807) 43.0 [40.2,45.9] 
non-Hispanic black 
(n=2,237) 45.5 [42.2,48.8] 
non-Hispanic black 
(n=926) 43.3 [39.2,47.5] 
non-Hispanic Asian 
(n=1,096) 28.3 [24.7,32.1] 
non-Hispanic Asian 
(n=1,002) 29.1 [25.2,33.2] 
non-Hispanic Asian 
(n=381) 24.4 [19.4,30.2] 
Other (n=402) 31.8 [27.0,37.0] Other (n=318) 31.7 [26.8,37.2] Other (n=138) 39.8 [31.2,49.1] 
         
Design-based F(3.85, 797.52) = 12.9225 Pr 
= 0.000 
Design-based F(3.80, 786.88) = 13.1340 Pr 
= 0.000 
Design-based F(3.68, 762.12) = 6.0854 Pr = 
0.000 
         
Marital status   Marital status   Marital status   
Married (n=8,474) 41.7 [40.0,43.5] Married (n=7,873) 42.3 [40.5,44.2] Married (n=2,734) 39.4 [36.8,42.0] 
Widowed (n=1,221) 46.8 [42.7,50.9] Widowed (n=1,072) 47.9 [43.6,52.2] Widowed (n=387) 41.8 [35.8,48.0] 
Divorced/Separated 
(n=2,949) 36.2 [33.9,38.6] 
Divorced/Separated 
(n=2,252) 36.7 [34.0,39.5] 
Divorced/Separated 
(n=993) 35.3 [31.5,39.3] 
Never married (n=1,285) 33.0 [29.5,36.8] Never married (n=906) 34.8 [30.7,39.2] Never married (n=460) 32.6 [27.5,38.2] 
         
Design-based F(2.93, 607.09) = 12.8878 Pr 
= 0.000 
Design-based F(2.96, 612.15) = 9.9234 Pr = 
0.000 
Design-based F(2.92, 604.56) = 2.7914 Pr = 
0.041 
         
         
         
         
         
         
         
 
 
104 
 
Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Full MEPS 2009-2011 sample  Full MEPS 2009-2011 sample  
Census region   Census region   Census region   
Northeast (n=2,279) 39.3 [36.4,42.3] Northeast (n=1,872) 39.8 [36.5,43.1] Northeast (n=780) 36.8 [32.4,41.4] 
Midwest (n=2,834) 38.0 [35.5,40.6] Midwest (n=2,552) 39.0 [36.3,41.8] Midwest (n=968) 36.1 [33.0,39.2] 
South (n=5,202) 39.7 [37.1,42.4] South (n=4,516) 40.3 [37.6,43.2] South (n=1,645) 37.8 [33.9,41.8] 
West (n=3,614) 44.3 [41.8,46.8] West (n=3,163) 45.9 [43.0,48.8] West (n=1,181) 41.6 [37.4,46.0] 
         
Design-based F(2.90, 600.73) = 3.9458 Pr = 
0.009 
Design-based F(2.93, 606.01) = 4.2629 Pr = 
0.006 
Design-based F(2.84, 587.08) = 1.3982 Pr = 
0.244 
         
Metropolitan Statistical Area 
Status  
Metropolitan Statistical Area 
Status  
Metropolitan Statistical Area 
Status  
Urban (n=11,642) 41.4 [39.8,42.9] Urban (n=10,142) 42.2 [40.5,43.9] Urban (n=3,852) 39.2 [37.1,41.4] 
Rural (n=2,287) 35.6 [32.5,38.8] Rural (n=1,961) 36.6 [33.2,40.2] Rural (n=722) 33.1 [28.2,38.4] 
         
Design-based F(1.00, 207.00) = 9.9994 Pr = 
0.002 
Design-based F(1.00, 207.00) = 7.6966 Pr = 
0.006 
Design-based F(1.00, 207.00) = 4.3751 Pr = 
0.038 
         
Immigration status   Immigration status   Immigration status   
US born (n=10,763) 41.2 [39.7,42.8] US born (n=9,468) 42.2 [40.5,43.8] US born (n=3,527) 39.5 [37.3,41.8] 
Foreign born, lived in US 
<15 years (n=475) 17.1 [12.3,23.3] 
Foreign born, lived in US 
<15 years (n=384) 17.0 [11.9,23.8] 
Foreign born, lived in US 
<15 years (n=166) 18.0 [12.1,25.9] 
Foreign born, lived in US 
> 15 years (n=2,558) 38.1 [35.3,41.0] 
Foreign born, lived in US 
> 15 years (n=2,134) 38.6 [35.3,41.9] 
Foreign born, lived in US 
> 15 years (n=823) 32.4 [28.2,37.0] 
missing (n=133) 27.6 [16.9,41.8] missing (n=117) 28.4 [16.9,43.6] missing (n=58) 27.3 [14.1,46.3] 
         
Design-based F(2.80, 580.08) = 18.6144 Pr 
= 0.000 
Design-based F(2.75, 568.93) = 16.7170 Pr 
= 0.000 
Design-based F(2.46, 509.16) = 10.4290 Pr 
= 0.000 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Full MEPS 2009-2011 sample  Full MEPS 2009-2011 sample  
Whether comfortable 
speaking English  
Whether comfortable 
speaking English  
Whether comfortable 
speaking English  
Comfortable (n=12,497) 40.9 [39.5,42.3] Comfortable (n=11,022) 41.8 [40.2,43.4] Comfortable (n=4,096) 38.5 [36.5,40.5] 
Not comfortable 
(n=1,102) 29.5 [26.0,33.1] Not comfortable (n=802) 28.1 [24.0,32.5] Not comfortable (n=369) 29.8 [24.2,36.2] 
missing (n=330) 30.1 [23.0,38.3] missing (n=279) 31.2 [23.2,40.5] missing (n=109) 39.7 [25.1,56.4] 
         
Design-based F(1.88, 389.41) = 17.2263 Pr 
= 0.000 
Design-based F(1.84, 379.93) = 16.7633 Pr 
= 0.000 
Design-based F(1.88, 389.84) = 2.7503 Pr = 
0.068** 
         
Interview Language   Interview Language   Interview Language   
English (n=12,554) 40.7 [39.3,42.1] English (n=11,067) 41.6 [40.1,43.1] English (n=4,122) 38.3 [36.3,40.3] 
Spanish, Spanish and 
English, or other 
(n=1,375) 34.0 [30.2,38.0] 
Spanish, Spanish and 
English, or other 
(n=1,036) 33.4 [29.1,38.0] 
Spanish, Spanish and 
English, or other (n=452) 35.2 [28.8,42.2] 
         
Design-based F(1.00, 207.00) = 10.0181 Pr 
= 0.002 
Design-based F(1.00, 207.00) = 11.7045 Pr 
= 0.001 
Design-based F(1.00, 207.00) = 0.7549 Pr = 
0.386 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Full MEPS 2009-2011 sample  Full MEPS 2009-2011 sample  
Dental checkup 
frequency   
Dental checkup 
frequency   
Dental checkup 
frequency   
Twice a year or more 
(n=5,020) 51.6 [49.4,53.9] 
Twice a year or more 
(n=4,775) 52.0 [49.7,54.4] 
Twice a year or more 
(n=1,638) 50.6 [47.4,53.9] 
Once a year (n=3,040) 37.9 [35.1,40.7] Once a year (n=2,659) 37.7 [34.7,40.9] Once a year (n=985) 34.8 [30.5,39.4] 
Less than once a year 
(n=2,769) 29.8 [27.4,32.2] 
Less than once a year 
(n=2,242) 29.1 [26.4,31.9] 
Less than once a year 
(n=916) 26.6 [23.2,30.4] 
Never go to dentist 
(n=2,766) 28.5 [26.3,30.6] 
Never go to dentist 
(n=2,120) 29.8 [27.2,32.6] 
Never go to dentist 
(n=902) 26.2 [22.5,30.2] 
missing (n=334) 3.2 [1.5,6.5] missing (n=307) 2.9 [1.3,6.3] missing (n=133) 1.9 [0.4,9.0] 
         
Design-based F(3.28, 679.69) = 101.5055 Pr 
= 0.000 
Design-based F(3.32, 687.54) = 85.3917 Pr 
= 0.000 
Design-based F(3.69, 764.61) = 42.8782 Pr 
= 0.000 
         
Most recent flu shot   Most recent flu shot   Most recent flu shot   
Within past year 
(n=6,484) 53.0 [51.0,54.9] 
Within past year 
(n=5,689) 53.9 [51.9,55.9] 
Within past year 
(n=2,108) 52.2 [49.5,54.9] 
Within past two years 
(n=1,138) 38.8 [35.3,42.5] 
Within past two years 
(n=960) 39.9 [36.1,43.9] 
Within past two years 
(n=385) 36.0 [29.9,42.5] 
More than two years 
(n=1,260) 32.4 [28.8,36.3] 
More than two years 
(n=1,079) 33.0 [29.0,37.3] 
More than two years 
(n=408) 31.3 [25.3,37.9] 
Never received flu shot 
(n=4,465) 26.2 [24.4,28.1] 
Never received flu shot 
(n=3,863) 27.0 [25.0,29.1] 
Never received flu shot 
(n=1,451) 22.0 [19.1,25.2] 
missing (n=582) 9.5 [6.4,14.0] missing (n=512) 9.6 [6.2,14.5] missing (n=222) 6.7 [3.1,14.1] 
         
Design-based F(3.87, 801.17) = 134.8566 Pr 
= 0.000 
Design-based F(3.84, 795.10) = 120.8314 Pr 
= 0.000 
Design-based F(3.93, 813.45) = 57.0418 Pr 
= 0.000 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Perceived health 
status   
Perceived health 
status   Perceived health status   
Excellent (n=2,340) 38.0 [35.4,40.6] Excellent (n=2,248) 38.4 [35.8,41.1] Excellent (n=820) 35.8 [32.0,39.9] 
Very good (n=4,147) 41.7 [39.5,43.9] Very good (n=3,921) 42.3 [40.1,44.6] Very good (n=1,340) 38.4 [35.0,42.0] 
Good (n=4,488) 40.7 [38.6,42.8] Good (n=3,890) 41.8 [39.6,44.1] Good (n=1,464) 37.9 [34.7,41.1] 
Fair/Poor (n=2,901) 40.1 [37.8,42.5] Fair/Poor (n=1,996) 42.0 [38.8,45.2] Fair/Poor (n=933) 41.1 [36.8,45.5] 
missing (n=53) 4.8 [1.0,19.8] missing (n=48) 5.1 [1.1,20.8] missing (n=17) 13.8 [2.0,55.1] 
         
Design-based F(3.46, 715.65) = 3.8410 Pr = 
0.007* 
Design-based F(3.45, 714.86) = 3.7640 Pr = 
0.007 
Design-based F(3.78, 781.76) = 1.2035 Pr = 
0.308 
         
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
No (n=12,051) 37.5 [36.2,38.9] No (n=10,456) 38.3 [36.9,39.8] No (n=3,978) 35.3 [33.4,37.2] 
Yes (n=1,852) 55.5 [51.9,59.0] Yes (n=1,622) 56.8 [52.9,60.6] Yes (n=585) 54.5 [48.9,59.9] 
missing (n=26) 26.4 [4.6,72.8] missing (n=25) 26.4 [4.6,72.8] missing (n=11) 0.0  
         
Design-based F(1.87, 386.74) = 66.3615 Pr 
= 0.000 
Design-based F(1.85, 382.35) = 62.5882 Pr 
= 0.000 
Design-based F(1.96, 405.85) = 27.9462 Pr 
= 0.000 
         
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
0 (n=8,838) 35.3 [33.8,36.7] 0 (n=8,051) 36.2 [34.6,37.8] 0 (n=2,919) 32.9 [31.0,35.0] 
1 (n=2,807) 45.2 [42.6,47.9] 1 (n=2,268) 46.5 [43.5,49.5] 1 (n=943) 43.9 [39.5,48.4] 
2 (n=1,320) 55.0 [51.2,58.8] 2 (n=1,076) 57.9 [53.5,62.2] 2 (n=417) 51.4 [44.7,58.0] 
3+ (n=964) 53.9 [50.0,57.9] 3+ (n=708) 56.0 [51.5,60.4] 3+ (n=295) 53.2 [46.8,59.6] 
         
Design-based F(2.91, 601.85) = 65.3284 Pr 
= 0.000 
Design-based F(2.84, 588.61) = 60.1533 Pr 
= 0.000 
Design-based F(2.88, 596.08) = 23.7676 Pr 
= 0.000 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Smoking status   Smoking status   Smoking status   
Non-smoker (n=10,158) 43.5 [41.9,45.1] Non-smoker (n=9,039) 44.2 [42.5,46.0] Non-smoker (n=3,328) 40.6 [38.1,43.1] 
Current Smoker 
(n=2,311) 30.2 [27.9,32.6] 
Current Smoker 
(n=1,781) 31.1 [28.6,33.8] Current Smoker (n=754) 29.9 [26.2,33.9] 
missing (n=1,460) 30.7 [26.8,34.8] missing (n=1,283) 31.0 [26.9,35.5] missing (n=492) 30.0 [24.1,36.7] 
         
Design-based F(1.91, 396.20) = 49.6083 Pr 
= 0.000 
Design-based F(1.92, 397.39) = 42.5504 Pr 
= 0.000 
Design-based F(1.95, 404.46) = 11.6417 Pr 
= 0.000 
         
BMI categories   BMI categories   BMI categories   
Underweight (n=141) 33.2 [23.8,44.0] Underweight (n=106) 34.4 [23.2,47.7] Underweight (n=54) 22.4 [11.0,40.1] 
Normal weight (n=3,662) 37.0 [34.9,39.2] Normal weight (n=3,274) 37.8 [35.5,40.2] Normal weight (n=1,192) 34.5 [31.4,37.8] 
Overweight (n=4,914) 41.0 [39.1,42.9] Overweight (n=4,355) 41.9 [39.9,43.9] Overweight (n=1,583) 38.2 [35.0,41.5] 
Obese (n=4,748) 43.8 [41.7,46.0] Obese (n=3,952) 45.0 [42.7,47.4] Obese (n=1,579) 43.2 [39.9,46.6] 
missing (n=464) 25.0 [19.7,31.1] missing (n=416) 25.5 [19.8,32.0] missing (n=166) 20.5 [14.2,28.6] 
         
Design-based F(3.83, 793.35) = 12.7750 Pr 
= 0.000 
Design-based F(3.79, 783.69) = 11.9071 Pr 
= 0.000 
Design-based F(3.83, 791.96) = 8.0895 Pr = 
0.000 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Poor/Negative (<100%) 
(n=1,851) 35.4 [32.7,38.2] 
Poor/Negative (<100%) 
(n=997) 38.5 [34.6,42.7] 
Poor/Negative (<100%) 
(n=632) 37.7 [32.8,42.8] 
Near poor/Low income 
(100-200%) (n=2,591) 34.3 [31.7,37.1] 
Near poor/Low income 
(100-200%) (n=2,001) 35.6 [32.7,38.7] 
Near poor/Low income 
(100-200%) (n=912) 33.1 [29.4,37.0] 
Middle Income (200-
400%) (n=4,217) 36.1 [33.8,38.5] 
Middle Income (200-
400%) (n=3,905) 36.5 [34.0,39.0] 
Middle Income (200-
400%) (n=1,363) 34.4 [31.3,37.7] 
High Income (>400%) 
(n=5,270) 45.6 [43.5,47.6] 
High Income (>400%) 
(n=5,200) 45.6 [43.5,47.7] 
High Income (>400%) 
(n=1,667) 42.1 [39.1,45.1] 
         
Design-based F(2.73, 564.10) = 27.4707 Pr 
= 0.000 
Design-based F(2.61, 539.82) = 20.3973 Pr 
= 0.000 
Design-based F(2.93, 606.05) = 7.3138 Pr = 
0.000 
         
Educational attainment   Educational attainment   Educational attainment   
Less than a HSD 
(n=2,705) 31.8 [29.2,34.5] 
Less than a HSD 
(n=1,957) 32.6 [29.5,35.8] 
Less than a HSD 
(n=863) 32.3 [28.0,36.8] 
HSD/GED (n=6,593) 38.0 [36.3,39.8] HSD/GED (n=5,782) 38.8 [36.8,40.7] HSD/GED (n=2,145) 37.1 [34.5,39.6] 
Bachelor's (n=2,085) 44.5 [41.7,47.4] Bachelor's (n=1,975) 45.0 [42.0,48.0] Bachelor's (n=702) 39.8 [35.6,44.1] 
Graduate/Doctorate 
Degree (n=1,232) 50.7 [46.9,54.6] 
Graduate/Doctorate 
Degree (n=1,196) 50.9 [46.9,54.8] 
Graduate/Doctorate 
Degree (n=413) 46.0 [39.7,52.3] 
Other Degree (n=1,108) 43.4 [39.5,47.5] Other Degree (n=1,019) 43.7 [39.6,48.0] Other Degree (n=366) 38.6 [32.5,45.1] 
missing (n=206) 27.2 [17.8,39.3] missing (n=174) 28.8 [18.4,42.1] missing (n=85) 28.8 [15.3,47.5] 
         
Design-based F(4.72, 976.47) = 18.3436 Pr 
= 0.000 
Design-based F(4.75, 982.79) = 14.5029 Pr 
= 0.000 
Design-based F(4.63, 957.46) = 3.2355 Pr = 
0.008 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Number of months insured in survey year Number of months insured in survey year Number of months insured in survey year 
 1-6  (n=689) 22.6 [18.2,27.8]  1-6  (n=490) 22.3 [17.2,28.4]  1-6  (n=248) 18.5 [11.5,28.5] 
 7-11  (n=781) 28.4 [24.2,32.9]  7-11  (n=591) 28.8 [23.9,34.3]  7-11  (n=282) 36.5 [28.8,45.0] 
 12  (n=12,459) 41.6 [40.1,43.2]  12  (n=11,022) 42.4 [40.8,44.1]  12  (n=4,044) 39.0 [37.0,41.2] 
         
Design-based F(1.99, 410.98) = 32.3347 Pr 
= 0.000 
Design-based F(2.00, 413.74) = 25.7721 Pr 
= 0.000 
Design-based F(1.98, 408.86) = 7.5503 Pr = 
0.001 
         
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
0 (n=3,297) 15.8 [14.0,17.6] 0 (n=2,960) 16.3 [14.5,18.3] 0 (n=1,173) 14.6 [12.1,17.6] 
1 (n=2,112) 29.4 [26.8,32.0] 1 (n=1,938) 30.3 [27.6,33.1] 1 (n=687) 29.3 [25.1,34.0] 
2 (n=1,756) 37.6 [34.8,40.6] 2 (n=1,554) 38.5 [35.4,41.7] 2 (n=571) 31.7 [27.2,36.6] 
3 (n=1,334) 40.7 [37.4,44.1] 3 (n=1,161) 42.4 [39.0,46.0] 3 (n=436) 40.7 [35.4,46.2] 
4 (n=1,025) 46.4 [42.3,50.6] 4 (n=904) 47.8 [43.5,52.1] 4 (n=331) 39.8 [33.6,46.3] 
5+ (n=4,405) 58.0 [55.7,60.3] 5+ (n=3,586) 60.2 [57.6,62.7] 5+ (n=1,376) 56.4 [52.9,59.8] 
         
Design-based F(4.86, 1005.15) = 166.0569 
Pr = 0.000 
Design-based F(4.84, 1002.10) = 157.7673 
Pr = 0.000 
Design-based F(4.90, 1014.22) = 65.6746 Pr 
= 0.000 
         
Had a usual source of 
care   
Had a usual source of 
care   
Had a usual source of 
care   
No (n=1,893) 16.8 [14.7,19.1] No (n=1,639) 17.3 [15.1,19.9] No (n=619) 13.1 [10.1,16.8] 
Yes (n=11,620) 44.1 [42.6,45.6] Yes (n=10,085) 45.1 [43.4,46.7] Yes (n=3,785) 42.1 [40.0,44.3] 
missing (n=416) 18.2 [12.8,25.2] missing (n=379) 17.7 [12.1,25.0] missing (n=170) 14.4 [7.2,26.7] 
         
Design-based F(1.86, 385.50) = 166.4117 Pr 
= 0.000 
Design-based F(1.89, 391.32) = 150.7793 Pr 
= 0.000 
Design-based F(2.00, 412.99) = 64.7690 Pr 
= 0.000 
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample  Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Year   Year   Year   
2009 (n=4,917) 40.3 [38.2,42.4] 2009 (n=4,296) 41.1 [38.9,43.4] 2009 (n=0) 0.0  
2010 (n=4,438) 42.6 [40.6,44.5] 2010 (n=3,864) 43.6 [41.5,45.8] 2010 (n=0) 0.0  
2011 (n=4,574) 38.1 [36.2,40.1] 2011 (n=3,943) 38.9 [36.8,41.0] 2011 (n=4,574) 38.1 [36.2,40.1] 
         
Design-based F(1.81, 375.35) = 5.9518 Pr = 
0.004 
Design-based F(1.86, 385.22) = 6.1986 Pr = 
0.003    
Insurance Features 
         
Insurance had a DPN  Coverage was restricted to a DPN Household had a FSA   
No (n=6,554) 40.5 [38.6,42.4] No (n=9,637) 40.9 [39.2,42.5] No (n=4,076) 37.9 [35.9,40.0] 
Yes (n=6,733) 40.6 [38.9,42.4] Yes (n=2,446) 42.7 [39.8,45.7] Yes (n=317) 43.6 [36.6,50.9] 
missing (n=642) 34.1 [29.5,39.1] missing (n=20) 49.7 [24.2,75.4] missing (n=181) 24.1 [14.7,37.0] 
         
Design-based F(1.92, 397.44) = 2.5191 Pr = 
0.084* 
Design-based F(1.95, 404.50) = 0.8896 Pr = 
0.410 
Design-based F(1.98, 410.67) = 3.5037 Pr = 
0.031* 
         
Insurance used 
gatekeeping         
No (n=7,854) 40.2 [38.3,42.2]       
Yes (n=5,491) 41.0 [39.0,43.0]       
missing (n=584) 34.2 [29.2,39.7]       
         
Design-based F(1.82, 376.83) = 1.9186 Pr = 
0.152       
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Table 4.3 (cont.) 
Full MEPS 2009-2011 sample    
Cost-sharing categories for Aim 1 
sensitivity analysis full sample       
0.0% (n=887) 32.1 [28.2,36.2]       
0.1 to 12.1% (n=4,006) 48.2 [46.1,50.3]       
12.2 to 29.4% (n=3,455) 48.2 [45.7,50.7]       
29.4 to 89.4% (n=3,451) 38.6 [36.3,41.0]       
89.4 to 100% (n=634) 18.9 [15.0,23.6]       
No spending in year 
(n=1,496) 8.0 [6.3,10.1]       
         
Design-based F(4.67, 965.89) = 98.0839 Pr 
= 0.000       
         
* this variable was not significant (p<0.1) after excluding the missing category 
** this variable was significant (p<0.05) after excluding the missing category 
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Notably, in the sensitivity analyses the Western census region had the highest 
likelihood of having received screening of the four census regions in all three 
samples, and there was overall significant variation in screening likelihood for the 
Aim 1 sensitivity analysis full sample and the reduced sample excluding those 
aged <65 with only public insurance.  In the main analyses census regions did 
not predict significantly varying screening likelihood and the Western census 
region had the second least screening likelihood in two samples and the least in 
the reduced sample of only MEPS 2011.  Another notable association in the Aim 
1 sensitivity analysis was that survey year 2011 significantly predicted the lowest 
likelihood of previous year screening of the three survey years.  In the main 
analysis, 2010 and 2011 had similarly screening likelihood, which was 
significantly greater than survey year 2009. 
Bivariate Findings for Aim 2 
In the Aim 2 sample, the patterns of bivariate associations were mostly 
consistent with findings for the Aim 1 samples (Table 4.4).  In the Aim 2 sample, 
the screening likelihood pattern by age was consistent with Aim 1 except that the 
70-75 age group had greater screening likelihood than the 65-69 group, although 
differences remained non-significant.   
Patterns were also similar to the Aim 1 sample for factors with greater relevance 
to Aim 2 including Hispanic ethnicity and the acculturation variables.  Screening 
likelihood was slightly greater for non-Hispanic whites in the Aim 2 sample vs. 
Aim 1 sample, 65.8 vs. 64.6%, and slightly lower for Hispanic whites, 50.2 vs. 
53.1%.  The covariates for survey language and for whether the respondent was 
comfortable speaking English had similar screening likelihood patterns.  For the 
covariate incorporating US vs. foreign birth and length of time in the US for 
foreign born persons, the category for foreign born, lived in the US <15 year had 
a very small sample size and the estimate for screening likelihood was much 
lower than in the Aim 1 sample, 13.4 vs. 33.7%, although the Aim 2 estimate had 
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Table 4.4 Aim 2 Bivariate Associations with Likelihood of Being Up-to-Date with Recommended CRC Screening 
for Main Analysis Samples 
Full MEPS 2009-2011 sample of 
Hispanic and non-Hispanic whites in 
Western census region 
Reduced MEPS 2009-2011 sample 
excluding those age 50-64 with only 
public insurance Reduced sample of only MEPS 2011 
 % 95% CI  % 95% CI  % 95% CI 
         
Total (n=3,751) 63.3 [60.8,65.8] Total (n=3,375) 64.8 [62.1,67.4] Total (n=1,272) 62.5 [58.3,66.6] 
         
Covariates 
         
Age groups   Age groups   Age groups   
50-54 (n=976) 43.9 [39.9,47.9] 50-54 (n=840) 44.4 [40.3,48.5] 50-54 (n=354) 41.2 [35.5,47.0] 
55-59 (n=848) 64.6 [58.5,70.1] 55-59 (n=724) 67.5 [61.6,73.0] 55-59 (n=259) 64.5 [55.8,72.3] 
60-64 (n=728) 70.0 [65.5,74.2] 60-64 (n=612) 72.3 [67.2,76.8] 60-64 (n=244) 70.6 [62.3,77.7] 
65-69 (n=675) 74.3 [67.8,79.9] 65-69 (n=675) 74.3 [67.8,79.9] 65-69 (n=228) 72.5 [64.3,79.4] 
70-75 (n=524) 76.0 [71.6,79.9] 70-75 (n=524) 76.0 [71.6,79.9] 70-75 (n=187) 80.8 [74.3,86.0] 
         
Design-based F(3.03, 481.44) = 28.3963 Pr 
= 0.000 
Design-based F(3.14, 486.28) = 28.1307 Pr 
= 0.000 
Design-based F(3.29, 502.89) = 20.3561 Pr 
= 0.000 
         
Sex   Sex   Sex   
Male (n=1,775) 64.9 [61.9,67.9] Male (n=1,616) 66.4 [63.1,69.6] Male (n=602) 64.6 [59.6,69.3] 
Female (n=1,976) 61.8 [58.5,65.0] Female (n=1,759) 63.2 [59.7,66.7] Female (n=670) 60.6 [55.8,65.2] 
         
Design-based F(1.00, 159.00) = 2.7558 Pr = 
0.099 
Design-based F(1.00, 155.00) = 2.3752 Pr = 
0.125 
Design-based F(1.00, 153.00) = 2.8811 Pr = 
0.092 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample Reduced sample of only MEPS 2011 
White/Ethnicity   White/Ethnicity   White/Ethnicity   
non-Hispanic white 
(n=2,584) 65.8 [62.9,68.6] 
non-Hispanic white 
(n=2,422) 66.9 [63.8,69.8] 
non-Hispanic white 
(n=899) 64.3 [59.6,68.8] 
Hispanic white (n=1,167) 50.2 [45.8,54.7] Hispanic white (n=953) 52.3 [47.3,57.3] Hispanic white (n=373) 53.8 [48.4,59.2] 
         
Design-based F(1.00, 159.00) = 32.3124 Pr 
= 0.000 
Design-based F(1.00, 155.00) = 24.7308 Pr 
= 0.000 
Design-based F(1.00, 153.00) = 10.2973 Pr 
= 0.002 
         
Marital status   Marital status   Marital status   
Married (n=2,463) 64.8 [61.2,68.3] Married (n=2,294) 65.9 [62.1,69.5] Married (n=859) 63.6 [58.0,68.7] 
Widowed (n=276) 71.9 [62.0,80.1] Widowed (n=252) 73.6 [63.3,81.8] Widowed (n=81) 73.5 [59.5,83.9] 
Divorced/Separated 
(n=741) 60.0 [55.4,64.5] 
Divorced/Separated 
(n=620) 62.1 [57.0,67.0] 
Divorced/Separated 
(n=241) 62.6 [53.1,71.1] 
Never married (n=271) 50.1 [41.4,58.9] Never married (n=209) 51.3 [41.0,61.4] Never married (n=91) 45.4 [33.1,58.3] 
         
Design-based F(2.86, 454.83) = 4.5696 Pr = 
0.004 
Design-based F(2.81, 436.05) = 3.7528 Pr = 
0.013 
Design-based F(2.74, 419.21) = 2.7791 Pr = 
0.046 
         
Metropolitan Statistical Area 
Status  
Metropolitan Statistical Area 
Status  
Metropolitan Statistical Area 
Status  
Urban (n=3,412) 63.5 [60.8,66.2] Urban (n=3,081) 64.9 [62.0,67.6] Urban (n=1,137) 62.3 [57.9,66.4] 
Rural (n=339) 61.8 [55.8,67.4] Rural (n=294) 64.1 [55.8,71.6] Rural (n=135) 64.2 [51.2,75.5] 
         
Design-based F(1.00, 159.00) = 0.2963 Pr = 
0.587 
Design-based F(1.00, 155.00) = 0.0343 Pr = 
0.853 
Design-based F(1.00, 153.00) = 0.0918 Pr = 
0.762 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Immigration status   Immigration status   Immigration status   
US born (n=2,843) 65.3 [62.5,67.9] US born (n=2,640) 66.5 [63.5,69.4] US born (n=971) 64.6 [59.9,69.1] 
Foreign born, lived in US 
<15 years (n=66) 13.4 [3.5,40.0] 
Foreign born, lived in US 
<15 years (n=53) 13.5 [3.1,43.0] 
Foreign born, lived in US 
<15 years (n=28) 14.5 [5.9,31.7] 
Foreign born, lived in US 
> 15 years (n=812) 56.2 [51.0,61.2] 
Foreign born, lived in US 
> 15 years (n=654) 58.6 [52.8,64.2] 
Foreign born, lived in US 
> 15 years (n=262) 55.1 [47.8,62.1] 
missing (n=30) 24.1 [9.0,50.6] missing (n=28) 25.5 [9.3,53.4] missing (n=11) 63.1 [23.3,90.6] 
         
Design-based F(2.35, 373.35) = 14.2586 Pr 
= 0.000 
Design-based F(2.32, 360.30) = 12.0744 Pr 
= 0.000 
Design-based F(2.70, 413.35) = 12.4822 Pr 
= 0.000 
         
Whether comfortable 
speaking English  
Whether comfortable 
speaking English  
Whether comfortable 
speaking English  
Comfortable (n=3,277) 64.6 [62.0,67.0] Comfortable (n=3,019) 65.8 [63.0,68.4] Comfortable (n=1,114) 63.4 [59.2,67.4] 
Not comfortable (n=374) 39.5 [30.8,48.9] Not comfortable (n=271) 41.3 [30.3,53.2] Not comfortable (n=128) 44.2 [33.7,55.2] 
missing (n=100) 44.3 [30.7,58.9] missing (n=85) 45.4 [30.2,61.6] missing (n=30) 68.5 [45.1,85.2] 
         
Design-based F(1.64, 260.64) = 21.5597 Pr 
= 0.000 
Design-based F(1.65, 256.50) = 13.7777 Pr 
= 0.000 
Design-based F(2.00, 305.54) = 6.8836 Pr = 
0.001 
         
Interview Language   Interview Language   Interview Language   
English (n=3,220) 64.8 [62.2,67.2] English (n=2,974) 66.0 [63.3,68.7] English (n=1,098) 63.7 [59.5,67.8] 
Spanish, Spanish and 
English, or other (n=531) 40.4 [32.8,48.6] 
Spanish, Spanish and 
English, or other (n=401) 41.1 [32.7,50.0] 
Spanish, Spanish and 
English, or other (n=174) 44.3 [33.1,56.2] 
         
Design-based F(1.00, 159.00) = 38.3291 Pr 
= 0.000 
Design-based F(1.00, 155.00) = 32.9106 Pr 
= 0.000 
Design-based F(1.00, 153.00) = 12.0262 Pr 
= 0.001 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Dental checkup 
frequency   
Dental checkup 
frequency   
Dental checkup 
frequency   
Twice a year or more 
(n=1,703) 72.7 [69.1,76.0] 
Twice a year or more 
(n=1,663) 72.8 [69.1,76.1] 
Twice a year or more 
(n=576) 74.9 [69.7,79.4] 
Once a year (n=837) 61.7 [56.4,66.8] Once a year (n=766) 62.4 [56.7,67.9] Once a year (n=282) 53.8 [46.1,61.4] 
Less than once a year 
(n=702) 50.5 [45.0,55.9] 
Less than once a year 
(n=562) 53.1 [47.1,59.0] 
Less than once a year 
(n=248) 48.9 [41.1,56.7] 
Never go to dentist 
(n=453) 42.6 [36.7,48.7] 
Never go to dentist 
(n=332) 43.5 [36.9,50.4] 
Never go to dentist 
(n=146) 42.6 [33.3,52.4] 
missing (n=56) 9.0 [2.6,26.8] missing (n=52) 7.3 [1.7,26.7] missing (n=20) 0.0  
         
Design-based F(3.50, 556.16) = 30.7634 Pr 
= 0.000 
Design-based F(3.46, 536.66) = 25.0290 Pr 
= 0.000 
Design-based F(3.75, 574.27) = 21.2913 Pr 
= 0.000 
         
Most recent flu shot   Most recent flu shot   Most recent flu shot   
Within past year 
(n=1,892) 74.6 [72.0,77.1] 
Within past year 
(n=1,711) 76.2 [73.4,78.7] Within past year (n=644) 76.6 [72.9,80.0] 
Within past two years 
(n=348) 61.1 [53.6,68.2] 
Within past two years 
(n=307) 63.5 [56.2,70.3] 
Within past two years 
(n=131) 66.3 [53.7,76.9] 
More than two years 
(n=354) 56.6 [50.4,62.6] 
More than two years 
(n=326) 55.3 [48.9,61.5] 
More than two years 
(n=109) 52.2 [41.5,62.6] 
Never received flu shot 
(n=1,046) 48.3 [43.5,53.2] 
Never received flu shot 
(n=935) 50.5 [45.2,55.8] 
Never received flu shot 
(n=349) 42.4 [34.9,50.3] 
missing (n=111) 24.9 [15.3,37.8] missing (n=96) 24.3 [14.2,38.4] missing (n=39) 13.0 [4.2,33.5] 
         
Design-based F(3.62, 576.28) = 38.8891 Pr 
= 0.000 
Design-based F(3.49, 541.61) = 36.5583 Pr 
= 0.000 
Design-based F(3.34, 511.74) = 25.7139 Pr 
= 0.000 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Perceived health 
status   
Perceived health 
status   Perceived health status   
Excellent (n=736) 62.0 [56.5,67.1] Excellent (n=713) 62.3 [56.8,67.6] Excellent (n=253) 57.9 [50.3,65.2] 
Very good (n=1,230) 65.7 [61.5,69.7] Very good (n=1,182) 66.2 [61.9,70.2] Very good (n=447) 66.1 [59.7,72.1] 
Good (n=1,064) 62.9 [58.3,67.3] Good (n=963) 64.5 [59.9,68.8] Good (n=345) 61.5 [53.1,69.3] 
Fair/Poor (n=713) 61.1 [56.8,65.3] Fair/Poor (n=509) 66.4 [61.0,71.4] Fair/Poor (n=224) 62.7 [55.1,69.7] 
missing (n=8) 15.4 [2.7,54.6] missing (n=8) 15.4 [2.7,54.6] missing (n=3) 54.4 [6.8,95.1] 
         
Design-based F(3.14, 499.29) = 1.5012 Pr = 
0.212 
Design-based F(3.01, 466.09) = 1.3615 Pr = 
0.254 
Design-based F(3.48, 532.52) = 0.9510 Pr = 
0.425 
         
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
No (n=3,139) 60.2 [57.6,62.7] No (n=2,801) 61.6 [58.7,64.3] No (n=1,082) 58.9 [54.7,62.9] 
Yes (n=611) 77.3 [72.1,81.8] Yes (n=573) 78.4 [73.0,83.0] Yes (n=190) 81.3 [73.8,87.0] 
missing (n=1) 0.0  missing (n=1) 0.0  missing (n=0) 0.0  
         
Design-based F(1.21, 192.20) = 32.0869 Pr 
= 0.000 
Design-based F(1.18, 183.16) = 26.8255 Pr 
= 0.000 
Design-based F(., .) = . 
Pr = . **   
         
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
0 (n=2,419) 60.0 [57.2,62.7] 0 (n=2,268) 61.3 [58.5,64.1] 0 (n=841) 57.7 [52.9,62.4] 
1 (n=709) 64.4 [59.8,68.7] 1 (n=590) 66.2 [61.3,70.9] 1 (n=239) 66.8 [59.3,73.5] 
2 (n=391) 76.3 [70.9,80.9] 2 (n=334) 79.1 [72.9,84.2] 2 (n=115) 83.5 [75.3,89.3] 
3+ (n=232) 72.6 [63.6,80.1] 3+ (n=183) 75.1 [64.9,83.1] 3+ (n=77) 73.0 [61.5,82.1] 
         
Design-based F(2.76, 438.78) = 11.7138 Pr 
= 0.000 
Design-based F(2.72, 421.43) = 11.4085 Pr 
= 0.000 
Design-based F(2.85, 435.50) = 11.2565 Pr 
= 0.000 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Smoking status   Smoking status   Smoking status   
Non-smoker (n=3,019) 66.1 [63.5,68.7] Non-smoker (n=2,735) 67.5 [64.8,70.1] Non-smoker (n=1,040) 65.1 [61.0,69.0] 
Current Smoker (n=394) 50.7 [45.0,56.3] Current Smoker (n=334) 52.6 [46.2,59.0] Current Smoker (n=120) 49.8 [41.2,58.3] 
missing (n=338) 48.8 [40.9,56.7] missing (n=306) 50.2 [41.9,58.5] missing (n=112) 47.5 [33.7,61.8] 
         
Design-based F(1.98, 315.15) = 21.9931 Pr 
= 0.000 
Design-based F(1.97, 304.65) = 19.1647 Pr 
= 0.000 
Design-based F(1.70, 259.74) = 8.3114 Pr = 
0.001 
         
BMI categories   BMI categories   BMI categories   
Underweight (n=29) 44.7 [25.3,65.9] Underweight (n=22) 40.5 [19.7,65.3] Underweight (n=13) 32.4 [11.4,64.2] 
Normal weight (n=1,025) 59.1 [55.1,63.1] Normal weight (n=948) 60.5 [56.3,64.5] Normal weight (n=341) 57.6 [50.9,64.0] 
Overweight (n=1,419) 63.4 [59.9,66.8] Overweight (n=1,289) 64.6 [61.1,67.9] Overweight (n=478) 62.7 [56.4,68.6] 
Obese (n=1,184) 68.9 [65.3,72.3] Obese (n=1,034) 71.0 [67.1,74.6] Obese (n=411) 69.3 [62.3,75.5] 
missing (n=94) 44.4 [30.9,58.8] missing (n=82) 47.1 [32.7,62.0] missing (n=29) 32.3 [14.2,57.9] 
         
Design-based F(3.67, 583.03) = 6.7332 Pr = 
0.000 
Design-based F(3.70, 574.27) = 7.0084 Pr = 
0.000 
Design-based F(3.55, 542.76) = 4.2589 Pr = 
0.003 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Poor/Negative (<100%) 
(n=353) 51.1 [43.0,59.2] 
Poor/Negative (<100%) 
(n=192) 58.5 [47.5,68.8] 
Poor/Negative (<100%) 
(n=125) 57.0 [43.6,69.4] 
Near poor/Low income 
(100-200%) (n=606) 52.8 [46.8,58.8] 
Near poor/Low income 
(100-200%) (n=478) 56.1 [49.5,62.4] 
Near poor/Low income 
(100-200%) (n=219) 55.2 [45.1,64.8] 
Middle Income (200-
400%) (n=1,107) 61.1 [57.0,65.0] 
Middle Income (200-
400%) (n=1,035) 61.7 [57.4,65.8] 
Middle Income (200-
400%) (n=373) 56.7 [48.7,64.4] 
High Income (>400%) 
(n=1,685) 68.3 [65.0,71.5] 
High Income (>400%) 
(n=1,670) 68.3 [64.9,71.5] 
High Income (>400%) 
(n=555) 68.1 [62.5,73.2] 
         
Design-based F(2.79, 444.14) = 12.1090 Pr 
= 0.000 
Design-based F(2.90, 449.90) = 6.2798 Pr = 
0.000 
Design-based F(2.87, 439.12) = 3.3720 Pr = 
0.020 
         
Educational attainment   Educational attainment   Educational attainment   
Less than a HSD 
(n=714) 48.0 [40.8,55.2] 
Less than a HSD 
(n=524) 51.6 [43.2,59.8] 
Less than a HSD 
(n=224) 52.1 [41.4,62.6] 
HSD/GED (n=1,581) 60.4 [56.8,63.9] HSD/GED (n=1,462) 62.0 [58.0,65.9] HSD/GED (n=509) 58.4 [52.2,64.3] 
Bachelor's (n=638) 66.7 [61.8,71.4] Bachelor's (n=608) 67.1 [62.1,71.8] Bachelor's (n=240) 61.5 [53.7,68.7] 
Graduate/Doctorate 
Degree (n=432) 74.2 [66.8,80.5] 
Graduate/Doctorate 
Degree (n=420) 74.0 [66.6,80.2] 
Graduate/Doctorate 
Degree (n=172) 73.7 [65.2,80.7] 
Other Degree (n=338) 71.7 [65.8,77.0] Other Degree (n=318) 71.9 [65.7,77.4] Other Degree (n=110) 76.2 [65.5,84.3] 
missing (n=48) 20.0 [10.2,35.5] missing (n=43) 21.0 [10.7,37.0] missing (n=17) 24.8 [10.5,47.9] 
         
Design-based F(3.85, 612.62) = 11.6172 Pr 
= 0.000 
Design-based F(3.87, 600.45) = 8.2979 Pr = 
0.000 
Design-based F(3.45, 527.53) = 5.5011 Pr = 
0.001 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Number of months insured in survey year Number of months insured in survey year Number of months insured in survey year 
 1-6  (n=161) 41.1 [29.5,53.7]  1-6  (n=120) 43.1 [30.3,56.8]  1-6  (n=51) 41.2 [23.9,60.9] 
 7-11  (n=206) 37.2 [26.6,49.2]  7-11  (n=150) 42.8 [30.0,56.6]  7-11  (n=72) 44.9 [31.0,59.7] 
 12  (n=3,384) 65.4 [62.9,67.8]  12  (n=3,105) 66.4 [63.7,69.0]  12  (n=1,149) 64.2 [59.9,68.2] 
         
Design-based F(2.00, 317.50) = 19.3913 Pr 
= 0.000 
Design-based F(1.99, 308.98) = 12.0756 Pr 
= 0.000 
Design-based F(1.91, 291.62) = 6.1270 Pr = 
0.003 
         
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
0 (n=827) 36.9 [32.4,41.6] 0 (n=759) 37.7 [33.1,42.5] 0 (n=290) 37.5 [30.7,44.7] 
1 (n=526) 56.3 [51.5,60.9] 1 (n=497) 56.8 [51.9,61.5] 1 (n=183) 53.8 [43.9,63.4] 
2 (n=486) 65.2 [59.7,70.4] 2 (n=453) 66.3 [60.8,71.5] 2 (n=158) 61.8 [52.0,70.8] 
3 (n=361) 67.8 [62.5,72.7] 3 (n=337) 69.6 [64.5,74.2] 3 (n=118) 61.5 [51.7,70.5] 
4 (n=271) 69.8 [61.8,76.7] 4 (n=245) 72.1 [64.1,78.9] 4 (n=90) 69.8 [57.2,80.0] 
5+ (n=1,280) 75.8 [72.0,79.2] 5+ (n=1,084) 78.8 [74.7,82.3] 5+ (n=433) 77.5 [72.1,82.1] 
         
Design-based F(4.29, 682.48) = 42.3014 Pr 
= 0.000 
Design-based F(4.23, 655.47) = 45.3505 Pr 
= 0.000 
Design-based F(4.29, 655.64) = 16.9422 Pr 
= 0.000 
         
Had a usual source of 
care   
Had a usual source of 
care   
Had a usual source of 
care   
No (n=415) 37.3 [31.1,43.9] No (n=360) 39.1 [32.9,45.7] No (n=136) 35.2 [24.7,47.3] 
Yes (n=3,270) 66.4 [63.8,69.0] Yes (n=2,954) 67.9 [65.0,70.7] Yes (n=1,112) 65.7 [61.6,69.6] 
missing (n=66) 28.4 [14.0,49.0] missing (n=61) 28.0 [13.4,49.5] missing (n=24) 23.2 [7.2,54.2] 
         
Design-based F(1.99, 317.08) = 49.8483 Pr 
= 0.000 
Design-based F(2.00, 309.76) = 47.8755 Pr 
= 0.000 
Design-based F(1.96, 300.19) = 19.0388 Pr 
= 0.000 
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Year   Year   Year   
2009 (n=1,283) 62.7 [59.6,65.8] 2009 (n=1,153) 64.3 [61.1,67.3] 2009 (n=0) 0.0  
2010 (n=1,196) 64.6 [61.4,67.7] 2010 (n=1,084) 66.0 [62.5,69.3] 2010 (n=0) 0.0  
2011 (n=1,272) 62.5 [58.3,66.6] 2011 (n=1,138) 64.0 [59.5,68.3] 2011 (n=1,272) 62.5 [58.3,66.6] 
         
Design-based F(1.72, 273.78) = 0.5828 Pr = 
0.534 
Design-based F(1.70, 264.08) = 0.4995 Pr = 
0.578    
Insurance Features 
         
Insurance had a DPN  Coverage was restricted to a DPN Household had a FSA   
No (n=1,596) 66.0 [61.9,69.8] No (n=2,469) 64.7 [61.1,68.2] No (n=1,130) 62.0 [57.4,66.5] 
Yes (n=2,048) 61.6 [59.0,64.3] Yes (n=903) 65.1 [60.9,69.0] Yes (n=101) 71.9 [58.9,82.0] 
missing (n=107) 51.3 [38.1,64.3] missing (n=3) 0.0  missing (n=41) 39.7 [21.5,61.3] 
         
Design-based F(1.86, 294.98) = 3.6761 Pr = 
0.030 
Design-based F(1.34, 207.11) = 0.4138 Pr = 
0.579 
Design-based F(1.85, 282.90) = 2.9640 Pr = 
0.057* 
         
Insurance used 
gatekeeping         
No (n=1,989) 64.1 [60.1,67.8]       
Yes (n=1,667) 62.9 
[59.1,66.5
]       
missing (n=95) 50.6 [36.9,64.3]       
          
Design-based F(1.79, 284.65) = 1.2425 Pr = 
0.288       
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Table 4.4  (cont.) 
Full MEPS 2009-2011 sample       
Cost-sharing categories for Aim 2 main 
analysis full sample       
0.0% (n=216) 43.2 [34.2,52.7]       
0.1 to 13.9% (n=1,127) 68.6 [64.9,72.2]       
14.0 to 32.3% (n=972) 72.1 [68.3,75.7]       
32.3 to 88.4% (n=974) 63.5 [59.3,67.5]       
88.4 to 100% (n=172) 35.2 [28.1,42.9]       
No spending in year 
(n=290) 27.3 [20.4,35.6]       
         
Design-based F(4.48, 712.21) = 33.1234 Pr 
= 0.000       
         
* there was not an overall significant difference (p<0.1) for the variable after excluding the missing category 
** there was an overall significant difference (p<0.05) for the variable after excluding the missing category 
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Table 4.5 Aim 2 Bivariate Associations with Likelihood of Having Received CRC Screening in the Past Year 
for Sensitivity Analysis Samples 
Full MEPS 2009-2011 sample of those 
screened in previous year and those 
not up-to-date with recommended CRC 
screening 
Reduced MEPS 2009-2011 sample 
excluding those age 50-64 with only 
public insurance Reduced sample of only MEPS 2011 
 % 95% CI  % 95% CI  % 95% CI 
         
Total (n=2,591) 45.7 [42.8,48.5] Total (n=2,275) 47.0 [43.7,50.3] Total (n=848) 41.9 [37.1,46.8] 
         
Covariates 
         
Age groups   Age groups   Age groups   
50-54 (n=801) 30.6 [25.7,36.0] 50-54 (n=680) 30.7 [25.7,36.3] 50-54 (n=291) 27.7 [23.1,32.9] 
55-59 (n=564) 45.0 [38.2,52.1] 55-59 (n=463) 48.1 [40.6,55.7] 55-59 (n=164) 41.9 [30.1,54.6] 
60-64 (n=475) 53.8 [47.8,59.6] 60-64 (n=381) 55.8 [49.2,62.1] 60-64 (n=141) 46.1 [34.4,58.3] 
65-69 (n=433) 57.8 [50.5,64.8] 65-69 (n=433) 57.8 [50.5,64.8] 65-69 (n=145) 55.6 [45.5,65.2] 
70-75 (n=318) 59.3 [52.5,65.8] 70-75 (n=318) 59.3 [52.5,65.8] 70-75 (n=107) 62.4 [53.9,70.2] 
         
Design-based F(2.80, 433.53) = 15.1307 Pr 
= 0.000 
Design-based F(2.81, 422.01) = 15.0016 Pr 
= 0.000 
Design-based F(3.00, 438.58) = 9.0388 Pr = 
0.000 
         
Sex   Sex   Sex   
Male (n=1,214) 47.6 [44.1,51.2] Male (n=1,084) 49.1 [45.0,53.1] Male (n=396) 43.9 [38.4,49.5] 
Female (n=1,377) 43.9 [40.0,47.8] Female (n=1,191) 45.0 [40.6,49.5] Female (n=452) 40.1 [34.1,46.4] 
         
Design-based F(1.00, 155.00) = 2.3592 Pr = 
0.127 
Design-based F(1.00, 150.00) = 2.2471 Pr = 
0.136 
Design-based F(1.00, 146.00) = 1.2273 Pr = 
0.270 
         
         
 
 
125 
 
Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
White/Ethnicity   White/Ethnicity   White/Ethnicity   
non-Hispanic white 
(n=1,635) 47.6 [44.4,50.9] 
non-Hispanic white 
(n=1,515) 48.9 [45.2,52.6] 
non-Hispanic white 
(n=563) 43.3 [37.5,49.2] 
Hispanic white (n=956) 37.1 [32.2,42.2] Hispanic white (n=760) 37.5 [32.1,43.3] Hispanic white (n=285) 35.9 [30.3,41.8] 
         
Design-based F(1.00, 155.00) = 12.7378 Pr 
= 0.000 
Design-based F(1.00, 150.00) = 11.7107 Pr 
= 0.001 
Design-based F(1.00, 146.00) = 2.8524 Pr = 
0.093 
         
Marital status   Marital status   Marital status   
Married (n=1,681) 46.8 [42.5,51.1] Married (n=1,533) 47.9 [43.4,52.4] Married (n=558) 41.7 [35.2,48.6] 
Widowed (n=175) 54.7 [43.0,66.0] Widowed (n=155) 56.7 [44.1,68.5] Widowed (n=51) 55.6 [37.4,72.4] 
Divorced/Separated 
(n=512) 41.8 [36.7,47.1] 
Divorced/Separated 
(n=419) 42.8 [36.6,49.3] 
Divorced/Separated 
(n=167) 43.7 [32.6,55.5] 
Never married (n=223) 40.0 [30.2,50.7] Never married (n=168) 41.0 [30.0,53.1] Never married (n=72) 31.7 [19.2,47.6] 
         
Design-based F(2.83, 438.34) = 1.6627 Pr = 
0.177 
Design-based F(2.83, 424.63) = 1.5494 Pr = 
0.203 
Design-based F(2.75, 401.17) = 1.0634 Pr = 
0.361 
         
Metropolitan Statistical Area Status Metropolitan Statistical Area Status Metropolitan Statistical Area Status 
Urban (n=2,352) 46.0 [43.0,49.1] Urban (n=2,072) 47.1 [43.7,50.6] Urban (n=757) 41.7 [36.8,46.7] 
Rural (n=239) 43.0 [35.4,50.9] Rural (n=203) 45.9 [36.1,56.1] Rural (n=91) 43.4 [30.1,57.6] 
         
Design-based F(1.00, 155.00) = 0.5333 Pr = 
0.466 
Design-based F(1.00, 150.00) = 0.0462 Pr = 
0.830 
Design-based F(1.00, 146.00) = 0.0554 Pr = 
0.814 
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Immigration status   Immigration status   Immigration status   
US born (n=1,849) 47.0 [43.6,50.4] US born (n=1,690) 48.2 [44.4,52.1] US born (n=618) 43.7 [38.1,49.6] 
Foreign born, lived in US 
<15 years (n=60) 6.0 [1.2,25.2] 
Foreign born, lived in US 
<15 years (n=48) 6.5 [1.3,27.4] 
Foreign born, lived in US 
<15 years (n=24) 2.8 [0.4,18.5] 
Foreign born, lived in US 
> 15 years (n=654) 43.4 [37.2,49.8] 
Foreign born, lived in US 
> 15 years (n=511) 45.0 [37.3,52.9] 
Foreign born, lived in US 
> 15 years (n=196) 37.0 [29.5,45.2] 
missing (n=28) 22.7 [7.8,50.5] missing (n=26) 24.1 [8.2,53.0] missing (n=10) 59.2 [18.3,90.4] 
         
Design-based F(2.66, 412.25) = 7.1710 Pr = 
0.000 
Design-based F(2.62, 392.39) = 6.1250 Pr = 
0.001 
Design-based F(2.65, 386.92) = 6.4274 Pr = 
0.001 
         
Whether comfortable speaking English Whether comfortable speaking English Whether comfortable speaking English 
Comfortable (n=2,186) 46.8 [43.6,50.0] Comfortable (n=1,979) 47.9 [44.4,51.5] Comfortable (n=724) 42.6 [37.5,47.7] 
Not comfortable (n=316) 26.7 [20.6,33.9] Not comfortable (n=221) 25.9 [18.5,35.1] Not comfortable (n=99) 25.8 [17.6,36.2] 
missing (n=89) 38.3 [26.3,52.0] missing (n=75) 39.5 [26.7,53.8] missing (n=25) 61.1 [37.1,80.7] 
         
Design-based F(1.84, 284.59) = 12.4500 Pr 
= 0.000 
Design-based F(1.78, 267.67) = 10.4856 Pr 
= 0.000 
Design-based F(1.98, 289.58) = 5.2244 Pr = 
0.006 
         
Interview Language   Interview Language   Interview Language   
English (n=2,136) 47.0 [43.9,50.2] English (n=1,939) 48.2 [44.7,51.8] English (n=713) 43.3 [38.2,48.5] 
Spanish, Spanish and 
English, or other (n=455) 28.6 [22.8,35.2] 
Spanish, Spanish and 
English, or other (n=336) 27.3 [21.0,34.6] 
Spanish, Spanish and 
English, or other (n=135) 22.8 [16.1,31.1] 
         
Design-based F(1.00, 155.00) = 22.0192 Pr 
= 0.000 
Design-based F(1.00, 150.00) = 23.5169 Pr 
= 0.000 
Design-based F(1.00, 146.00) = 15.9766 Pr 
= 0.000 
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Reduced MEPS 2009-2011 sample  Reduced sample of only MEPS 2011 
Dental checkup 
frequency   
Dental checkup 
frequency   
Dental checkup 
frequency   
Twice a year or more 
(n=1,074) 57.6 [52.4,62.7] 
Twice a year or more 
(n=1,043) 57.6 [52.3,62.8] 
Twice a year or more 
(n=345) 57.9 [49.6,65.7] 
Once a year (n=580) 42.2 [37.0,47.6] Once a year (n=517) 42.6 [36.9,48.6] Once a year (n=195) 31.6 [23.8,40.5] 
Less than once a year 
(n=518) 30.3 [25.5,35.7] 
Less than once a year 
(n=400) 30.9 [25.5,36.9] 
Less than once a year 
(n=178) 26.3 [19.1,35.1] 
Never go to dentist 
(n=366) 27.9 [23.4,33.0] 
Never go to dentist 
(n=265) 28.9 [23.6,34.8] 
Never go to dentist 
(n=110) 20.0 [14.2,27.3] 
missing (n=53) 1.1 [0.1,8.0] missing (n=50) 1.2 [0.2,8.2] missing (n=20) 0.0  
         
Design-based F(2.81, 435.37) = 32.4849 Pr 
= 0.000 
Design-based F(2.95, 443.22) = 28.1272 Pr 
= 0.000 
Design-based F(3.24, 472.92) = 16.4994 Pr 
= 0.000 
         
Most recent flu shot   Most recent flu shot   Most recent flu shot   
Within past year 
(n=1,215) 59.9 [56.5,63.1] 
Within past year 
(n=1,070) 61.5 [57.8,65.0] Within past year (n=392) 59.7 [55.0,64.3] 
Within past two years 
(n=226) 42.7 [34.5,51.3] 
Within past two years 
(n=190) 45.3 [36.3,54.6] 
Within past two years 
(n=75) 40.2 [24.0,58.7] 
More than two years 
(n=249) 36.7 [28.8,45.5] 
More than two years 
(n=232) 36.5 [28.1,45.8] 
More than two years 
(n=79) 35.3 [23.5,49.2] 
Never received flu shot 
(n=803) 30.4 [25.4,35.8] 
Never received flu shot 
(n=699) 31.9 [26.5,37.8] 
Never received flu shot 
(n=266) 22.2 [16.5,29.2] 
missing (n=98) 11.1 [4.3,25.6] missing (n=84) 8.4 [2.1,28.5] missing (n=36) 5.8 [1.3,22.0] 
         
Design-based F(3.65, 565.00) = 27.7441 Pr 
= 0.000 
Design-based F(3.47, 521.01) = 23.5668 Pr 
= 0.000 
Design-based F(3.44, 502.74) = 17.7983 Pr 
= 0.000 
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Perceived health 
status   
Perceived health 
status   Perceived health status   
Excellent (n=467) 41.6 [34.8,48.6] Excellent (n=447) 41.9 [35.1,49.0] Excellent (n=172) 39.2 [31.0,48.1] 
Very good (n=838) 48.5 [43.9,53.1] Very good (n=800) 49.1 [44.4,53.8] Very good (n=286) 43.4 [36.2,51.0] 
Good (n=751) 46.3 [41.7,51.1] Good (n=665) 47.7 [42.7,52.7] Good (n=231) 40.3 [31.0,50.4] 
Fair/Poor (n=527) 44.4 [39.4,49.5] Fair/Poor (n=355) 48.6 [41.6,55.6] Fair/Poor (n=156) 45.2 [34.9,55.9] 
missing (n=8) 15.4 [2.7,54.6] missing (n=8) 15.4 [2.7,54.6] missing (n=3) 54.4 [6.8,95.1] 
         
Design-based F(3.14, 487.29) = 1.4754 Pr = 
0.219 
Design-based F(3.11, 466.78) = 1.6063 Pr = 
0.185 
Design-based F(3.48, 507.44) = 0.3121 Pr = 
0.845 
         
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
Have any personal non-CRC cancer 
history 
No (n=2,221) 41.9 [39.1,44.8] No (n=1,938) 43.1 [39.9,46.4] No (n=748) 38.4 [34.1,42.8] 
Yes (n=369) 64.0 [57.8,69.8] Yes (n=336) 65.1 [58.3,71.4] Yes (n=100) 64.5 [51.1,75.9] 
missing (n=1) 0.0  missing (n=1) 0.0  missing (n=0) 0.0  
         
Design-based F(1.32, 204.22) = 45.0785 Pr 
= 0.000 
Design-based F(1.28, 192.69) = 38.0901 Pr 
= 0.000 
Design-based F(., .) = . Pr = . 
**  
         
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
Quan et al.'s updated Charlson 
comorbidity index 
0 (n=1,679) 40.8 [37.5,44.2] 0 (n=1,546) 42.2 [38.7,45.8] 0 (n=574) 36.5 [31.7,41.5] 
1 (n=500) 47.9 [43.3,52.5] 1 (n=399) 49.4 [44.0,54.9] 1 (n=166) 49.0 [40.7,57.3] 
2 (n=267) 65.8 [57.9,73.0] 2 (n=221) 68.8 [59.1,77.1] 2 (n=64) 68.5 [53.8,80.2] 
3+ (n=145) 56.4 [46.7,65.6] 3+ (n=109) 58.8 [47.3,69.5] 3+ (n=44) 53.0 [35.8,69.6] 
         
Design-based F(2.51, 389.08) = 16.8927 Pr 
= 0.000 
Design-based F(2.50, 374.92) = 14.2369 Pr 
= 0.000 
Design-based F(2.64, 385.35) = 8.8260 Pr = 
0.000 
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Smoking status   Smoking status   Smoking status   
Non-smoker (n=2,045) 48.8 [45.5,52.2] Non-smoker (n=1,802) 50.0 [46.3,53.7] Non-smoker (n=676) 44.4 [39.6,49.2] 
Current Smoker (n=281) 31.3 [25.3,38.1] Current Smoker (n=237) 32.7 [26.2,40.0] Current Smoker (n=84) 28.8 [19.7,39.9] 
missing (n=265) 33.3 [25.5,42.0] missing (n=236) 34.4 [26.2,43.6] missing (n=88) 32.7 [18.6,50.9] 
         
Design-based F(1.98, 307.20) = 13.9238 Pr 
= 0.000 
Design-based F(1.97, 295.34) = 12.6360 Pr 
= 0.000 
Design-based F(1.80, 262.13) = 3.3220 Pr = 
0.043 
         
BMI categories   BMI categories   BMI categories   
Underweight (n=20) 20.4 [9.8,37.7] Underweight (n=16) 16.1 [4.3,45.0] Underweight (n=10) 19.7 [4.1,58.3] 
Normal weight (n=701) 40.5 [35.5,45.7] Normal weight (n=634) 41.5 [36.2,47.0] Normal weight (n=220) 35.1 [28.8,42.1] 
Overweight (n=974) 46.3 [42.4,50.3] Overweight (n=862) 47.1 [42.8,51.5] Overweight (n=321) 41.9 [34.4,49.7] 
Obese (n=823) 52.3 [47.9,56.6] Obese (n=701) 54.7 [49.7,59.6] Obese (n=274) 51.1 [41.6,60.4] 
missing (n=73) 24.4 [13.0,41.1] missing (n=62) 26.6 [14.2,44.3] missing (n=23) 10.2 [2.3,35.3] 
         
Design-based F(2.97, 459.73) = 7.1376 Pr = 
0.000 
Design-based F(3.11, 466.48) = 6.7012 Pr = 
0.000 
Design-based F(3.04, 443.26) = 3.9143 Pr = 
0.009 
         
   
   
   
   
   
   
   
   
   
 
 
130 
 
Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Household income as a percentage of the 
federal poverty level 
Poor/Negative (<100%) 
(n=277) 37.0 [29.9,44.8] 
Poor/Negative (<100%) 
(n=143) 41.4 [29.7,54.2] 
Poor/Negative (<100%) 
(n=93) 39.6 [27.8,52.6] 
Near poor/Low income 
(100-200%) (n=472) 37.6 [31.5,44.1] 
Near poor/Low income 
(100-200%) (n=362) 40.3 [32.9,48.2] 
Near poor/Low income 
(100-200%) (n=157) 35.3 [24.5,47.7] 
Middle Income (200-
400%) (n=780) 43.0 [37.9,48.2] 
Middle Income (200-
400%) (n=719) 43.3 [38.0,48.7] 
Middle Income (200-
400%) (n=260) 36.2 [27.6,45.6] 
High Income (>400%) 
(n=1,062) 50.6 [45.8,55.4] 
High Income (>400%) 
(n=1,051) 50.7 [45.9,55.5] 
High Income (>400%) 
(n=338) 47.4 [39.7,55.2] 
         
Design-based F(2.92, 453.25) = 5.5083 Pr = 
0.001 
Design-based F(2.95, 442.35) = 2.9773 Pr = 
0.032 
Design-based F(2.82, 412.20) = 1.8679 Pr = 
0.138 
         
Educational attainment   Educational attainment   Educational attainment   
Less than a HSD 
(n=583) 31.6 [26.1,37.7] 
Less than a HSD 
(n=413) 33.6 [27.0,40.9] 
Less than a HSD 
(n=168) 26.3 [18.3,36.1] 
HSD/GED (n=1,095) 43.0 [38.5,47.6] HSD/GED (n=996) 44.3 [39.2,49.6] HSD/GED (n=346) 38.5 [32.5,45.0] 
Bachelor's (n=403) 48.3 [41.5,55.2] Bachelor's (n=382) 48.7 [41.7,55.8] Bachelor's (n=157) 41.2 [32.7,50.2] 
Graduate/Doctorate 
Degree (n=247) 56.8 [47.5,65.6] 
Graduate/Doctorate 
Degree (n=240) 56.4 [47.0,65.3] 
Graduate/Doctorate 
Degree (n=94) 52.1 [39.4,64.6] 
Other Degree (n=217) 57.5 [49.8,64.8] Other Degree (n=203) 57.5 [49.0,65.6] Other Degree (n=68) 61.7 [47.7,74.0] 
missing (n=46) 17.8 [8.0,35.2] missing (n=41) 18.7 [8.3,36.7] missing (n=15) 16.1 [3.0,54.3] 
         
Design-based F(3.96, 613.72) = 7.1938 Pr = 
0.000 
Design-based F(3.99, 597.76) = 5.1157 Pr = 
0.000 
Design-based F(4.24, 619.35) = 4.8126 Pr = 
0.001 
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Number of months insured in survey year Number of months insured in survey year Number of months insured in survey year 
 1-6  (n=125) 22.9 [13.9,35.5]  1-6  (n=88) 24.4 [13.9,39.1]  1-6  (n=38) 18.7 [6.2,44.5] 
 7-11  (n=169) 20.9 [12.1,33.7]  7-11  (n=119) 24.5 [13.3,40.7]  7-11  (n=54) 18.5 [7.2,39.8] 
 12  (n=2,297) 48.1 [44.9,51.3]  12  (n=2,068) 48.9 [45.3,52.6]  12  (n=756) 44.0 [39.0,49.1] 
         
Design-based F(1.98, 306.56) = 13.7066 Pr 
= 0.000 
Design-based F(1.97, 295.69) = 8.4935 Pr = 
0.000 
Design-based F(2.00, 291.59) = 4.7499 Pr = 
0.009 
         
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
Number of outpatient provider visits in 
year including physicians PAs and NPs 
0 (n=674) 19.3 [14.8,24.8] 0 (n=614) 20.1 [15.3,25.8] 0 (n=233) 20.1 [14.3,27.5] 
1 (n=376) 37.8 [32.2,43.8] 1 (n=353) 38.7 [32.9,44.9] 1 (n=132) 36.9 [26.4,48.7] 
2 (n=322) 46.4 [38.9,54.0] 2 (n=294) 47.7 [39.8,55.8] 2 (n=108) 39.5 [29.7,50.2] 
3 (n=232) 51.4 [43.7,58.9] 3 (n=211) 53.3 [45.8,60.7] 3 (n=74) 41.1 [28.9,54.5] 
4 (n=181) 54.6 [43.4,65.4] 4 (n=157) 56.4 [44.7,67.5] 4 (n=59) 49.0 [33.6,64.6] 
5+ (n=806) 61.4 [56.8,65.7] 5+ (n=646) 64.7 [59.3,69.8] 5+ (n=242) 59.3 [50.8,67.3] 
         
Design-based F(4.17, 645.97) = 28.2297 Pr 
= 0.000 
Design-based F(4.17, 626.12) = 29.1859 Pr 
= 0.000 
Design-based F(4.34, 633.99) = 9.9258 Pr = 
0.000 
         
Had a usual source of 
care   
Had a usual source of 
care   
Had a usual source of 
care   
No (n=336) 19.3 [14.4,25.3] No (n=286) 20.2 [15.0,26.7] No (n=106) 16.2 [8.6,28.3] 
Yes (n=2,195) 49.4 [46.4,52.3] Yes (n=1,933) 50.8 [47.3,54.2] Yes (n=721) 45.5 [40.6,50.4] 
missing (n=60) 16.4 [4.4,45.2] missing (n=56) 16.9 [4.6,46.2] missing (n=21) 8.8 [1.1,45.6] 
         
Design-based F(1.77, 273.70) = 30.6188 Pr 
= 0.000 
Design-based F(1.80, 269.50) = 28.5074 Pr 
= 0.000 
Design-based F(1.95, 285.39) = 12.3316 Pr 
= 0.000 
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample Full MEPS 2009-2011 sample 
Year   Year   Year   
2009 (n=925) 47.4 [42.6,52.2] 2009 (n=811) 48.9 [43.8,54.0] 2009 (n=0) 0.0  
2010 (n=818) 47.6 [43.5,51.8] 2010 (n=725) 48.8 [44.3,53.3] 2010 (n=0) 0.0  
2011 (n=848) 41.9 [37.1,46.8] 2011 (n=739) 43.1 [37.7,48.8] 2011 (n=848) 41.9 [37.1,46.8] 
         
Design-based F(1.61, 248.92) = 2.1301 Pr = 
0.131 
Design-based F(1.66, 248.66) = 1.8588 Pr = 
0.165  
Insurance Features 
         
Insurance had a DPN  Coverage was restricted to a DPN Household had a FSA   
No (n=1,040) 45.4 [40.8,50.1] No (n=1,621) 44.7 [40.4,49.0] No (n=759) 41.7 [36.7,47.0] 
Yes (n=1,468) 46.3 [42.9,49.7] Yes (n=651) 53.1 [47.5,58.6] Yes (n=58) 49.7 [33.0,66.5] 
missing (n=83) 34.2 [22.6,48.0] missing (n=3) 0.0  missing (n=31) 20.4 [8.1,42.7] 
         
Design-based F(1.75, 270.70) = 1.1566 Pr = 
0.311 
Design-based F(1.32, 197.29) = 4.2290 Pr = 
0.030 
Design-based F(1.70, 247.75) = 1.7669 Pr = 
0.178 
         
Insurance used 
gatekeeping         
No (n=1,290) 42.5 [37.8,47.4]       
Yes (n=1,228) 49.9 [45.4,54.4]       
missing (n=73) 32.9 [21.0,47.5]       
         
Design-based F(1.61, 249.64) = 3.6949 Pr = 
0.035       
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Table 4.5 (cont.) 
Full MEPS 2009-2011 sample       
Cost-sharing categories for Aim 2 
sensitivity analysis full sample       
0.0% (n=156) 24.9 [16.7,35.5]       
0.1 to 13.0% (n=759) 54.3 [50.0,58.4]       
13.1 to 32.3% (n=647) 56.0 [51.0,60.8]       
32.3 to 93.1% (n=659) 43.0 [37.9,48.2]       
93.1 to 100% (n=116) 14.5 [8.7,23.1]       
No spending in year 
(n=254) 11.7 [7.6,17.7]       
         
Design-based F(4.55, 705.07) = 28.8871 Pr 
= 0.000       
       
** there was an overall significant difference (p<0.05) for the variable after excluding the missing category 
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a very wide confidence interval (3.5 to 40.0%). 
Some variables that had significant variation, but of a small difference, in the Aim 
1 sample were not significant in the Aim 2 sample, which had about one-sixth the 
sample size as the full Aim 1 sample 3,751 vs. 21,085.  In the Aim 2 full sample 
and both reduced samples, screening likelihood did not significantly vary 
depending on urban vs. rural MSA designation, perceived health status, or 
survey year. 
Bivariate associations for the Aim 2 sensitivity analysis for the binary outcome of 
had received any CRC screening in the previous year vs. was not up-to-date with 
recommended screening were generally consistent with the main analysis 
findings (Table 4.5).  Notably, in the sensitivity analyses marital status no longer 
predicted significant variation in screening likelihood as it had in the main 
analyses.  In the sensitivity analyses, foreign born persons who had lived in the 
US for less than 15 years were predicted to have a 6.0% likelihood of having 
received screening in the previous year in the full sample for the Aim 2 sensitivity 
analysis, and only a 2.8% likelihood in the reduced sample of only MEPS 2011.  
Those estimates were 13.4 and 14.5% for the same samples of the main 
analyses, respectively.  In the Aim 2 sensitivity analysis, the overall significance 
tests for the bivariate associations for the insurance features switched from the 
findings for the main analyses’ samples.  In the sensitivity analyses’ samples, 
having a DPN was no longer significant, while each having insurance that used 
gatekeeping and having insurance with coverage that was restricted to a DPN 
was significant.  
 
Multivariate Logistic Regression Model Specifications 
 
Covariate Effects 
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In the first part of the multivariate logistic regression procedure, the covariates 
from the bivariate analyses were fit into blocks of substantively related variables, 
with a separate model fitting for each unique sample used in the main and 
sensitivity analyses for Aims 1 and 2.  Although generally similar overall (Table 
4.6), the covariates included in each block varied some across the 10 analytic 
samples.  The prevention history and health care access blocks were consistent 
across the samples, while the education and income block was consistent except 
for the two Aim 2 sensitivity analysis samples, which dropped the income 
variable.  In all samples, the health/lifestyle block included all covariates minus 
perceived health status, except for two samples that did not drop perceived 
health status.  The sociodemographics block had the most variation in included 
covariates:  MEPS interview language was dropped from the block in all 
samples; census regions were dropped in four of the six applicable Aim 1 
samples; and urban vs. rural residence and whether comfortable speaking 
English were dropped in five and six of the ten samples, respectively.  For the 
covariates that remained following the first step of the multivariate logistic 
regression procedure, collinearity diagnostics indicated no collinearity, so no 
covariates were excluded due to collinearity.  The collinearity diagnostics 
revealed that there were no Western Hispanics who had an FSA in MEPS 2011, 
so the FSA variable was not assessed for the Aim 2 main or sensitivity analyses. 
Table 4.7 reports multivariate-adjusted screening likelihoods across the levels of 
covariates for the full set of covariates controlled for in the analyses of each of 
the full samples (the full sample is the first row for each Aim’s main and 
sensitivity analyses in Table 4.6).  For centered age (age minus 50) and squared 
centered age the predicted continuous change in screening likelihood for each 
one year of age or squared age change is reported.  Covariates that are blank in 
the table were dropped from the covariate block as either noted in Table 4.6 or 
were not applicable to a particular analysis (census region and race/Hispanic 
ethnicity for Aim 2 and Hispanic ethnicity for Aim 1). 
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Table 4.6 Covariates Included/Dropped in Blocks for each Multivariate Logistic Regression Analysis 
Analyses 
Sample and 
Insurance 
Features 
Analyzed 
Covariate Blocks† 
Sociodemographics  Education and income Health/lifestyle 
Included Dropped Included Dropped Included Dropped 
Aim 1 main 
analyses 
Full MEPS 
2009-2011 
Sample: 
Whether 
insurance had 
DPN; Whether 
insurance used 
gatekeeping; 
and Cost-
sharing 
categories 
Age and Age2; Sex; 
Race/Hispanic 
ethnicity; Urban vs. 
rural residence; 
Marital status; 
Immigration 
categories; and 
Whether comfortable 
speaking English 
Census 
regions*; and 
MEPS interview 
language 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; 
Perceived 
health status; 
Whether ever 
had non-CRC 
cancer 
diagnosis; 
Smoking 
status; and 
BMI categories - 
Aim 1 
Sensitivity 
Analyses 
with 
previous 
year CRC 
screening 
outcome 
Full MEPS 
2009-2011 
Sample: 
Whether 
insurance had 
DPN; Whether 
insurance used 
gatekeeping; 
and Cost-
sharing 
categories 
Age and Age2; Sex; 
Race/Hispanic 
ethnicity; Marital 
status; Census 
regions; Urban vs. 
rural residence; 
Marital status; 
Immigration 
categories; and 
Whether comfortable 
speaking English 
MEPS interview 
language 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
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Table 4.6 (cont.) Sociodemographics Education and income Health/lifestyle 
Analyses Sample Included Dropped Included Dropped Included Dropped 
Aim 1 main 
analyses 
Reduced MEPS 
2009-2011 
Sample 
excluding 
those age 50-64 
with only 
public 
insurance: 
Whether 
insurance 
restricted 
coverage to 
DPN 
Age and Age2; Sex; 
Race/Hispanic 
ethnicity; Urban vs. 
rural residence; 
Marital status; 
Immigration 
categories; and 
Whether comfortable 
speaking English 
Census 
regions*; and 
MEPS interview 
language 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
Aim 1 
Sensitivity 
Analyses 
with 
previous 
year CRC 
screening 
outcome 
Reduced MEPS 
2009-2011 
Sample 
excluding 
those age 50-64 
with only 
public 
insurance: 
Whether 
insurance 
restricted 
coverage to 
DPN 
Age and Age2; Sex; 
Race/Hispanic 
ethnicity; Marital 
status; Census 
regions; Urban vs. 
rural residence;  
Immigration 
categories; and 
Whether comfortable 
speaking English 
MEPS interview 
language* 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; 
Perceived 
health status; 
Whether ever 
had non-CRC 
cancer 
diagnosis; 
Smoking 
status; and 
BMI categories - 
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Table 4.6 (cont.) Sociodemographics Education and income Health/lifestyle 
Analyses Sample Included Dropped Included Dropped Included Dropped 
Aim 1 main 
analyses 
Reduced MEPS 
2011 Sample: 
Whether 
respondent had 
FSA in 2011 
Age and Age2; Sex; 
Race/Hispanic 
ethnicity; Marital 
status; and 
Immigration 
categories 
Census 
regions*; Urban 
vs. rural 
residence*; 
Whether 
comfortable 
speaking 
English; and 
MEPS interview 
language 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
Aim 1 
Sensitivity 
Analyses 
with 
previous 
year CRC 
screening 
outcome 
Reduced MEPS 
2011 Sample: 
Whether 
respondent had 
FSA in 2011 
Age and Age2; Sex; 
Race/Hispanic 
ethnicity; Marital 
status; Urban vs. 
rural residence; and 
Immigration 
categories 
Census 
regions*;  
Whether 
comfortable 
speaking 
English; and 
MEPS interview 
language* 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
Aim 2 main 
analyses** 
Full MEPS 
2009-2011 
Sample: 
Whether 
insurance had 
DPN; Whether 
insurance used 
gatekeeping; 
and Cost-
sharing 
categories 
Age and Age2; Sex; 
and Immigration 
categories 
Urban vs. rural 
residence;* 
Marital status; 
Whether 
comfortable 
speaking 
English; and 
MEPS interview 
language 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
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Table 4.6 (cont.) Sociodemographics Education and income Health/lifestyle 
Analyses Sample Included Dropped Included Dropped Included Dropped 
Aim 2 
Sensitivity 
Analyses 
with 
previous 
year CRC 
screening 
outcome 
Full MEPS 
2009-2011 
Sample: 
Whether 
insurance had 
DPN; Whether 
insurance used 
gatekeeping; 
and Cost-
sharing 
categories 
Age and Age2; Sex; 
and Immigration 
categories 
Marital status; 
Urban vs. rural 
residence; 
Whether 
comfortable 
speaking 
English; and 
MEPS interview 
language 
Educational 
attainment  
FPL 
categories 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
Aim 2 main 
analyses** 
Reduced MEPS 
2009-2011 
Sample 
excluding 
those age 50-64 
with only 
public 
insurance: 
Whether 
insurance 
restricted 
coverage to 
DPN 
Age and Age2; Sex; 
and Immigration 
categories 
Urban vs. rural 
residence;* 
Marital status; 
Whether 
comfortable 
speaking 
English; and 
MEPS interview 
language 
Educational 
attainment and 
FPL categories - 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
        
        
        
        
        
 
 
140 
 
Table 4.6 (cont.) Sociodemographics Education and income Health/lifestyle 
Analyses Sample Included Dropped Included Dropped Included Dropped 
Aim 2 
Sensitivity 
Analyses 
with 
previous 
year CRC 
screening 
outcome 
Reduced MEPS 
2009-2011 
Sample 
excluding 
those age 50-64 
with only 
public 
insurance: 
Whether 
insurance 
restricted 
coverage to 
DPN 
Age and Age2; Sex; 
and Immigration 
categories 
Marital status; 
Urban vs. rural 
residence; 
Whether 
comfortable 
speaking 
English; and 
MEPS interview 
language 
Educational 
attainment  
FPL 
categories 
Charlson 
comorbidity 
index; Whether 
ever had non-
CRC cancer 
diagnosis; 
Smoking 
status; and 
BMI categories 
Perceived 
health status* 
†The prevention history block consistently included the same two variables: dental checkup frequency and time since most recent flu shot.  The 
health care access block consistently included the same three variables: survey year insurance duration; Number of outpatient provider visits; 
and Whether had a usual source of care. 
* Covariate was dropped after having non-significant (p<0.1) bivariate association with CRC screening outcome and was not included in 
multivariate analyses 
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Table 4.7 Multivariate Adjusted Predicted Effects and Likelihoods of CRC Screening for Fully Adjusted Models 
Including All  Covariates Without Insurance Features 
Covariates 
Table 4.7a: Aim 1  
Main Analysis 
Table 4.7b: Aim 1 
Sensitivity Analysis 
Table 4.7c: Aim 2  
Main Analysis 
Table 4.7d: Aim 2 
Sensitivity Analysis 
 
Predicted 
continuous 
change in 
likelihood 
of being 
up-to-date 
with CRC 
screening 
95% 
Confidence 
Interval 
Predicted 
continuous 
change in 
likelihood 
of Having 
Received 
CRC 
screening 
in the 
Previous 
Year 
95% 
Confidence 
Interval 
Predicted 
continuous 
change in 
likelihood 
of being 
up-to-date 
with CRC 
screening 
95% 
Confidence 
Interval 
Predicted 
continuous 
change in 
likelihood 
of Having 
Received 
CRC 
screening 
in the 
Previous 
Year 
95% 
Confidence 
Interval 
Centered age 2.68%* 2.26% to 3.10% 2.10%* 1.58% to 2.63% 3.16%* 1.98% to 4.34% 2.87%* 1.30% to 4.45% 
Squared centered 
age  -0.08%* 
-0.09% to -
0.06% -0.05%* 
-0.08% to -
0.03% -0.09%* 
-0.14% to -
0.04% -0.08%* 
-0.15% to -
0.02% 
         
 
Predicted 
likelihood 
of being 
up-to-date 
with CRC 
screening 
95% 
Confidence 
Interval 
Predicted 
likelihood 
of having 
received 
CRC 
screening 
in previous 
year 
95% 
Confidence 
Interval 
Predicted 
likelihood 
of being 
up-to-date 
with CRC 
screening 
95% 
Confidence 
Interval 
Predicted 
likelihood 
of having 
received 
CRC 
screening 
in previous 
year 
95% 
Confidence 
Interval 
         
Full Sample 62.50% 61.3% to 63.8% 40.30% 39.0% to 41.7% 63.30% 60.8% to 65.8% 45.70% 42.8% to 48.5% 
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Table 4.7 cont.) Aim 1 Main Analysis Aim 1 Sensitivity Analysis Aim 2 Main Analysis Aim 2 Sensitivity Analysis 
Sex 
Male   65.4%* 63.8% to 66.9% 44.0%* 42.2% to 45.9% 66.7%* 63.6% to 69.7% 49.7%* 46.1% to 53.3% 
Female   60.00% 58.4% to 61.5% 37.20% 35.6% to 38.9% 60.20% 57.1% to 63.2% 42.20% 38.3% to 46.2% 
         
Race/Hispanic Ethnicity 
REF: Non-Hispanic 
white   62.30% 60.8% to 63.7% 39.20% 37.6% to 40.8%     
Hispanic white   61.60% 58.4% to 64.7% 42.40% 38.7% to 46.2%     
Non-Hispanic black   68.7%* 66.7% to 70.8% 51.1%* 48.5% to 53.7%     
Non-Hispanic Asian   54.6%* 50.3% to 58.8% 32.3%* 27.6% to 37.0%     
Other   59.60% 54.1% to 65.1% 35.20% 29.9% to 40.6%     
         
Hispanic ethnicity 
REF: Non-Hispanic 
white       64.10% 61.3% to 66.8% 46.00% 43.2% to 48.8% 
Hispanic white       59.70% 54.3% to 65.1% 44.10% 37.8% to 50.4% 
         
Census region  
REF: Northeast     38.80% 36.2% to 41.5%     
Midwest     38.10% 35.6% to 40.6%     
South     39.70% 37.5% to 41.9%     
West     44.6%* 42.4% to 46.8%     
         
MSA Designation 
Urban   63.1%* 61.7% to 64.5% 40.9%* 39.4% to 42.4%     
Rural   60.10% 57.5% to 62.7% 37.60% 34.7% to 40.4%     
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Table 4.7 cont.) Aim 1 Main Analysis Aim 1 Sensitivity Analysis Aim 2 Main Analysis Aim 2 Sensitivity Analysis 
Marital Status 
REF: Married   63.20% 61.6% to 64.7% 40.90% 39.3% to 42.6%     
Widowed   64.90% 62.0% to 67.9% 42.90% 39.4% to 46.4%     
Divorced/Separated   61.60% 59.6% to 63.6% 38.90% 36.8% to 41.1%     
Never married   57.0%* 54.0% to 60.0% 36.1%* 32.6% to 39.5%     
         
Immigration Status 
REF: US born   62.80% 61.4% to 64.1% 40.20% 38.7% to 41.7% 63.80% 61.1% to 66.5% 45.50% 42.1% to 48.8% 
Foreign born, lived 
in the US <15 years 50.1%* 43.1% to 57.2% 29.1%* 21.6% to 36.5% 32.9%* 6.1% to 59.7% 15.3%* -2.2% to 32.8% 
Foreign born, lived 
in the US >15 years 62.40% 59.2% to 65.6% 42.90% 39.0% to 46.7% 62.80% 57.7% to 67.9% 49.00% 42.5% to 55.5% 
missing   63.10% 48.8% to 77.4% 44.70% 24.2% to 65.2% 55.60% 5.4% to 105.8% 42.50% 
-19.1% to 
104.2% 
         
Whether comfortable speaking English 
REF: Comfortable   62.60% 61.3% to 63.8% 40.40% 39.0% to 41.8%     
Not comfortable   61.60% 56.7% to 66.5% 38.60% 33.4% to 43.8%     
missing   62.40% 55.9% to 69.0% 38.60% 29.8% to 47.4%     
         
Educational attainment 
Less than a HSD   57.9%* 54.9% to 60.9% 36.4%* 33.3% to 39.4% 59.80% 53.6% to 66.0% 38.2%* 31.3% to 45.1% 
REF: HSD/GED   61.90% 60.3% to 63.4% 39.80% 38.1% to 41.5% 62.50% 59.3% to 65.7% 46.00% 42.0% to 50.1% 
Bachelor's   64.8%* 62.7% to 67.0% 41.80% 39.3% to 44.4% 63.00% 58.6% to 67.4% 44.20% 38.3% to 50.1% 
Graduate/Doctoral 
degree 65.3%* 62.3% to 68.3% 42.80% 39.3% to 46.4% 65.50% 58.8% to 72.2% 47.50% 40.1% to 54.9% 
Other Degree   63.30% 60.5% to 66.2% 41.50% 37.9% to 45.1% 69.30% 63.3% to 75.2% 52.70% 44.8% to 60.7% 
missing   64.30% 55.7% to 72.9% 43.90% 34.3% to 53.5% 43.4%* 29.9% to 56.8% 36.40% 19.1% to 53.7% 
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Table 4.7 cont.) Aim 1 Main Analysis Aim 1 Sensitivity Analysis Aim 2 Main Analysis Aim 2 Sensitivity Analysis 
Household Income as a % of the FPL 
Poor/Negative 
(<100%)   61.60% 58.7% to 64.4% 39.00% 36.0% to 41.9% 61.00% 54.5% to 67.5%   
Near poor/Low 
income (100-200%)   58.5%* 56.1% to 60.9% 37.1%* 34.2% to 40.0% 56.8%* 51.2% to 62.4%   
Middle Income 
(200-400%)   61.70% 59.9% to 63.4% 39.00% 36.6% to 41.3% 64.40% 60.9% to 67.9%   
REF: High Income 
(>400%)   64.30% 62.7% to 65.9% 42.30% 40.5% to 44.1% 64.70% 61.7% to 67.7%   
         
Charlson Comorbidity Index 
REF: 0 62.50% 61.1% to 63.9% 40.00% 38.3% to 41.7% 63.50% 60.6% to 66.4% 45.30% 41.9% to 48.7% 
1 62.50% 60.2% to 64.7% 40.40% 38.1% to 42.8% 62.00% 58.2% to 65.8% 44.40% 40.1% to 48.6% 
2 62.60% 59.7% to 65.5% 41.70% 38.4% to 45.0% 64.20% 58.4% to 70.1% 49.80% 41.9% to 57.7% 
3+   63.30% 59.9% to 66.6% 41.00% 37.5% to 44.5% 63.20% 54.8% to 71.7% 45.50% 37.6% to 53.5% 
         
Perceived Health Status 
REF: Excellent   64.10% 62.1% to 66.0%       
Very good   63.50% 61.8% to 65.3%       
Good   61.7%* 60.1% to 63.3%       
Fair/Poor   60.3%* 57.9% to 62.7%       
missing   31.2%* 14.8% to 47.7%       
         
Whether ever had any non-CRC cancer diagnosis 
REF: No   62.00% 60.7% to 63.3% 39.70% 38.3% to 41.1% 62.80% 60.2% to 65.4% 45.20% 42.3% to 48.0% 
Yes   65.7%* 62.9% to 68.6% 43.8%* 40.6% to 47.0% 66.00% 59.8% to 72.2% 48.20% 41.7% to 54.7% 
missing   46.50% -4.2% to 97.2% 37.8% 
-15.2% to 
90.9% .  .  
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Table 4.7 cont.) Aim 1 Main Analysis Aim 1 Sensitivity Analysis Aim 2 Main Analysis Aim 2 Sensitivity Analysis 
Smoking status 
REF: Non-smoker   63.40% 62.1% to 64.7% 41.10% 39.6% to 42.6% 64.20% 61.7% to 66.8% 46.90% 43.8% to 49.9% 
Current Smoker   59.3%* 56.9% to 61.6% 37.2%* 34.6% to 39.7% 59.80% 54.0% to 65.6% 37.6%* 30.6% to 44.6% 
missing   60.70% 57.6% to 63.9% 38.70% 35.0% to 42.5% 58.3%* 51.9% to 64.7% 43.90% 36.1% to 51.8% 
         
BMI categories 
Underweight   61.00% 53.0% to 69.1% 37.60% 27.8% to 47.5% 52.10% 30.5% to 73.7% 25.60% 5.9% to 45.3% 
REF: Normal weight   61.40% 59.7% to 63.2% 39.30% 37.4% to 41.2% 59.80% 56.3% to 63.3% 42.00% 38.1% to 46.0% 
Overweight   62.90% 61.3% to 64.5% 40.50% 38.7% to 42.2% 63.10% 59.7% to 66.4% 45.80% 42.4% to 49.3% 
Obese   63.5%* 61.9% to 65.1% 41.40% 39.5% to 43.4% 67.4%* 64.3% to 70.6% 49.7%* 45.2% to 54.2% 
missing   55.3%* 49.9% to 60.7% 34.70% 28.6% to 40.8% 57.60% 47.1% to 68.0% 36.50% 25.8% to 47.1% 
         
Dental checkup frequency 
REF: Twice a year 
or more 68.70% 67.1% to 70.3% 47.70% 45.7% to 49.7% 69.40% 66.1% to 72.7% 53.50% 48.7% to 58.2% 
Once a year   62.1%* 59.9% to 64.4% 39.8%* 37.0% to 42.5% 63.6%* 59.2% to 68.1% 44.5%* 39.3% to 49.7% 
Less than once a 
year   56.5%* 54.3% to 58.7% 31.8%* 29.5% to 34.2% 54.6%* 49.9% to 59.3% 34.5%* 29.8% to 39.1% 
Never go to dentist   52.4%* 50.0% to 54.7% 31.4%* 29.0% to 33.7% 47.5%* 42.3% to 52.7% 30.9%* 25.7% to 36.1% 
missing   20.3%* 10.9% to 29.8% 8.3%* 2.6% to 14.1% 28.1%* -0.2% to 56.3% 4.6%* -5.4% to 14.6% 
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Table 4.7 cont.) Aim 1 Main Analysis Aim 1 Sensitivity Analysis Aim 2 Main Analysis Aim 2 Sensitivity Analysis 
Time since last flu shot 
REF: Within past 
year   67.50% 66.2% to 68.8% 46.10% 44.4% to 47.9% 68.00% 65.1% to 70.9% 51.10% 47.8% to 54.4% 
Within past two 
years 62.2%* 59.4% to 65.0% 40.1%* 36.8% to 43.5% 64.00% 58.0% to 70.1% 45.10% 37.6% to 52.6% 
More than two 
years   59.3%* 56.5% to 62.1% 36.8%* 32.9% to 40.7% 61.6%* 55.9% to 67.3% 42.90% 34.6% to 51.2% 
Never received flu 
shot   56.2%* 54.2% to 58.2% 32.3%* 30.2% to 34.3% 56.6%* 52.3% to 61.0% 38.1%* 32.9% to 43.3% 
missing   45.5%* 38.3% to 52.8% 21.4%* 13.9% to 28.9% 48.0%* 33.1% to 62.8% 29.60% 8.1% to 51.2% 
         
Duration insured during survey year 
1-6 months 60.40% 56.2% to 64.6% 35.40% 30.1% to 40.6% 58.40% 49.1% to 67.7% 38.60% 27.4% to 49.9% 
7-11 months 60.40% 56.5% to 64.3% 40.40% 35.6% to 45.1% 54.0%* 43.3% to 64.7% 34.7%* 22.9% to 46.5% 
REF: Full year 62.70% 61.4% to 64.0% 40.50% 39.1% to 41.9% 64.00% 61.5% to 66.4% 46.40% 43.5% to 49.3% 
         
Number of Outpatient Provider visits in Survey year 
REF: 0 46.60% 44.2% to 49.0% 23.20% 20.8% to 25.6% 48.70% 43.7% to 53.8% 29.50% 23.1% to 35.8% 
1 56.1%* 54.0% to 58.2% 32.2%* 29.8% to 34.6% 58.5%* 53.8% to 63.2% 40.1%* 35.2% to 44.9% 
2 61.3%* 59.0% to 63.5% 38.0%* 35.3% to 40.7% 64.5%* 59.4% to 69.5% 46.7%* 39.7% to 53.6% 
3 63.0%* 60.3% to 65.7% 39.4%* 36.3% to 42.5% 66.6%* 62.4% to 70.9% 49.6%* 43.6% to 55.6% 
4 65.2%* 62.3% to 68.0% 43.0%* 39.2% to 46.7% 66.3%* 58.7% to 74.0% 49.9%* 38.4% to 61.4% 
5+   71.6%* 69.9% to 73.3% 51.5%* 49.3% to 53.7% 70.7%* 67.2% to 74.3% 53.8%* 49.4% to 58.2% 
         
Whether had a Usual Source of Care 
REF: No   49.80% 46.7% to 52.9% 29.30% 26.2% to 32.4% 55.80% 49.7% to 61.8% 35.50% 27.8% to 43.3% 
Yes   64.0%* 62.7% to 65.2% 41.5%* 40.1% to 42.9% 64.2%* 61.6% to 66.8% 46.7%* 43.8% to 49.7% 
missing   57.90% 50.4% to 65.5% 38.8%* 30.2% to 47.4% 52.60% 34.2% to 71.0% 33.70% 10.9% to 56.5% 
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Table 4.7 cont.) Aim 1 Main Analysis Aim 1 Sensitivity Analysis Aim 2 Main Analysis Aim 2 Sensitivity Analysis 
Survey Year 
REF: 2009 61.10% 59.6% to 62.7% 40.40% 38.4% to 42.4% 63.20% 60.3% to 66.2% 46.90% 42.3% to 51.5% 
2010 63.1%* 61.6% to 64.7% 42.00% 40.1% to 43.8% 63.70% 60.7% to 66.8% 46.50% 42.6% to 50.5% 
2011 63.3%* 61.5% to 65.1% 38.60% 36.7% to 40.5% 63.00% 59.2% to 66.7% 43.50% 39.4% to 47.6% 
         
*  covariate level was significantly different (p<0.05) than the referent level (REF:) in the multivariate logistic 
regression   
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Some covariates were included in all analyses and had consistent multivariate-
adjusted effects including age, sex and immigration status for the 
sociodemographics block, Quan et al.’s Charlson comorbidity index for the 
health/lifestyle block, dental checkup frequency for the prevention history block, 
and count of outpatient provider visits in the survey year and having a usual 
source of care for the health care access block.  Increasing age significantly 
increased screening likelihood with a decreasing rate of increase, which was 
indicated by a positive 2.10-3.16% point increase in screening likelihood for each 
year increase of the centered age variable and a negative 0.05-0.09% point 
change in screening likelihood for each squared year increase.  The net effect of 
the two age variables, for example, for a person aged 75 years in the Aim 2 main 
analysis is 3.16*25 – 0.09*(25^2)= 79 - 56.25 = a 22.75% points predicted 
greater likelihood of being up-to-date with recommended CRC screening than a  
person aged 50 years.  In comparison to females, males’ predicted likelihood of 
CRC screening was 5.4-7.5% points higher across all analyses.  For immigration 
status, US-born persons consistently had significantly higher screening likelihood 
than foreign-born persons who had lived in the US less than 15 years, although 
screening likelihood was not significantly lower for foreign-born person who had 
lived in the US more than 15 years.  The disparity between recent immigrants 
and US-born persons increased from ~10% points in the Aim 1 analyses to ~30% 
points in the Aim 2 analyses.  The Charlson comorbidity index was included in all 
analyses and there were no significant differences in any analyses for having a 
positive value (1, 2, or 3+) vs. having an index score of zero.  More frequent 
dental checkups and a greater number of outpatient provider visits in the survey 
year each significantly predicted higher screening likelihood in a dose-response 
fashion in all analyses.  Reporting having a usual source of care significantly 
predicted higher screening likelihood in all analyses. 
Some covariates were included in all analyses and had inconsistent effects 
including educational attainment for the education and income block; having any 
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non-CRC cancer diagnosis, smoking status, and BMI categories for the 
health/lifestyle block; most recent flu shot for the prevention history block; 
duration of time insured in the survey year for the health care access block; and 
survey year.  For educational attainment, having a HSD/GED predicted 
significantly higher screening likelihood than having less than a HSD/GED and 
significantly lower screening likelihood than those with a Bachelor’s degree or 
Graduate/Doctoral degree in the Aim 1 main analyses.  Educational attainment 
did not significantly predict screening likelihood in the Aim 2 main analysis and in 
both sensitivity analyses was only significant for having a HSD/GED predicting 
higher screening likelihood than having less than a HSD/GED.  Ever having a 
non-CRC cancer diagnosis vs. not predicted higher screening likelihood and was 
statistically significant in the Aim 1 analyses, while in the Aim 2 analyses, 
differences with the same direction and similar magnitude were not significant.  
Being a current smoker vs. non-smoker predicted lower screening likelihood, 
although the effect did not reach significance for the Aim 2 main analysis.  For 
BMI categories, being normal weight predicted significantly lower screening 
likelihood than being obese, although did not predict significantly different 
screening likelihood in comparison to being overweight or underweight.  There 
was not a significant difference between being obese vs. normal weight in the 
Aim 1 sensitivity analysis.  A more recent last flu shot usually predicted 
significantly higher screening likelihood, although in both the Aim 2 main and 
sensitivity analyses, having received a flu shot within the past year did not predict 
significantly different screening likelihood than having last received a flu shot 
between one and two years ago.  Duration of time insured in the survey year 
generally was not a significant predictor, although for the Aim 2 main and 
sensitivity analyses, having been insured for 7-11 months predicted lower 
screening than having been insured for the full year, although there was not a 
significant difference for being insured for 1-6 months compared to the full year.  
In the Aim 1 main analysis, survey years 2011 and 2010 each predicted higher 
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screening likelihood than survey year 2009, although there were not significant 
differences between survey years in the other analyses. 
Some variables had consistent effects, but were not included in all analyses 
including race/Hispanic ethnicity, census region, marital status, and whether a 
person was comfortable speaking English for the sociodemographics block; 
household income as a percentage of FPL categories for the education and 
income block; and perceived health status for the health/lifestyle block.  By 
design, Aim 1 analyses had a race/Hispanic ethnicity category, while Aim 2 only 
had a Hispanic ethnicity indicator.  For race/Hispanic ethnicity groups in the Aim 
1 analyses, non-Hispanic whites had significantly lower screening likelihood of 
both CRC screening outcomes than non-Hispanic blacks and significantly higher 
screening likelihood than non-Hispanic Asians, although screening likelihood did 
not significantly differ between non-Hispanic and Hispanic whites.  In the Aim 1 
analyses, Hispanic whites had slightly higher predicted screening likelihood than 
non-Hispanic whites for screening in the previous year 42.4 vs. 39.4%, while 
non-Hispanic whites had slightly higher screening likelihood for being up-to-date 
with recommended screening, 62.3 vs. 61.6%.  For the Aim 2 analyses, 
screening likelihood also did not significantly differ between non-Hispanic and 
Hispanic whites, although non-Hispanic whites had higher screening likelihood 
for both the primary outcome (64.1 vs. 59.7% up-to-date with recommended 
screening) and for having had any screening in the previous year (46.0 vs. 
44.1%).  By design, census region was only applicable to the Aim 1 analyses and 
ultimately was non-significant in the main analysis, although was included in the 
Aim 1 sensitivity analysis.  Screening likelihood was similar in the Northeast, 
Midwest, and South, although was significantly higher in the Western census 
region.  Respondents residing in Urban areas had significantly higher screening 
likelihood than rural residents in the Aim 1 main analysis by 3.0% points 
(p=0.049) and in the sensitivity analysis sample by 3.3% points (p=0.042), 
although urban vs. rural residence was dropped from the Aim 2 analyses.  Marital 
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status was dropped from the Aim 2 analyses, and in the Aim 1 analyses, those 
who were married had significantly higher screening likelihood than those who 
were never married, although there was no significant difference compared to 
widowed or divorced/separated persons.  Whether a person was comfortable 
speaking English was only included in the Aim 1 analyses and was non-
significant.  Income was included in all analyses except the Aim 2 sensitivity 
analyses, and being high income consistently predicted higher screening 
likelihood than being near poor/low income, but did not predict significantly 
different screening than being middle income or being poor/having negative 
income.  Perceived health status was only included in the Aim 1 main analyses 
and having Excellent health predicted significantly greater screening likelihood, 
64.1%, than having Good health, 61.7%, or Fair/Poor health, 60.3%.  
 
Aim 1 Multivariate Findings for Binary Insurance Features 
 
Aim 1 Main and Sensitivity Analyses 
Figures 4.1-8 report the Aim 1 main multivariate logistic regression and sensitivity 
analysis findings for binary insurance features.  The insurance feature main 
effect is reported as the multivariate-adjusted percentage change in the predicted 
likelihood of CRC screening and the 95% confidence interval if a respondent had 
a binary insurance feature vs. not.  Each figure reports the insurance feature 
effect and confidence interval for eight models: the unadjusted effect (adjusting 
only for survey year), five models adjusting separately for each of the covariate 
blocks, the full model with all covariate blocks, and a reduced full model without 
the prevention history and health care access covariates.  If controlling for a 
covariate block or set of blocks increases an insurance feature effect, the change 
suggests that the unadjusted insurance feature effect was confounded downward 
by not having adjusted for the covariates, meaning the respondents with the 
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insurance feature in aggregate have values of the covariates that are less 
favorable to their screening likelihood.  If controlling for a covariate block 
decreases an insurance feature effect, the change suggests the opposite is true: 
the covariates confound upward the insurance feature effect by not having 
adjusted for the covariates, so respondents with the insurance feature in 
aggregate have values of the covariates that are more favorable to their 
screening likelihood. 
Figure 4.1 reports the findings for whether a respondent had insurance with a 
DPN in the Aim 1 main analyses.  In the unadjusted model, having a DPN 
predicted a non-significant 1.4% point reduction (95% CI: -3.4 to 0.6%) in the 
likelihood of being up-to-date with recommended CRC screening.  The adjusted 
changes in predicted screening likelihood for the separate covariate block 
models ranged from a high estimate of a significant increase of 3.1% points (95% 
CI: 0.9 to 5.3%) in screening likelihood if a person had a DPN after controlling for 
the sociodemographics block (a 4.5% point increase from the effect in the 
unadjusted model suggesting that respondents who had insurance with a DPN 
had unfavorable sociodemographics characteristics in aggregate compared to 
those who did not have insurance with a DPN) to a low estimate of a significant 
negative 3.6% point reduction (95% CI: -5.6 to -1.6%) in screening likelihood 
after controlling for the education and income block (a 2.2% point decrease from 
the effect in the unadjusted model suggesting that respondents who had 
insurance with a DPN had favorable education and income values in aggregate 
compared to those who did not have insurance with a DPN).  In the fully-adjusted 
model and the full reduced model without the prevention history and health care 
access blocks, having insurance with a DPN predicted small non-significant 
increases in screening likelihood, 0.5% points (95% CI: -1.4 to 2.4%) and 1.8% 
points (95% CI: -0.3 to 3.9%).  In total, the findings suggest whether a person’s 
insurance had a DPN did not strongly influence screening likelihood. 
 
 
153 
 
Figure 4.2 reports the findings for whether a respondent had insurance that used 
gatekeeping in the Aim 1 main analyses.  In the unadjusted model, having 
insurance  
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Figure 4.1 
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that used gatekeeping predicted a significant 2.9% point reduction in screening 
likelihood (95% CI: -5.1 to -0.6%).  The adjusted changes in predicted screening 
likelihood for the separate covariate block models ranged from a high estimate of 
a non-significant 1.9% point increase in screening likelihood (95% CI: -0.4% to 
4.1%) after adjusting for the sociodemographics block to a low estimate of a 
significant reduction in screening likelihood of 3.1% points (95% CI: -0.9 to -
5.2%) after adjusting for the education and income block.  In the fully adjusted 
model and the full reduced model, having insurance that used gatekeeping 
predicted small non-significant increases in screening likelihood, 1.0% (95% CI: -
1.1 to 3.0%) and 1.8% (95% CI: -0.4 to 4.0%), respectively.  In total, the findings 
suggest that whether a person’s health plan used gatekeeping did not strongly 
influence screening likelihood, and that the significant negative unadjusted effect 
for gatekeeping is confounded by those who have insurance with gatekeeping 
tending to have less favorable other characteristics that predict lower screening 
likelihood. 
Figure 4.3 reports the findings for whether a respondent had a health plan that 
restricted coverage to a DPN in the Aim 1 main analyses.  In the unadjusted 
model, having coverage restricted to a DPN predicted a non-significant 1.8% 
point reduction in screening likelihood (95% CI: -4.5 to 0.9%).  The adjusted 
changes in predicted screening likelihood for the separate covariate block 
models ranged from a high estimate of a non-significant 2.0% point  increase 
(95% CI: -0.6 to 4.7%) in screening likelihood if coverage was restricted to a DPN 
after controlling for the sociodemographics block to a low estimate of a non-
significant negative 2.6% point reduction (95% CI: -5.4 to 0.1%) in screening 
likelihood after controlling for the education and income block.  In the fully 
adjusted model and the full reduced model, having insurance that restricted 
coverage to a DPN predicted small non-significant increases in screening 
likelihood, 1.2% points (95% CI: -1.2 to 3.7%) and 1.6% points (95% CI: -1.1 to 
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Figure 4.3 
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4.2%).  In total, the findings suggest whether a person’s insurance restricted 
coverage to a DPN did not influence screening likelihood. 
Figure 4.4 reports the findings for whether a respondent’s household had a FSA 
in the Aim 1 main analyses.  In the unadjusted model, having a FSA predicted a 
significant 6.8% point increase in screening likelihood (95% CI: 1.7 to 11.8%).  
The adjusted changes in predicted screening likelihood for the separate covariate 
block models ranged from a high estimate of a significant 9.7 % point increase 
(95% CI: 4.9 to 14.4%) after controlling for the sociodemographics block to a low 
estimate of a null effect, 0.1% point increase (95% CI: -5.0 to 5.2%), after 
controlling for the prevention history block.  In the fully adjusted model, having an 
FSA predicted a no longer significant increase in screening likelihood of 2.6% 
points (95% CI: -2.0 to 7.2%).  In the full reduced model without the prevention 
history and health care access blocks, having an FSA still had a significant 
positive effect, 7.2% points (95% CI: 2.2 to 12.2%).  In total, the findings suggest 
that having an FSA may have predicted a small increase in CRC screening 
likelihood.  Since the FSA effect was adjusted downward after controlling for 
each the prevention history block and the education and income block, but did 
not change after adjusting for the health/lifestyle covariate block, having an FSA 
may be a marker of being generally more health aware, but not substantively 
healthier. 
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Figure 4.4 
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Aim 1 Sensitivity Analyses for Binary Insurance Features 
In the Aim 1 sensitivity analyses (Figures 4.5-8), the binary insurance feature 
effects followed the same pattern across the eight models as in the main 
analyses, although the overall pattern was shifted upward or downward.  The 
insurance feature effects in the Aim 1 sensitivity analyses were greater than in 
the main analyses for the organizational insurance features.  In the main 
analyses, the unadjusted effects had been negative and non-significant (except 
having insurance that used gatekeeping was significant (Figure 4.2)), and the 
effects in the fully adjusted and full reduced models were positive and non-
significant.  In the sensitivity analyses, the organizational features’ unadjusted 
effects were slightly positive and still non-significant, although the effects in the 
fully adjusted and full reduced models were positive and usually significant.  
Having insurance with a DPN was non-significant in the fully adjusted model 
(Figure 4.5) (a 1.6% point increase in likelihood of screening in the previous year 
(95% CI: -0.5 to 3.7%)), although in the full reduced model, significantly predicted 
3.2% points greater likelihood of screening in the previous year (95% CI: 0.8 to 
5.6%).  In the fully adjusted and full reduced models, having insurance with 
gatekeeping (Table 4.6) significantly predicted greater likelihood of screening in 
the previous year, respectively, by 3.6% points (95% CI: 1.1 to 6.0%) and 4.6% 
points (95% CI: 1.9 to 7.4%), respectively.  In the fully adjusted and full reduced 
models, having insurance that restricted coverage to a DPN (Figure 4.7) 
significantly predicted greater likelihood of screening in the previous year by 
3.4% points (95% CI: 0.7 to 6.2%) and 4.0% points (95% CI: 0.9 to 7.0%), 
respectively.  In total, the sensitivity analysis findings suggest that having 
insurance with a DPN, having insurance with a gatekeeper, and having insurance 
that restricted coverage to a DPN more strongly predicted recent CRC screening 
in the previous year than predicted being up-to-date with recommended 
screening according to the USPSTF recommended time intervals for different 
techniques. 
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Figure 4.5 
 
Figure 4.6 
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Figure 4.7 
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For having an FSA, in contrast to the other binary insurance features, the pattern 
of the change in the sensitivity analysis across the eight models was shifted 
down in comparison to the pattern in the main analysis (Figure 4.8).  In the main 
analysis unadjusted model, having an FSA predicted positive and significantly 
greater likelihood of being up-to-date with recommended screening (Figure 4.4), 
and the effects in the fully adjusted and full reduced models were positive and 
significant for the full reduced model, although non-significant for the fully 
adjusted model.  In the sensitivity analysis, having an FSA in the unadjusted 
model predicted smaller positive increase in screening likelihood than the main 
analysis that did not reach significance, 5.6% points (95% CI: -1.7 to 12.8%), and 
the fully adjusted and full reduced models also had positive non-significant 
effects 0.1% points (95% CI: -6.3 to 6.5%) and 7.0% points (95% CI: -0.3% to 
14.2%).  In total, the sensitivity analysis findings suggest that having an FSA less 
strongly predicted recent CRC screening in the previous year than being up-to-
date with recommended screening.
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Figure 4.8 
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Aim 2 Multivariate Findings for Binary Insurance Features 
 
Aim 2 Main and Sensitivity Analyses 
The Aim 2 main analysis findings for the three binary features (excluding whether 
a person had an FSA because no Western Hispanic whites had an FSA) reveal 
consistent patterns of the effects of having each feature for and between 
Hispanic and non-Hispanic whites (Figures 4.9a, 4.10a, and 4.11a).  Four 
patterns were consistent for each of the three insurance features in all eight 
models: Hispanic whites that did not have the insurance feature had the lowest 
predicted likelihood of being up-to-date with recommended CRC screening; 
Hispanic whites that had an insurance feature had greater screening likelihood 
than Hispanic whites that did not have the feature; non-Hispanic whites with and 
without the insurance feature had similar screening likelihood; and Hispanic and 
non-Hispanic whites with the insurance feature had similar screening likelihood in 
the fully adjusted and full reduced models, which had changed from non-Hispanic 
whites with the insurance feature having higher predicted screening than 
Hispanic whites with the insurance feature in the unadjusted estimates and in the 
five models adjusted for each covariate block individually.   
Figures 4.9b, 10b, and 11b report five contrast tests of selected comparisons of 
Hispanic vs. non-Hispanic whites and of those with the insurance feature vs. not.  
These figures and subsequent figures of contrast tests present a set of contrast 
tests that were repeated in multiple models.  On the horizontal axis, a label 
indicates the covariates adjusted for in each model.  Above the model label, the 
contrast tests performed are numbered, and the legend notes which contrast test 
each number corresponds to.  In figures 4.9b, 10b, and 11b, each of the eight 
models has the same pattern of point estimates and confidence intervals for the 
five contrast tests.  Tests 1 and 2 are estimates of the disparity in predicted 
screening likelihood for Hispanics compared to the non-Hispanics in the 
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subsamples of those without the insurance feature (Test 1) and those with the 
feature (Test 2).  Tests 3 and 4 are estimates of the change in predicted 
screening likelihood due to having the insurance feature vs. not for non-Hispanic 
whites (Test 3) and for Hispanic whites (Test 4).  Test 5 estimated the double 
difference contrast, the difference between the marginal effect of Hispanic whites 
having a feature vs. not and the marginal effect of non-Hispanic 
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Figure 4.9a 
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Figure 4.9b 
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Figure 4.10a 
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Figure 4.10b 
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Figure 4.11a 
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Figure 4.11b 
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whites having a feature vs. not (i.e. Test 4 minus Test 3). 
Tests 1 and 2 show that each Hispanic whites with and without the insurance 
features were predicted to have significantly lower screening likelihood than their 
non-Hispanic white counterparts who also had or did not have the feature, and 
the disparity was larger for Hispanic whites without the insurance feature.  For 
having insurance with a DPN and having insurance that used gatekeeping, 
Hispanic whites that did not have the feature had significantly lower screening 
likelihood than non-Hispanic whites without the feature by more than 20% points 
in every model, and Hispanic whites who had the feature had significantly lower 
screening likelihood than non-Hispanic whites with the feature by around 10% 
points across the models.  For having insurance that restricted coverage to a 
DPN, Hispanic whites that did not have restricted coverage had significantly 
lower screening likelihood than non-Hispanic whites without restricted coverage 
by more than 15% points in every model, and Hispanic whites who did have 
restricted coverage had lower screening likelihood than non-Hispanic whites with 
restricted coverage by 7.3 to 11.9% points across the models, although the 
disparity did not reach significance in the full or full reduced model.  
The third test estimated the difference in predicted screening likelihood for non-
Hispanic whites who had the feature vs. those that did not.  For whether a person 
had insurance with a DPN (Figure 4.9b), non-Hispanic whites with a DPN 
significantly predicted 5.3-6.1% points lower screening likelihood than non-
Hispanic whites without a DPN across the eight models.  For whether a person 
had insurance that used gatekeeping and whether a person’s insurance was 
restricted to a DPN, there were not significant differences in screening likelihood 
for non-Hispanic whites. 
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The fourth test estimated the difference in predicted screening likelihood for 
Hispanic whites who had the feature vs. those that did not.  Hispanic whites who 
had any of the features had higher predicted screening likelihood, although the 
difference was non-significant for having insurance with a DPN (Figure 4.9b) and 
having insurance that restricted coverage to a DPN (Figure 4.11b).  For whether 
a persons’ insurance used gatekeeping (Figure 4.10b), Hispanic whites had 
higher screening likelihood by 8.8 to 13.8% points, and the difference was 
significant in all models except the fully adjusted model. 
The fifth test suggests the impact that having the insurance feature vs. not had 
on the total disparity in CRC screening among Hispanics.  The double difference 
contrast was positive (favorable for Hispanic whites) for all three features and 
was 10% points or more and consistently significant for two variables, whether a 
person had insurance with a DPN and whether a person had insurance that used 
gatekeeping.  For whether a person had insurance that restricted coverage to a 
DPN, the double difference contrast was positive and ranged from 3.9 to 11.3% 
points.  Test 5 did not reach significance in the unadjusted model and five of the 
adjusted models, although the effect was significant in the full reduced model and 
nearly significant in the fully adjusted model with a predicted increase in 
screening likelihood of 9.8% points (95% CI: -0.3 to 19.9%).   
Overall, the contrast tests and observed patterns suggest that having the 
insurance features predicted higher screening likelihood for Hispanic whites, but 
no change or a reduction in screening likelihood for non-Hispanic whites.  The 
double difference contrasts suggest that these features affect or are associated 
with other insurance features that affect or predict reduced CRC screening 
disparities for Western US Hispanic whites vs. non-Hispanic whites. 
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Aim 2 Sensitivity Analyses for Binary Insurance Features 
In the sensitivity analyses for Aim 2 (4.12, 4.13, and 4.14), the patterns of 
predicted screening likelihood for having had any screening in the previous year 
appear similar to the main analyses, although the sensitivity analyses have some 
notable differences in magnitude and significance of effects.   
First, in the sensitivity analyses, the magnitude of the disparity between Hispanic 
and non-Hispanic whites’ predicted screening likelihood usually decreased for 
both those with and without the insurance feature.  For those without the 
insurance feature, the Hispanic disparity decreased, although remained 
significant for all three insurance features.  For those with the insurance feature, 
the change in the interpretation for each insurance feature was slightly differently.  
For those who had insurance with a DPN, the Hispanic disparity from the main 
analysis decreased and changed from being significant in all models to being 
non-significant in all sensitivity analysis models.  For those with insurance that 
used gatekeeping, the Hispanic disparity decreased and changed from being 
significant in all models to not reaching significance in most models, although 
remained significant in the fully adjusted model.  For those with insurance that 
restricted coverage to a DPN, the range of the point estimates did not change 
from the main analysis to the sensitivity analysis, although those differences had 
been significant in some of the main analysis models, but were not significant in 
any of the sensitivity analysis models (the no-longer significant difference likely 
reflects the reduced sample size).
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Figure 4.12a 
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Figure 4.12b 
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Figure 4.13a 
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Figure 4.13b 
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Figure 4.14a 
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Figure 4.14b 
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Next, for each Hispanic and non-Hispanic whites, having the insurance feature 
vs. not predicted a more positive change in screening likelihood in the sensitivity 
analysis than had been found in the main analysis.  The positive change from the 
main analysis to the sensitivity analysis was usually accompanied by a change in 
significance toward a positive and significant effect for having the feature.  For 
non-Hispanic whites in the main analysis, having insurance with a DPN predicted 
a significant reduction in screening likelihood, and in the sensitivity analysis, 
there was still a reduction, but it was much smaller and consistently non-
significant.  For non-Hispanic whites in the main analysis, having insurance that 
used gatekeeping vs. not predicted a non-significant reduction in screening 
likelihood, but predicted a significant increase in screening likelihood in the 
sensitivity analysis.  For non-Hispanic whites in the main analysis, having 
insurance that restricted coverage to a DPN vs. not predicted a negligible non-
significant change in screening likelihood, while in the sensitivity analysis, the 
magnitude of the change increased, but did not quite reach significance.   
Similar changes were found for Hispanic whites in the sensitivity analyses.  For 
Hispanic whites in the main analysis, having insurance with a DPN predicted a 
non-significant increase in screening likelihood, although the change was greater 
and significant in the sensitivity analysis.  For Hispanic whites in the main 
analysis, having insurance that used gatekeeping vs. not predicted a positive and 
usually significant (except for the fully adjusted model) change in screening 
likelihood, and in the sensitivity analysis, the predicted change in screening 
likelihood was greater and always significant.  For Hispanic whites, having 
insurance that restricted coverage to a DPN vs. not predicted a positive, although 
non-significant change in screening likelihood in the main analysis, and in the 
sensitivity analysis, that effect was larger and sometimes significant including the 
fully adjusted and full reduced models. 
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Last, two features had a change in the double difference contrast in the 
sensitivity analysis, while one did not.  In the sensitivity analysis, the double 
difference contrast was essentially unchanged for having insurance with a DPN, 
so it was still positive and significant in the sensitivity analysis.  The double 
difference contrast decreased and was less often significant in the sensitivity 
analyses for having insurance that used gatekeeping (a change from being 
always significant in the main analysis to sometimes significant or nearly 
significant in the sensitivity analysis) and having insurance that restricted 
coverage to a DPN (a change from sometimes significant in the main analysis to 
always non-significant in the sensitivity analysis).  The reductions in the double 
difference contrasts reflects the greater changes in predicted screening likelihood 
from the main analysis to the sensitivity analysis for non-Hispanic whites than 
Hispanic whites.    
 
Multivariate Findings for Cost-Sharing Categories 
 
Aim 1 main and sensitivity analyses 
Figure 4.15 reports the Aim 1 main analysis findings of the predicted screening 
likelihoods across the cost-sharing categories.  In the unadjusted analysis, 
predicted screening likelihood is highest and similar for the three internal tertiles 
of the cost-sharing distribution; is lower for those with 0% cost-sharing; is lower 
for those in the top 5th percentile of cost-sharing, which overlaps the confidence 
interval for the 0% cost-sharing group; and is much lower among those with no 
spending in the survey year.  In three of the covariate block models 
(sociodemographics, education and income, and health/lifestyle), the pattern of 
the cost-sharing categories is very similar to the unadjusted model, suggesting 
that those factors did not substantively correlate with the cost-sharing categories.  
In the prevention history block model, predicted screening likelihood for the first 
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five cost-sharing categories did not change very much from the unadjusted 
model, although screening likelihood increased noticeably for those with no 
spending in the survey year by ~10% points suggesting that those people tend to 
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Figure 4.15 
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have an unfavorable history of having received the preventive services 
covariates, which consistently were strong predictors of screening likelihood.  In 
the health care access model, predicted screening likelihood for the first four 
cost-sharing categories did not change very much from the unadjusted model, 
although screening likelihood increased substantially for the top 5th percentile of 
cost-sharing by >10% points and for the no spending category by >20% points.  
After adjusting for the health care access factors, the top fifth percentile category 
had a predicted screening likelihood that was slightly greater than the 0% cost-
sharing category and the overlapping confidence interval indicates that it was not 
significantly different from the 0% cost-sharing category and the first and third 
internal tertiles of the cost-sharing distribution.  The change in the HC access 
block model is consistent with the known inverse relationship between cost-
sharing and health care utilization.   
The patterns in the fully adjusted and full reduced models are consistent with the 
changes in the individual covariate block models.  In the fully adjusted model, 
controlling for all covariates balanced predicted screening likelihood across the 
cost-sharing categories.  The five cost-sharing categories have overlapping 
confidence intervals, while the no-spending group overlaps with the top fifth 
percentile of cost-sharing category.  In contrast, the full reduced model retains 
the pattern of the unadjusted model and the covariate block models controlling 
for each the sociodemographics, education and income, and health/lifestyle 
blocks.   
Predicted Screening Likelihood Depending on Cost-Sharing Categories for 
Aim 1 Sensitivity Analysis 
The sensitivity analysis findings for Aim 1 (Figure 4.16) are consistent with the 
main analysis findings.  One noticeable difference is that the third tertile of the 
internal part of the cost-sharing distribution had consistently lower predicted 
screening likelihood than the first and second tertiles in the sensitivity analysis, 
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Figure 4.16 
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although three internal tertiles had similar predicted screening likelihood in all 
models of the main analysis. 
Predicted Screening Likelihood Depending on Cost-Sharing Categories for 
Aim 2 
In the Aim 2 analysis of the cost-sharing variable, Hispanic and non-Hispanic 
whites had distinct patterns of predicted screening likelihood over the cost-
sharing categories (Figure 4.17).  The pattern for non-Hispanic whites was 
consistent with the pattern observed in the Aim 1 analysis.  For Hispanic whites, 
the predicted screening likelihoods were less for the internal tertiles of the cost-
sharing distribution and for the no-spending group than for the same categories 
for non-Hispanic whites, while the ends of the cost-sharing distribution (0% cost-
sharing and the top fifth percentile of cost-sharing) had greater point estimates 
than the same categories for non-Hispanic whites.  The Aim 2 individual 
covariate block adjustments had similar effects as in the Aim 1 analyses.  For 
both Hispanic and non-Hispanic whites, the prevention history block model 
predicted noticeably higher screening likelihood for the no-spending group than 
was predicted in the unadjusted model.  For each Hispanic and non-Hispanic 
whites, the health care access block model predicted substantially increased 
screening likelihood for the top fifth percentile group and the no spending group 
than was predicted in the unadjusted model.  The Aim 2 fully adjusted and full 
reduced cost-sharing models (Figure 4.17b) changed the pattern of predicted 
screening likelihood in comparison to the unadjusted model similar to the change 
in the Aim 1 analyses.  The fully adjusted model balanced the predicted 
screening likelihoods across cost-sharing categories for both Hispanic and non-
Hispanic whites.  The full reduced model did not substantially change the pattern 
of predicted screening likelihoods compared to the unadjusted model. 
Because the Aim 2 cost-sharing analysis had a much smaller sample size than 
the Aim 1 analysis, confidence intervals are large for most estimates and it is not  
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Figure 4.17a 
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Figure 4.17b 
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Figure 4.17c 
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clear if Hispanic and non-Hispanic whites significantly differed in screening 
likelihood across cost-sharing categories.  Figure 4.17c reports the contrast tests 
for the difference between the predicted screening likelihoods for Hispanic and 
non-Hispanic whites in each cost-sharing category.  For the internal tertiles of the 
cost-sharing distribution, Hispanic whites consistently had significantly lower 
predicted screening likelihood than their non-Hispanic white counterparts in each 
tertile.  Differences between Hispanic and non-Hispanic whites for the other cost-
sharing categories were non-significant in all models except that in the fully 
adjusted model, Hispanics in the no spending category had 19.5% points 
significantly lower predicted screening likelihood than non-Hispanic whites.  
Hispanics with no spending in the survey year had lower predicted screening 
likelihood than non-Hispanics in all the other models, although the differences did 
not reach significance.  Although also never a significant difference, Hispanics in 
the top fifth percentile of cost-sharing category consistently had higher predicted 
screening likelihood than non-Hispanic whites in the top fifth percentile of cost-
sharing.  For the 0% cost-sharing category, Hispanic whites sometimes had 
higher and sometimes lower predicted screening likelihood than non-Hispanic 
whites.   
In total, these findings suggest that Hispanics with some cost-sharing (including 
most of the cost-sharing distribution) had decreased predicted screening 
likelihood than non-Hispanic whites with equivalent cost-sharing, although there 
are not differences in screening likelihood for Hispanic and non-Hispanic whites 
at the extremes of the cost-sharing distribution.  Hispanics with no spending likely 
have lower screening likelihood than their non-Hispanic white counterparts. 
Aim 2 Sensitivity Analysis Findings 
The Aim 2 sensitivity analysis findings for the cost-sharing variable overall exhibit 
very similar patterns to the main analysis of screening likelihood across the 
categories and between Hispanic and non-Hispanic whites (Figure 4.18).  Figure  
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Figure 4.18a 
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Figure 4.18b 
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Figure 4.18c 
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4.18c reports the contrast tests for the difference between the predicted 
likelihood of any screening in the previous year for Hispanic and non-Hispanic 
whites in each cost-sharing category.  The estimated differences are more 
positive across all models than in the main analysis and only Hispanics vs. non-
Hispanics in the third tertile of cost-sharing still had a consistent significant 
disparity in screening likelihood.  The difference consistently did not reach 
significance for the first tertile, and only reached significance in three of eight 
models for the second tertile, which included significant differences for the fully 
adjusted and full reduced models.  For the 0% cost-sharing category and the top 
fifth percentile, the differences are more favorable to Hispanics, although did not 
reach significance.  Hispanics may have higher predicted screening likelihood for 
screening in the previous year than non-Hispanic whites at the extremes of the 
cost-sharing distribution.  
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Chapter 5 
Discussion 
This section contains a discussion of key findings, limitations, policy issues, and 
the conclusion. 
 
Key Findings 
 
This study investigated the influence of a person’s health insurance features, 
including organizational and financial features, on whether they obtain CRC 
screening and whether there is a difference in insurance feature effects for 
Western US Hispanic whites vs. non-Hispanic whites.  The analyses found that 
the multiple insurance features studied predicted varying use of CRC screening, 
which suggests insurance design may have public health importance for CRC 
screening.  If insurance features even modestly affect CRC screening use, the 
population health implications would be large considering that more than 75 
million Americans are eligible for CRC screening and only around 60% of eligible 
persons are up-to-date with recommended CRC screening. To the best of my 
knowledge, this is the first study to assess these potential relationships, which is 
relevant to insurers’, providers’ and policymakers’ efforts to increase use of 
recommended CRC screening, a notably underused highly effective cancer 
screening, and is relevant to efforts to increase use of other preventive services.  
This section discusses the key findings for each analysis, relevant evidence from 
other studies, and implications of the findings.  Notable limitations and policy 
issues are discussed before concluding. 
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Aim 1 Organizational Insurance Features 
Two of the three organizational features (using gatekeeping and restricting 
coverage to a DPN) predicted significantly greater CRC screening in the 
previous-year in the sensitivity analyses after controlling for covariates, although 
none of the three features significantly predicted being up-to-date with 
recommended CRC screening in the main analyses.  The sensitivity analysis 
findings may support the hypothesis that an insurer will achieve greater 
screening use if they have a greater capacity to communicate appropriate CRC 
screening to providers and enrollees.  Whether a person had insurance with a 
DPN may not have been significant in both analyses because it did not 
substantially increase an insurer’s capacity to communicate appropriate 
screening, in contrast to the seemingly greater administrative controls of 
restricting coverage to a DPN and using gatekeeping.  The significant sensitivity 
analyses findings and non-significant main analyses findings supports the 
rationale for the sensitivity analyses: insurers may be less able or not able to 
influence being up-to-date with recommended screening because enrollees could 
be up-to-date with CRC screening due to having been screened prior to gaining 
their current insurance.  Overall, these findings indicate that certain 
organizational insurance features may support increasing use of CRC screening 
and that further research is needed particularly with study designs that are able 
to estimate a causal effect of the significant associations found here. 
The same organizational features were assessed in Tye et al.’s evaluation of 
insurance features as predictors of having received mammography in the 
previous two years using 1996 MEPS data.  Tye et al. found that women who 
had insurance with a DPN had a multivariate adjusted predicted probability of 
screening of 78%, in comparison to 75% for women with plans that did not have 
a DPN (OR: 1.21, 95% CI = 1.07-1.36).  Tye et al. also found that women whose 
insurance used gatekeeping had a multivariate adjusted predicted probability of 
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screening of 78% vs. 75% for women with insurance that did not use 
gatekeeping (OR: 1.18, 95% CI = 1.03-1.36).  No other health insurance features 
significantly predicted mammography use including whether coverage was 
restricted to a DPN, which was also assessed here, and several financial 
features that were not available to be evaluated in this study.  While the studies 
are not comparable in many ways (including outcomes, the year(s) of data and 
sample sizes, covariates controlled for, and eligibility criteria), Tye et al.’s 
significant findings for two organizational features are consistent with this study’s 
sensitivity analysis findings suggesting a potential modest positive influence of 
certain insurance organizational features on likelihood of having recently 
received cancer screening.   
Other studies provide evidence regarding the influence of types of insurance and 
features on use of CRC screening, although the findings are not easily 
comparable or relatable to this study’s findings.  Pertaining to types of insurance, 
HMOs have consistently achieved higher screening use than PPOs on the 
HEDIS CRC screening measure since they were first measured for both 
insurance types in 2005 (National Committee for Quality Assurance 2013), which 
may be partially attributable to favorable organizational features including the 
ones here that more commonly occur in HMOs than PPOs.  O’Malley et al. found 
that Medicare beneficiaries who had specialists available when the patient 
thought they were needed had a higher likelihood of recent CRC screening, 
which may be inconsistent with the positive effects for this study’s organizational 
features including using gatekeepers and restricting coverage to a DPN.  These 
conjectures comparing this study’s findings to other evidence reflect the 
fundamental difficulties that inhibit comparing and making connections between 
studies of insurance effects on CRC screening use and studies of insurance 
effects on health services use more generally.   
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Aim 1 Financial Insurance Features 
Regarding the Aim 1 findings for financial insurance features, the evaluated 
financial features (whether a person’s household had a FSA and categories of 
cost-sharing) had substantial unadjusted differences in predicted screening 
likelihood, which mostly did not remain significant in fully adjusted analyses.  
Whether a person had a FSA may have been a proxy for being health aware, 
since adjusting for the education and income covariate block and the prevention 
history block each pushed downward the estimated change in predicted 
screening likelihood due to having an FSA.  In order to have a FSA, the 
respondent or someone in the respondent’s household had to have been 
employed.  If people with a FSA were employed and therefore generally younger, 
this employment criterion may have biased downward the effect of having an 
FSA since younger people tend to have a lower screening likelihood and if being 
employed creates a barrier to a person having the time to seek CRC screening.  
Ultimately, whether a person has an FSA does not seem to be an independently 
significant predictor of CRC screening and it is not clear what proxy effects it 
represents. 
Cost-sharing levels may be proxies for adequacy of health care access and 
inclination to seek needed care, although may not be independently significant 
factors, since significant unadjusted differences for these variables were largely 
mitigated after adjusting for the prevention history and health care access 
covariate blocks.  The effect of categories of cost-sharing on use of CRC 
screening may be mediated by health care access factors (e.g. number of 
outpatient provider visits), so it may be inappropriate to include health care 
access factors as covariates in the model.  In addition, although dental checkup 
frequency or time of most recent flu shot would not seem to mediate the 
influence of cost-sharing on CRC screening use, those prevention history 
variables may be correlated with other factors on the causal pathway, which 
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would make it also inappropriate to control for the prevention history covariate 
block.  The Aim 1 sensitivity analysis for the cost-sharing categories was 
essentially equivalent to the main analysis findings.   
Notably, respondents with 0% cost-sharing had lower screening likelihood than 
respondents from the three internal tertiles of the cost-sharing distribution 
(greater than 0% and less than the 95th percentile).  When the distribution of 
cost-sharing values was broken up into 20 approximately equally populated 
quantiles (respondents with 0% cost-sharing are the first quantile), the finding 
remained: 0% cost-sharing had lower likelihood of screening than every quantile 
except the highest, 95th to 100th.  Even in comparison to respondents in the 
quantile with the smallest non-zero cost sharing (0.1-2.1%), who would be 
expected to be similar to the 0% subgroup, the 0% subgroup had substantially 
lower likelihood of being up-to-date with recommended screening, 54.0 vs. 
66.3%.   
A comparison of respondent characteristics revealed that the 0% and 0.1-2.1% 
cost-sharing subgroups were similar for many characteristics (socioeconomics, 
acculturation, the organizational health insurance features and some other health 
care access factors), although had notable differences.  The 0% subgroup was 
significantly >1.3 years younger, more male, more likely Hispanic or non-
Hispanic Black and was more likely from the Western Census region than the 
South or Midwest.  The 0% cost-sharing group was significantly healthier than 
the 0.1-2.1% cost-sharing subgroup across many health measures including 
having a lower rate of obesity, lower Charlson comorbidity index scores, better 
perceived health status and less personal non-CRC cancer history.  The 0% 
subgroup also had significantly lower health services utilization across multiple 
measures including having last received a flu shot further in the past, having 
fewer outpatient provider visits in the survey year, and being less likely to have a 
usual source of care.  Source of health insurance was similar except for the 0% 
cost-sharing subgroup had a larger composition of persons aged <65 years with 
any private insurance 42.5% vs. 36.0% in the 0.1-2.1% subgroup (although both 
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subgroups have a substantially smaller proportion of the subgroup aged <65 
years with private insurance than the full sample, 62.5%).   
The different characteristics in the 0% and 0.1-2.1% cost-sharing subgroups 
suggest that relatively good health and less interaction with the health care 
system result in the 0% subgroup avoiding out-of-pocket health care expenses 
and also not obtaining CRC screening.  The increased likelihood of CRC 
screening for someone with 0.1-2.1% cost-sharing could plausibly be the result of 
someone with 0% cost-sharing having a sudden health shock or electively 
deciding to seek care, and as a result, both incurring out-of-pocket costs and 
have increased probability of obtaining CRC screening due to increased 
interaction with the health care system.  
In total, the Aim 1 cost-sharing findings indicate further research is needed 
particularly with study designs that are able to eliminate residual confounding in 
order to estimate a causal effect of level of cost-sharing on CRC screening use.  
Cost-sharing categories may be a useful unadjusted proxy in other data sources 
such as administrative data that do not include detailed personal characteristics 
to adjust as covariates. 
Aim 2 Organizational Features 
The Aim 2 findings indicated that organizational insurance features might 
influence screening use differently for Hispanic whites than non-Hispanic whites 
in the Western US.  The main analyses found that having the organizational 
features predicted decreased or unchanged screening likelihood for non-Hispanic 
whites, while Hispanic whites had unchanged or increased predicted screening 
likelihood.  Hispanic whites had more positive effects of having an organizational 
insurance feature vs. not than non-Hispanic whites, and the differences of the 
effect for Hispanic whites minus the effect for non-Hispanic whites were usually 
significant, which suggests that some insurance features may contribute to 
reducing disparate screening among Hispanic whites.  In the Aim 2 sensitivity 
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analyses compared to the main analyses, Hispanics whites did not benefit as 
much due to having two of the organizational features (insurance with 
gatekeeping or coverage restricted to a DPN) in comparison to non-Hispanic 
whites, and the differences of the effect for Hispanic whites minus the effect for 
non-Hispanic whites were less likely to be significant in the sensitivity analysis, 
which suggests organizational features may affect reduced disparities in being 
up-to-date with recommended CRC screening although not reduce disparities for 
having been screened in the previous year.  In the Aim 2 sensitivity analysis, 
whether a person had a DPN equally predicted a reduced screening disparity for 
Hispanics in the sensitivity analysis as in the main analysis.  The Aim 2 main and 
sensitivity analysis findings largely agree and contradict the hypothesis that 
Hispanic whites would benefit less due to having the insurance features than 
non-Hispanic whites.  The organizational features may mitigate an access 
deficiency that is more of an issue for Hispanic whites than non-Hispanic whites 
(Singal 2013). 
Aim 2 Financial Insurance Features 
For the cost-sharing variable in the Aim 2 main analyses, non-Hispanic whites 
had a pattern of predicted screening likelihoods across the cost-sharing 
categories that was similar to the Aim 1 findings for the cost-sharing variable.  
Hispanic whites had a less varied pattern in a narrower range than non-Hispanic 
whites did.  Variation in predicted screening likelihood was essentially eliminated 
for Hispanic whites and largely mitigated for non-Hispanic whites in the fully-
adjusted model.  Hispanic whites in the internal tertiles of the cost-sharing 
distribution usually had significantly lower predicted screening likelihood than 
non-Hispanic whites by greater than 10% points in most models.  For those who 
had no spending in the survey year, those with 0% cost-sharing and those in the 
top fifth percentile of the cost-sharing distribution, Hispanic and non-Hispanic 
whites did not have significantly differing screening likelihood.  In the sensitivity 
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analysis, findings were similar although there were no longer significant 
differences for Hispanics vs. non-Hispanics in the first internal tertile of the cost-
sharing distribution.  There is not an obvious explanation for why cost-sharing 
categories predicted less variation in screening likelihood for Hispanic whites 
than non-Hispanic whites or why Hispanic whites in the internal tertiles of the 
cost-sharing distribution had lower predicted screening likelihood than non-
Hispanic whites.  Since there was not a significant difference for Hispanic whites 
vs. non-Hispanic whites among those who had no spending in the survey year, 
those with 0% cost-sharing and those in the top fifth percentile of the cost-
sharing distribution, the most disadvantaged Hispanic whites may not have 
disparate CRC screening use compared to their non-Hispanic white counterparts. 
 
Limitations 
 
The study has some notable limitations.  First, estimates of insurance feature 
effects may be biased by unobserved differences between those with and without 
the insurance features (i.e. residual confounding/endogeneity (Levy and Meltzer 
2008)) as is a potential threat in all cross-sectional studies of observational 
studies where the independent variable of interest is not known to vary randomly.  
By adjusting for a broad set of covariates in eight models for each analysis, this 
study made a substantial effort to mitigate residual confounding.  In addition, the 
threat of residual confounding may be small for the evaluated organizational 
insurance features because those administrative features would prima facie only 
weakly have any association with other personal characteristics that influence 
use of CRC screening including health care access factors and other 
predisposing and enabling factors.  On the other hand, the financial features, 
categories of cost-sharing and whether a person has an FSA, may more strongly 
reflect a person’s other health care access factors and other predisposing and 
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enabling factors, so the threat of residual confounding may be greater.  The 
range of estimates generated in each analysis provide valuable evidence 
regarding how certain clusters of covariates and larger groups of covariates were 
correlated with and influenced estimates of insurance feature effects. 
A study design that isolates the exogenous effect of insurance features on CRC 
screening use is needed to estimate an unbiased causal effect.  Suitable study 
designs could include a natural or quasi-experiment where some exogenous 
event results in variation in insurance coverage and suitable analyses are 
performed such as difference-in-difference estimation or instrumental variables, 
or could use a randomized controlled experiment where insurance features are 
randomly assigned to a sample.  Substantial challenges impede carrying out 
these study designs.  A natural experiment may be feasible in the context of a 
large employer that randomly varied insurance design for some of its employees, 
although such a study would likely exclude retired persons aged 65-75 who are 
eligible for CRC screening.  A state-level policy that constrained insurance 
design could possibly permit comparing those in the state to those in a 
neighboring state without the insurance design constraint, although again it may 
be unlikely such a situation would apply to those aged 65-75 who are almost 
completely federally insured by Medicare.  To date, the RAND Health Insurance 
Experiment (Manning 1987) and the Oregon Medicaid lottery (Baicker and 
Finkelstein 2011) are the only true social experiments where insurance plans 
were randomly allocated to individuals.  A true randomized experiment would be 
an expensive and in other ways resource-intensive undertaking, and it is highly 
unlikely that such an undertaking would be worthwhile solely to identify the 
effects of insurance features on CRC screening use.  It is possible that a larger 
experiment of insurance design could be worthwhile including CRC screening as 
one of several outcomes.  Future research should use natural and quasi-
experiments to generate evidence regarding insurance feature effects on use of 
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CRC screening and other health services, which would likely need to focus on 
either the 50-64 year age group or the 65-75 year age group considering the 
notable difference in insurance provision before and after Medicare eligibility. 
A second notable limitation is the data limitations of the evaluated insurance 
features including known inaccuracies in the MEPS source variables, how the 
variables were constructed in this study, and the features’ limited capacity to 
measure meaningful variation in insurance design.  The source MEPS managed 
care variables are known to be biased by respondent error in household-reported 
information, which, for instance, results in MEPS overestimating the number of 
persons in HMOs in comparison to estimates from industry sources (Agency for 
Healthcare Research and Quality 2013b).  In addition, a person’s insurance 
features reported in MEPS correspond to the last insurance held by a person, 
although the person could have had different insurance at an earlier point in the 
interview period.   
In addition to the limitations of MEPS’s source variables, the construction of the 
insurance features for this study has a potential for bias.  First, two of the 
organizational features, whether a person’s insurance had a DPN and whether a 
person’s insurance used gatekeeping, had overlapping definitions, since a 
person was identified as having either of those two features by having been 
enrolled in an HMO (either a private HMO or a Medicaid HMO) in addition to 
unique criteria for each variable using MEPS variables that directly asked if the 
respondent’s insurance used gatekeeping or if the respondents’ insurance 
defined a provider network.  The overlapping constructions mean that the two 
variables are partially evaluating the same effect of being enrolled in an HMO.  
There was also a limitation for the construction of the variable of whether a 
person’s insurance restricted coverage to a DPN as was noted in the Methods 
section.  MEPS only had specific information to construct the variable for persons 
with private insurance.  Medicare beneficiaries without any private insurance 
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(16.7% of the full Aim 1 sample) were assumed not to have coverage restricted 
to a DPN.  This assumption may be somewhat inaccurate.  Lower payment rates 
for Medicare than the commercial market inherently restricts coverage to a DPN, 
since Medicare beneficiaries can only see providers who are willing to accept 
those lower payment rates.  This issue may be more salient for some 
beneficiaries than others.  The local panel of providers who will see Medicare 
beneficiaries might be large and offer a large amount of provider choice in some 
places, but not others.  For instance, such a discrepancy may occur in urban vs. 
rural areas or suburban vs. inner city areas.  Last, as noted in the methods, those 
under age 65 with only public insurance were excluded from the analysis of 
whether a person’s insurance restricted coverage to a DPN.  A large portion of 
those under age 65 with only public insurance may have had restricted coverage 
by having Medicaid or other public insurance that is directly administered by 
managed care organizations or may have de facto restricted coverage to the 
providers that are willing to accept lower payment rates from public insurance.  
The aforementioned data construction limitations have a potential to bias the 
evaluated effects of the organizational insurance features and indicate a need for 
better information about insurance characteristics in publically available datasets. 
Last, the evaluated insurance features had limited capacity to measure 
meaningful variation in insurance design in several ways.  Insurance features 
were evaluated in this study rather than insurance types to avoid the problem of 
evaluating binary categorizations of health insurance types that are too general 
to have precise meaning and yield actionable evidence.  Ideally, features that 
directly pertained to use of CRC screening would have been studied although 
none were available.  Of the available measures, the organizational insurance 
features were very general with a breadth of possible meanings for each having 
a DPN, having gatekeeping insurance, and having insurance that restricted 
coverage to a DPN, so they suffer from the same problem as binary categories of 
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health insurance types.  The financial features are specific constructs related to a 
person’s health insurance and health care experience, although are only proxies 
for more suitable variables.  Whether or not a person has a FSA relates to a 
specific health savings account that is tied to employment, although persons may 
have other types of savings accounts for medical expenses.  Categories of cost-
sharing are a proxy for burden of health care expenses, although they do not 
specifically reflect cost-sharing for CRC screening.  Thus, the limited relevance of 
the evaluated insurance features also indicates a need for better information 
about insurance characteristics in publically available datasets. 
A third limitation is the accuracy of self-reported CRC screening history in MEPS, 
which may be inaccurate with respect to type of screening used and time since 
last screening.  Meta-analysis findings have found that cancer-screening 
prevalence estimates from national health surveys are likely overestimated and 
that differences in reporting accuracy between whites, blacks, and Hispanics 
likely bias estimates of disparities in screening use (Rauscher 2008).  The meta-
analysis findings suggested that Hispanics might tend to underreport CRC 
screening history while African Americans tend to over-report CRC screening 
history.  A key reason for over-reporting of CRC screening use for all 
respondents in study’s using survey data is non-response bias, since non-
responders are less likely to have been screened (Schneider 2008a).  Indeed, 
the aggregate estimate of the proportion of the population up-to-date with 
recommended CRC screening was 62.5% in this study for the full US population 
from 2009-2011.  That estimate is less than the estimate for the 2010 BRFSS 
(Joseph 2012), 64.5%, which has a lower response rate than MEPS, and is 
greater than the estimate for the 2010 NHIS (Shapiro 2012), 58.3%, which has a 
higher response rate than MEPS.  Another issue affecting the accuracy of self-
reported CRC screening history is question phrasing.  Comparing the EARTH 
study of an AIAN sample and the Alaska BRFSS, it was noted that question 
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phrasing might have contributed to overestimates of screening use in the Alaska 
BRFSS (Schumacher 2008).  The EARTH study asked respondents “how old 
were you at your last screening”, while BRFSS asks “how long has it been since 
your last test”, which people tend to underestimate, thereby making persons 
noted as up-to-date with screening when they were not.  MEPS uses the same 
phrasing as BRFSS.  National health surveys should strive to optimize response 
rates to yield accurate estimates of health services use and accurately estimate 
disparities. 
A fourth limitation is that the study does not explore varying use of the distinct 
CRC screening techniques.  In the summary of univariate counts and 
percentages (Table 4.1), the Aim 2 sample of Western US Hispanic and non-
Hispanic whites had lower use of colonoscopy within the past ten years than the 
Aim 1 sample 56.2 vs. 58.8%, higher use of FSIG in the past five year with FOBT 
in the past three years 5.1% vs. 2.7%, and higher use of FOBT in the previous 
year 16.7 vs. 12.2%.  Higher use of FSIG and FOBT resulted in the Aim 2 
sample having a higher percentage of respondents up-to-date with screening by 
any technique despite having a lower rate of colonoscopy, 63.3 vs. 62.5%.  The 
differences in screening by specific technique between the full US Aim 1 sample 
and the Western US Aim 2 sample suggest regional differences in screening 
preferences that are driven by the preferences of providers, of persons receiving 
screening, and of insurers.   
With respect to insurers’ preferences, if certain insurance features correlated with 
a preference for a particular screening technique, those preferences could 
influence estimates of aggregate screening use differently for the different 
screening outcomes in the main and sensitivity analyses.  Indeed, a previous 
study noted in the literature review found that Medicare managed care plans 
predicted greater FOBT use (Schneider 2008b).  Having each of the 
organizational insurance features did not significantly predict being up-to-date 
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with recommended screening in the fully adjusted main analyses, although If 
insurers having a certain organizational insurance feature corresponded with a 
greater preference for low cost FOBT, persons with insurance with the 
organizational feature would seem to have greater screening likelihood in the 
sensitivity analysis for the outcome of any screening in the previous year.  This 
situation could explain that discrepant significance between the Aim 1 main and 
sensitivity analysis findings for organizational insurance features.   
Differential preference for screening techniques may also potentially alter the 
influence of financial insurance features on the different outcomes in the main 
and sensitivity analyses.  Having an FSA had a reduced effect in the sensitivity 
analysis compared to the main analysis, which could reflect less preference for 
FOBT among FSA holders than non-holders.  For the cost-sharing categories, 
the main and sensitivity analysis findings are similar and do not suggest a 
differential preference for distinct screening techniques across the cost-sharing 
categories.  Future research could evaluate an alternative sensitivity analysis 
outcome of only colonoscopy in the previous year (in comparison to a main 
analysis of colonoscopy within the past ten years), which would eliminate the 
threat of bias due to a correlation between organizational insurance features and 
screening technique preference. 
Last, the study’s analytic strategy has notable limitations.  A repeated 
regressions approach with separate analyses for each insurance feature was 
employed in order to isolate effects of distinct insurance features, although that 
strategy does not reflect the reality of many insurance features operating 
simultaneously in concert.  In a study evaluating the effects of managed care 
characteristics on health services use among children with special healthcare 
needs, principal components analysis was used to cluster managed care 
characteristics into managed care indices, although the authors noted the 
limitation that the findings did not identify specific influential features (Shenkman 
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2003).  Ultimately, isolating insurance feature effects and modeling reality as fully 
as possible are opposing interests that it may not be possible to reconcile.  
Another important pair of analytic limitations was the decision not to conduct 
analyses stratified by gender and age.  Stratified analyses have shown that many 
covariates have different effects for females compared to males (Gonzales 
2012), which likely applies to this study and possible to the insurance feature 
effects.  Also, Medicare eligibility at age 65 meaningfully divides the population 
that is eligible for CRC screening, so stratified analyses of those aged 50-64 and 
those aged 65-75 would have likely yielded different covariate effects and 
possibly insurance feature effects.  In the interest of preserving sample size to 
permit modest insurance feature effects to be identified as significant, stratified 
analyses were not conducted.  As noted before, more rigorous natural and quasi-
experimental study designs of insurance features are needed.  Studies focusing 
on subpopulations or conducting stratified analyses may be necessary. 
 
Policy Issues 
 
CRC screening insurance coverage had a major change when the ACA 
mandated that private insurers cover all services recommended by the USPSTF 
with an “A” or “B” recommendation with zero cost-sharing, which includes CRC 
screening at guideline-consistent time intervals (Pollitz 2013).  Although the rule 
was implemented September 23, 2010, grandfathered plans were (and are still) 
not required to comply with the rule and patients supposedly in plans with the 
rule were (and are still) not assured a zero cost-sharing screening because 
certain circumstances negate the rule including screening for diagnostic 
purposes and screening that becomes therapeutic if a polyp is removed.  For 
Medicare beneficiaries as well, cost-sharing is not waived in the case that a polyp 
is removed.  Ultimately, full financial coverage for CRC screening is not assured 
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for either Medicare beneficiaries or privately insured persons and is uncertain 
before the procedure is completed.  Considering the highly invasive nature of the 
colonoscopy and FSIG procedures, gaps in insurance coverage and uncertainty 
about whether one’s insurer will waive cost-sharing mean that substantial 
financial barriers to CRC screening persist.  The potentially large expense of 
cost-sharing may inhibit people from receiving screening and particularly may 
dissuade low income persons from receiving screening and therefore widen 
disparities.  This barrier may be eliminated soon as existing legislation before 
Congress would truly eliminate cost-sharing for CRC screening <sup>122</sup>.  
In light of uncertainty about cost-sharing being waived, other aspects of 
insurance design are still relevant factors to study in order to understand the 
myriad influences on whether people receive CRC screening.  
 
Conclusion 
 
This study found that insurance features sometimes modestly predicted 
significantly varied use of CRC screening, which sometimes was mitigated by 
adjusting for covariates and depended on whether the outcome was being up-to-
date with recommended CRC screening or was having recently received CRC 
screening in the previous year.  In the analyses pertaining to the study’s first aim, 
the organizational insurance features did not predict significantly different 
likelihood of being up-to-date with recommended CRC screening in the main 
analyses, although in the sensitivity analyses, having insurance that used 
gatekeeping and having insurance that restricted coverage to a DPN each 
predicted a greater than 3% point increase in likelihood of having received CRC 
screening in the previous year.  For the financial features, effects for each having 
an FSA and categories of cost-sharing were each largely mitigated after 
adjusting for covariates, although such financial features may be valuable proxies 
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in other studies.  In the analyses pertaining to the study’s second aim, findings 
suggest that having each of the three organizational features predicted increased 
likelihood of being up-to-date with recommended screening for Hispanic whites, 
although did not change or decreased screening likelihood for non-Hispanic 
whites.  In total, the organizational insurance features may have the effect of 
reducing disparate screening use among Western US Hispanic whites.  In the 
Aim 2 sensitivity analysis, having insurance with a DPN suggested the same 
reduced disparity as in the main analysis, although for each having insurance 
that used gatekeeping and having insurance that restricted coverage to a DPN, 
the effect was smaller and less likely to be significant.  For the Aim 2 main and 
sensitivity analyses of cost-sharing, screening likelihood for Hispanic whites 
varied less than for non-Hispanic whites, and Hispanics whites had significantly 
lower screening likelihood than non-Hispanic whites for some cost-sharing 
categories. 
The findings of this study suggest a potentially meaningful, modest influence of 
specific insurance features on use of CRC screening although do not provide 
strong enough evidence to support any action by insurers or through policy to 
change insurance design in the interest of increasing CRC screening use.  
Sufficient evidence for such an administrative or policy change would require 
experimental evidence and in consideration of any change’s influence on use of 
other health services.  Modifying insurance design in a targeted way that is 
specific to CRC screening would probably be a better approach for specifically 
increasing CRC screening use.  MEPS has a limited offering of insurance 
features, so it was not possible to evaluate any features that pertained directly to 
CRC screening.  Despite that limitation, the modest predicted 3% point increase 
in predicted screening likelihood for some insurance features is still notable.  If 
such an insurance feature was adopted by the entire eligible population and 
increased screening use by a few percentage points, it could correspond to more 
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than a million additional persons having received screening and a substantial 
reduction in CRC incidence, morbidity, and mortality. 
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Appendix National Cancer Institute’s Cancer Topic Search for “Digestive 
System Cancer: Screening and Prevention” Modified to Exclude Non-
Colorectal Cancers 
(((digestive system neoplasms/prevention[majr] OR (digestive system 
neoplasms[mesh] AND (mass screening[mesh] OR preventive medicine[mesh] 
OR preventive health services[mesh] OR chemoprevention[mesh] OR cancer 
vaccines[mesh]))) AND human[mh] AND english[la]) OR ((intestine[ti] OR 
intestines[ti] OR intestinal[ti] OR bowel[ti] OR bowels[ti] OR duodenal[ti] OR 
duodenum[ti] OR ileal[ti] OR ileum[ti] OR jejunal[ti] OR jejunum[ti] OR 
colorectal[ti] OR colon[ti] OR colonic[ti] OR rectal[ti] OR rectum[ti] OR 
rectosigmoid[ti] OR anal[ti] OR anus[ti] OR perianal[ti]) AND (cancer*[ti] OR 
carcinoma*[ti] OR adenocarcinoma*[ti] OR malignan*[ti] OR tumor*[ti] OR 
tumour*[ti] OR neoplasm*[ti]) AND (prevention[ti] OR prevent[ti] OR screen[ti] OR 
screening[ti] OR chemoprevent*[ti] OR surveillance[ti]))) 
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